id	sid	tid	token	lemma	pos
aiua-9512	1	1	stesura	stesura	PROPN
aiua-9512	1	2	seveso	seveso	PROPN
aiua-9512	1	3	143archivio	143archivio	PROPN
aiua-9512	1	4	italiano	italiano	NOUN
aiua-9512	1	5	di	di	X
aiua-9512	1	6	urologia	urologia	PROPN
aiua-9512	1	7	e	e	PROPN
aiua-9512	1	8	andrologia	andrologia	NOUN
aiua-9512	1	9	2021	2021	NUM
aiua-9512	1	10	;	;	PUNCT
aiua-9512	1	11	93	93	NUM
aiua-9512	1	12	,	,	PUNCT
aiua-9512	1	13	2	2	NUM
aiua-9512	1	14	original	original	ADJ
aiua-9512	1	15	paper	paper	NOUN
aiua-9512	1	16	no	no	DET
aiua-9512	1	17	conflict	conflict	NOUN
aiua-9512	1	18	of	of	ADP
aiua-9512	1	19	interest	interest	NOUN
aiua-9512	1	20	declared	declare	VERB
aiua-9512	1	21	.	.	PUNCT
aiua-9512	2	1	tification	tification	NOUN
aiua-9512	2	2	of	of	ADP
aiua-9512	2	3	the	the	DET
aiua-9512	2	4	patients	patient	NOUN
aiua-9512	2	5	who	who	PRON
aiua-9512	2	6	will	will	AUX
aiua-9512	2	7	not	not	PART
aiua-9512	2	8	respond	respond	VERB
aiua-9512	2	9	to	to	ADP
aiua-9512	2	10	bcg	bcg	PROPN
aiua-9512	2	11	,	,	PUNCT
aiua-9512	2	12	in	in	ADP
aiua-9512	2	13	order	order	NOUN
aiua-9512	2	14	to	to	PART
aiua-9512	2	15	implement	implement	VERB
aiua-9512	2	16	an	an	DET
aiua-9512	2	17	aggressive	aggressive	ADJ
aiua-9512	2	18	therapy	therapy	NOUN
aiua-9512	2	19	,	,	PUNCT
aiua-9512	2	20	aiming	aim	VERB
aiua-9512	2	21	to	to	PART
aiua-9512	2	22	maximize	maximize	VERB
aiua-9512	2	23	the	the	DET
aiua-9512	2	24	clinical	clinical	ADJ
aiua-9512	2	25	benefit	benefit	NOUN
aiua-9512	2	26	,	,	PUNCT
aiua-9512	2	27	is	be	AUX
aiua-9512	2	28	clinically	clinically	ADV
aiua-9512	2	29	important	important	ADJ
aiua-9512	2	30	(	(	PUNCT
aiua-9512	2	31	4	4	NUM
aiua-9512	2	32	)	)	PUNCT
aiua-9512	2	33	.	.	PUNCT
aiua-9512	3	1	endothelin-1	endothelin-1	NOUN
aiua-9512	3	2	(	(	PUNCT
aiua-9512	3	3	et-1	et-1	X
aiua-9512	3	4	)	)	PUNCT
aiua-9512	3	5	is	be	AUX
aiua-9512	3	6	a	a	DET
aiua-9512	3	7	multifunctional	multifunctional	ADJ
aiua-9512	3	8	peptide	peptide	NOUN
aiua-9512	3	9	.	.	PUNCT
aiua-9512	3	10	et-1	et-1	PUNCT
aiua-9512	4	1	and	and	CCONJ
aiua-9512	4	2	its	its	PRON
aiua-9512	4	3	receptors	receptor	NOUN
aiua-9512	4	4	a	a	DET
aiua-9512	4	5	/	/	SYM
aiua-9512	4	6	etar	etar	NOUN
aiua-9512	4	7	and	and	CCONJ
aiua-9512	4	8	b	b	X
aiua-9512	4	9	/	/	SYM
aiua-9512	4	10	etbr	etbr	NOUN
aiua-9512	4	11	consist	consist	VERB
aiua-9512	4	12	the	the	DET
aiua-9512	4	13	endothelin	endothelin	NOUN
aiua-9512	4	14	-	-	PUNCT
aiua-9512	4	15	axis	axis	NOUN
aiua-9512	4	16	(	(	PUNCT
aiua-9512	4	17	et	et	NOUN
aiua-9512	4	18	axis	axis	NOUN
aiua-9512	4	19	)	)	PUNCT
aiua-9512	4	20	,	,	PUNCT
aiua-9512	4	21	which	which	PRON
aiua-9512	4	22	plays	play	VERB
aiua-9512	4	23	a	a	DET
aiua-9512	4	24	role	role	NOUN
aiua-9512	4	25	in	in	ADP
aiua-9512	4	26	cancer	cancer	NOUN
aiua-9512	4	27	biology	biology	NOUN
aiua-9512	4	28	.	.	PUNCT
aiua-9512	4	29	et-1	et-1	PUNCT
aiua-9512	5	1	stimulates	stimulate	VERB
aiua-9512	5	2	tumor	tumor	NOUN
aiua-9512	5	3	cell	cell	NOUN
aiua-9512	5	4	proliferation	proliferation	NOUN
aiua-9512	5	5	,	,	PUNCT
aiua-9512	5	6	facilitates	facilitate	VERB
aiua-9512	5	7	tumor	tumor	NOUN
aiua-9512	5	8	invasion	invasion	NOUN
aiua-9512	5	9	and	and	CCONJ
aiua-9512	5	10	metastasis	metastasis	PRON
aiua-9512	5	11	and	and	CCONJ
aiua-9512	5	12	has	have	VERB
aiua-9512	5	13	antiapoptotic	antiapoptotic	ADJ
aiua-9512	5	14	and	and	CCONJ
aiua-9512	5	15	neoangiogenic	neoangiogenic	ADJ
aiua-9512	5	16	effects	effect	NOUN
aiua-9512	5	17	(	(	PUNCT
aiua-9512	5	18	5	5	NUM
aiua-9512	5	19	)	)	PUNCT
aiua-9512	5	20	.	.	PUNCT
aiua-9512	6	1	etar	etar	PROPN
aiua-9512	6	2	associates	associate	NOUN
aiua-9512	6	3	with	with	ADP
aiua-9512	6	4	tumor	tumor	NOUN
aiua-9512	6	5	-	-	PUNCT
aiua-9512	6	6	cell	cell	NOUN
aiua-9512	6	7	proliferation	proliferation	NOUN
aiua-9512	6	8	and	and	CCONJ
aiua-9512	6	9	tumor	tumor	NOUN
aiua-9512	6	10	progression	progression	NOUN
aiua-9512	6	11	,	,	PUNCT
aiua-9512	6	12	inhibition	inhibition	NOUN
aiua-9512	6	13	of	of	ADP
aiua-9512	6	14	apoptosis	apoptosis	NOUN
aiua-9512	6	15	,	,	PUNCT
aiua-9512	6	16	effects	effect	NOUN
aiua-9512	6	17	on	on	ADP
aiua-9512	6	18	bone	bone	NOUN
aiua-9512	6	19	matrix	matrix	NOUN
aiua-9512	6	20	,	,	PUNCT
aiua-9512	6	21	production	production	NOUN
aiua-9512	6	22	of	of	ADP
aiua-9512	6	23	vascular	vascular	ADJ
aiua-9512	6	24	endothelial	endothelial	ADJ
aiua-9512	6	25	growth	growth	NOUN
aiua-9512	6	26	factor	factor	NOUN
aiua-9512	6	27	(	(	PUNCT
aiua-9512	6	28	vegf	vegf	PROPN
aiua-9512	6	29	)	)	PUNCT
aiua-9512	6	30	leading	lead	VERB
aiua-9512	6	31	to	to	ADP
aiua-9512	6	32	endothelial	endothelial	ADJ
aiua-9512	6	33	cell	cell	NOUN
aiua-9512	6	34	proliferation	proliferation	NOUN
aiua-9512	6	35	and	and	CCONJ
aiua-9512	6	36	vascular	vascular	ADJ
aiua-9512	6	37	permeability	permeability	NOUN
aiua-9512	6	38	,	,	PUNCT
aiua-9512	6	39	by	by	ADP
aiua-9512	6	40	increasing	increase	VERB
aiua-9512	6	41	the	the	DET
aiua-9512	6	42	levels	level	NOUN
aiua-9512	6	43	of	of	ADP
aiua-9512	6	44	hypoxia	hypoxia	NOUN
aiua-9512	6	45	-	-	PUNCT
aiua-9512	6	46	inducible	inducible	ADJ
aiua-9512	6	47	factor1a	factor1a	PROPN
aiua-9512	6	48	/	/	SYM
aiua-9512	6	49	hif-1a	hif-1a	NOUN
aiua-9512	6	50	(	(	PUNCT
aiua-9512	6	51	5	5	NUM
aiua-9512	6	52	)	)	PUNCT
aiua-9512	6	53	.	.	PUNCT
aiua-9512	7	1	etbr	etbr	NOUN
aiua-9512	7	2	inducts	induct	VERB
aiua-9512	7	3	proliferation	proliferation	NOUN
aiua-9512	7	4	of	of	ADP
aiua-9512	7	5	endothelial	endothelial	ADJ
aiua-9512	7	6	cells	cell	NOUN
aiua-9512	7	7	and	and	CCONJ
aiua-9512	7	8	migration	migration	NOUN
aiua-9512	7	9	(	(	PUNCT
aiua-9512	7	10	5	5	NUM
aiua-9512	7	11	)	)	PUNCT
aiua-9512	7	12	.	.	PUNCT
aiua-9512	8	1	our	our	PRON
aiua-9512	8	2	purpose	purpose	NOUN
aiua-9512	8	3	is	be	AUX
aiua-9512	8	4	to	to	PART
aiua-9512	8	5	conduct	conduct	VERB
aiua-9512	8	6	a	a	DET
aiua-9512	8	7	prospective	prospective	ADJ
aiua-9512	8	8	study	study	NOUN
aiua-9512	8	9	of	of	ADP
aiua-9512	8	10	the	the	DET
aiua-9512	8	11	potential	potential	ADJ
aiua-9512	8	12	prognostic	prognostic	ADJ
aiua-9512	8	13	significance	significance	NOUN
aiua-9512	8	14	of	of	ADP
aiua-9512	8	15	et-1	et-1	NUM
aiua-9512	8	16	in	in	ADP
aiua-9512	8	17	a	a	DET
aiua-9512	8	18	cohort	cohort	NOUN
aiua-9512	8	19	of	of	ADP
aiua-9512	8	20	primary	primary	ADJ
aiua-9512	8	21	hgnmiubc	hgnmiubc	NOUN
aiua-9512	8	22	patients	patient	NOUN
aiua-9512	8	23	who	who	PRON
aiua-9512	8	24	were	be	AUX
aiua-9512	8	25	treated	treat	VERB
aiua-9512	8	26	postoperatively	postoperatively	ADV
aiua-9512	8	27	with	with	ADP
aiua-9512	8	28	bcg	bcg	PROPN
aiua-9512	8	29	(	(	PUNCT
aiua-9512	8	30	induction	induction	NOUN
aiua-9512	8	31	as	as	ADV
aiua-9512	8	32	well	well	ADV
aiua-9512	8	33	as	as	ADP
aiua-9512	8	34	maintenance	maintenance	NOUN
aiua-9512	8	35	)	)	PUNCT
aiua-9512	8	36	.	.	PUNCT
aiua-9512	9	1	material	material	NOUN
aiua-9512	9	2	and	and	CCONJ
aiua-9512	9	3	methods	method	NOUN
aiua-9512	9	4	we	we	PRON
aiua-9512	9	5	prospectively	prospectively	ADV
aiua-9512	9	6	included	include	VERB
aiua-9512	9	7	patients	patient	NOUN
aiua-9512	9	8	with	with	ADP
aiua-9512	9	9	transurethrally	transurethrally	ADV
aiua-9512	9	10	(	(	PUNCT
aiua-9512	9	11	tur	tur	INTJ
aiua-9512	9	12	)	)	PUNCT
aiua-9512	9	13	resected	resect	VERB
aiua-9512	9	14	,	,	PUNCT
aiua-9512	9	15	primary	primary	ADJ
aiua-9512	9	16	(	(	PUNCT
aiua-9512	9	17	single	single	ADJ
aiua-9512	9	18	or	or	CCONJ
aiua-9512	9	19	multiple	multiple	ADJ
aiua-9512	9	20	)	)	PUNCT
aiua-9512	9	21	,	,	PUNCT
aiua-9512	9	22	non	non	ADJ
aiua-9512	9	23	-	-	ADJ
aiua-9512	9	24	muscle	muscle	ADJ
aiua-9512	9	25	-	-	PUNCT
aiua-9512	9	26	invasive	invasive	ADJ
aiua-9512	9	27	,	,	PUNCT
aiua-9512	9	28	high	high	ADJ
aiua-9512	9	29	-	-	PUNCT
aiua-9512	9	30	grade	grade	NOUN
aiua-9512	9	31	,	,	PUNCT
aiua-9512	9	32	urothelial	urothelial	ADJ
aiua-9512	9	33	carcinoma	carcinoma	NOUN
aiua-9512	9	34	of	of	ADP
aiua-9512	9	35	the	the	DET
aiua-9512	9	36	urinary	urinary	ADJ
aiua-9512	9	37	bladder	bladder	NOUN
aiua-9512	9	38	.	.	PUNCT
aiua-9512	10	1	the	the	DET
aiua-9512	10	2	follow	follow	VERB
aiua-9512	10	3	-	-	PUNCT
aiua-9512	10	4	up	up	NOUN
aiua-9512	10	5	period	period	NOUN
aiua-9512	10	6	started	start	VERB
aiua-9512	10	7	on	on	ADP
aiua-9512	10	8	the	the	DET
aiua-9512	10	9	day	day	NOUN
aiua-9512	10	10	of	of	ADP
aiua-9512	10	11	the	the	DET
aiua-9512	10	12	first	first	ADJ
aiua-9512	10	13	postoperative	postoperative	ADJ
aiua-9512	10	14	follow	follow	NOUN
aiua-9512	10	15	-	-	PUNCT
aiua-9512	10	16	up	up	ADP
aiua-9512	10	17	cystoscopy	cystoscopy	NOUN
aiua-9512	10	18	(	(	PUNCT
aiua-9512	10	19	at	at	ADP
aiua-9512	10	20	3	3	NUM
aiua-9512	10	21	months	month	NOUN
aiua-9512	10	22	after	after	ADP
aiua-9512	10	23	the	the	DET
aiua-9512	10	24	original	original	ADJ
aiua-9512	10	25	endoscopic	endoscopic	ADJ
aiua-9512	10	26	surgery	surgery	NOUN
aiua-9512	10	27	)	)	PUNCT
aiua-9512	10	28	.	.	PUNCT
aiua-9512	11	1	exclusion	exclusion	NOUN
aiua-9512	11	2	criteria	criterion	NOUN
aiua-9512	11	3	were	be	AUX
aiua-9512	11	4	:	:	PUNCT
aiua-9512	11	5	present	present	ADJ
aiua-9512	11	6	or	or	CCONJ
aiua-9512	11	7	previous	previous	ADJ
aiua-9512	11	8	upper	upper	ADJ
aiua-9512	11	9	urinary	urinary	ADJ
aiua-9512	11	10	tract	tract	NOUN
aiua-9512	11	11	carcinoma	carcinoma	NOUN
aiua-9512	11	12	and	and	CCONJ
aiua-9512	11	13	muscle	muscle	NOUN
aiua-9512	11	14	-	-	PUNCT
aiua-9512	11	15	invasive	invasive	ADJ
aiua-9512	11	16	disease	disease	NOUN
aiua-9512	11	17	.	.	PUNCT
aiua-9512	12	1	the	the	DET
aiua-9512	12	2	patients	patient	NOUN
aiua-9512	12	3	received	receive	VERB
aiua-9512	12	4	a	a	DET
aiua-9512	12	5	single	single	ADJ
aiua-9512	12	6	immediate	immediate	ADJ
aiua-9512	12	7	postoperative	postoperative	ADJ
aiua-9512	12	8	intravesical	intravesical	ADJ
aiua-9512	12	9	instillation	instillation	NOUN
aiua-9512	12	10	of	of	ADP
aiua-9512	12	11	chemotherapy	chemotherapy	NOUN
aiua-9512	12	12	(	(	PUNCT
aiua-9512	12	13	epirubicin	epirubicin	VERB
aiua-9512	12	14	50	50	NUM
aiua-9512	12	15	mg	mg	NOUN
aiua-9512	12	16	)	)	PUNCT
aiua-9512	12	17	,	,	PUNCT
aiua-9512	12	18	if	if	SCONJ
aiua-9512	12	19	there	there	PRON
aiua-9512	12	20	was	be	VERB
aiua-9512	12	21	no	no	DET
aiua-9512	12	22	contraindication	contraindication	NOUN
aiua-9512	12	23	.	.	PUNCT
aiua-9512	13	1	random	random	ADJ
aiua-9512	13	2	biopsies	biopsy	NOUN
aiua-9512	13	3	of	of	ADP
aiua-9512	13	4	the	the	DET
aiua-9512	13	5	bladder	bladder	NOUN
aiua-9512	13	6	were	be	AUX
aiua-9512	13	7	performed	perform	VERB
aiua-9512	13	8	,	,	PUNCT
aiua-9512	13	9	if	if	SCONJ
aiua-9512	13	10	there	there	PRON
aiua-9512	13	11	was	be	VERB
aiua-9512	13	12	a	a	DET
aiua-9512	13	13	suspicion	suspicion	NOUN
aiua-9512	13	14	of	of	ADP
aiua-9512	13	15	carcinoma	carcinoma	NOUN
aiua-9512	13	16	in	in	ADP
aiua-9512	13	17	situ	situ	PROPN
aiua-9512	13	18	(	(	PUNCT
aiua-9512	13	19	tis	tis	PROPN
aiua-9512	13	20	)	)	PUNCT
aiua-9512	13	21	.	.	PUNCT
aiua-9512	14	1	whenever	whenever	SCONJ
aiua-9512	14	2	necessary	necessary	ADJ
aiua-9512	14	3	(	(	PUNCT
aiua-9512	14	4	cases	case	NOUN
aiua-9512	14	5	of	of	ADP
aiua-9512	14	6	incomplete	incomplete	ADJ
aiua-9512	14	7	resection	resection	NOUN
aiua-9512	14	8	or	or	CCONJ
aiua-9512	14	9	biopsy	biopsy	NOUN
aiua-9512	14	10	material	material	NOUN
aiua-9512	14	11	without	without	ADP
aiua-9512	14	12	muscle	muscle	NOUN
aiua-9512	14	13	fibers	fiber	NOUN
aiua-9512	14	14	)	)	PUNCT
aiua-9512	14	15	,	,	PUNCT
aiua-9512	14	16	a	a	DET
aiua-9512	14	17	tur	tur	X
aiua-9512	14	18	was	be	AUX
aiua-9512	14	19	repeated	repeat	VERB
aiua-9512	14	20	within	within	ADP
aiua-9512	14	21	6	6	NUM
aiua-9512	14	22	weeks	week	NOUN
aiua-9512	14	23	.	.	PUNCT
aiua-9512	15	1	all	all	DET
aiua-9512	15	2	patients	patient	NOUN
aiua-9512	15	3	received	receive	VERB
aiua-9512	15	4	an	an	DET
aiua-9512	15	5	induction	induction	NOUN
aiua-9512	15	6	(	(	PUNCT
aiua-9512	15	7	6	6	NUM
aiua-9512	15	8	weekly	weekly	ADJ
aiua-9512	15	9	intravesical	intravesical	ADJ
aiua-9512	15	10	bcg	bcg	PROPN
aiua-9512	15	11	instillations	instillation	NOUN
aiua-9512	15	12	)	)	PUNCT
aiua-9512	15	13	as	as	ADV
aiua-9512	15	14	well	well	ADV
aiua-9512	15	15	as	as	ADP
aiua-9512	15	16	a	a	DET
aiua-9512	15	17	3	3	NUM
aiua-9512	15	18	-	-	PUNCT
aiua-9512	15	19	year	year	NOUN
aiua-9512	15	20	maintenance	maintenance	NOUN
aiua-9512	15	21	bcg	bcg	NOUN
aiua-9512	15	22	therapy	therapy	NOUN
aiua-9512	15	23	(	(	PUNCT
aiua-9512	15	24	6	6	NUM
aiua-9512	15	25	)	)	PUNCT
aiua-9512	15	26	.	.	PUNCT
aiua-9512	16	1	the	the	DET
aiua-9512	16	2	follow	follow	NOUN
aiua-9512	16	3	-	-	PUNCT
aiua-9512	16	4	up	up	NOUN
aiua-9512	16	5	was	be	AUX
aiua-9512	16	6	based	base	VERB
aiua-9512	16	7	on	on	ADP
aiua-9512	16	8	the	the	DET
aiua-9512	16	9	guidelines	guideline	NOUN
aiua-9512	16	10	for	for	ADP
aiua-9512	16	11	“	"	PUNCT
aiua-9512	16	12	non	non	ADJ
aiua-9512	16	13	-	-	ADJ
aiua-9512	16	14	muscle	muscle	ADJ
aiua-9512	16	15	-	-	PUNCT
aiua-9512	16	16	invasive	invasive	ADJ
aiua-9512	16	17	bladder	bladder	NOUN
aiua-9512	16	18	cancer	cancer	NOUN
aiua-9512	16	19	”	"	PUNCT
aiua-9512	16	20	by	by	ADP
aiua-9512	16	21	the	the	DET
aiua-9512	16	22	european	european	ADJ
aiua-9512	16	23	objective	objective	NOUN
aiua-9512	16	24	:	:	PUNCT
aiua-9512	16	25	to	to	PART
aiua-9512	16	26	conduct	conduct	VERB
aiua-9512	16	27	a	a	DET
aiua-9512	16	28	prospective	prospective	ADJ
aiua-9512	16	29	study	study	NOUN
aiua-9512	16	30	of	of	ADP
aiua-9512	16	31	the	the	DET
aiua-9512	16	32	potential	potential	ADJ
aiua-9512	16	33	prognostic	prognostic	ADJ
aiua-9512	16	34	role	role	NOUN
aiua-9512	16	35	of	of	ADP
aiua-9512	16	36	endothelin-1	endothelin-1	PROPN
aiua-9512	16	37	(	(	PUNCT
aiua-9512	16	38	et-1	et-1	X
aiua-9512	16	39	)	)	PUNCT
aiua-9512	16	40	in	in	ADP
aiua-9512	16	41	a	a	DET
aiua-9512	16	42	cohort	cohort	NOUN
aiua-9512	16	43	of	of	ADP
aiua-9512	16	44	primary	primary	ADJ
aiua-9512	16	45	high	high	ADJ
aiua-9512	16	46	-	-	PUNCT
aiua-9512	16	47	grade	grade	NOUN
aiua-9512	16	48	non	non	ADJ
aiua-9512	16	49	-	-	ADJ
aiua-9512	16	50	muscle	muscle	ADJ
aiua-9512	16	51	-	-	PUNCT
aiua-9512	16	52	invasive	invasive	ADJ
aiua-9512	16	53	urothelial	urothelial	ADJ
aiua-9512	16	54	bladder	bladder	NOUN
aiua-9512	16	55	cancer	cancer	NOUN
aiua-9512	16	56	patients	patient	NOUN
aiua-9512	16	57	,	,	PUNCT
aiua-9512	16	58	who	who	PRON
aiua-9512	16	59	were	be	AUX
aiua-9512	16	60	treated	treat	VERB
aiua-9512	16	61	with	with	ADP
aiua-9512	16	62	adjuvant	adjuvant	ADJ
aiua-9512	16	63	intravesical	intravesical	ADJ
aiua-9512	16	64	bacillus	bacillus	NOUN
aiua-9512	16	65	calmette	calmette	NOUN
aiua-9512	16	66	-	-	PUNCT
aiua-9512	16	67	guérin	guérin	PROPN
aiua-9512	16	68	(	(	PUNCT
aiua-9512	16	69	bcg	bcg	PROPN
aiua-9512	16	70	)	)	PUNCT
aiua-9512	16	71	.	.	PUNCT
aiua-9512	17	1	material	material	NOUN
aiua-9512	17	2	and	and	CCONJ
aiua-9512	17	3	methods	method	NOUN
aiua-9512	17	4	:	:	PUNCT
aiua-9512	17	5	patients	patient	NOUN
aiua-9512	17	6	with	with	ADP
aiua-9512	17	7	primary	primary	ADJ
aiua-9512	17	8	high	high	ADJ
aiua-9512	17	9	-	-	PUNCT
aiua-9512	17	10	grade	grade	NOUN
aiua-9512	17	11	nonmuscle	nonmuscle	NOUN
aiua-9512	17	12	-	-	PUNCT
aiua-9512	17	13	invasive	invasive	ADJ
aiua-9512	17	14	urothelial	urothelial	ADJ
aiua-9512	17	15	bladder	bladder	NOUN
aiua-9512	17	16	cancer	cancer	NOUN
aiua-9512	17	17	,	,	PUNCT
aiua-9512	17	18	who	who	PRON
aiua-9512	17	19	received	receive	VERB
aiua-9512	17	20	postoperatively	postoperatively	ADJ
aiua-9512	17	21	induction	induction	NOUN
aiua-9512	17	22	and	and	CCONJ
aiua-9512	17	23	maintenance	maintenance	NOUN
aiua-9512	17	24	bcg	bcg	NOUN
aiua-9512	17	25	therapy	therapy	NOUN
aiua-9512	17	26	,	,	PUNCT
aiua-9512	17	27	were	be	AUX
aiua-9512	17	28	prospectively	prospectively	ADV
aiua-9512	17	29	included	include	VERB
aiua-9512	17	30	.	.	PUNCT
aiua-9512	18	1	recurrence	recurrence	NOUN
aiua-9512	18	2	and	and	CCONJ
aiua-9512	18	3	progression	progression	NOUN
aiua-9512	18	4	were	be	AUX
aiua-9512	18	5	histologically	histologically	ADV
aiua-9512	18	6	proven	prove	VERB
aiua-9512	18	7	.	.	PUNCT
aiua-9512	19	1	immunohistochemical	immunohistochemical	ADJ
aiua-9512	19	2	staining	stain	VERB
aiua-9512	19	3	for	for	ADP
aiua-9512	19	4	et-1	et-1	NUM
aiua-9512	19	5	was	be	AUX
aiua-9512	19	6	assessed	assess	VERB
aiua-9512	19	7	.	.	PUNCT
aiua-9512	20	1	epidemiological	epidemiological	ADJ
aiua-9512	20	2	,	,	PUNCT
aiua-9512	20	3	pathological	pathological	ADJ
aiua-9512	20	4	and	and	CCONJ
aiua-9512	20	5	clinical	clinical	ADJ
aiua-9512	20	6	parameters	parameter	NOUN
aiua-9512	20	7	as	as	ADV
aiua-9512	20	8	well	well	ADV
aiua-9512	20	9	as	as	ADP
aiua-9512	20	10	the	the	DET
aiua-9512	20	11	expression	expression	NOUN
aiua-9512	20	12	of	of	ADP
aiua-9512	20	13	et-1	et-1	NUM
aiua-9512	20	14	in	in	ADP
aiua-9512	20	15	tumor	tumor	NOUN
aiua-9512	20	16	specimens	specimen	NOUN
aiua-9512	20	17	were	be	AUX
aiua-9512	20	18	statistically	statistically	ADV
aiua-9512	20	19	analyzed	analyze	VERB
aiua-9512	20	20	for	for	ADP
aiua-9512	20	21	recurrence	recurrence	NOUN
aiua-9512	20	22	,	,	PUNCT
aiua-9512	20	23	progression	progression	NOUN
aiua-9512	20	24	,	,	PUNCT
aiua-9512	20	25	recurrence	recurrence	NOUN
aiua-9512	20	26	-	-	PUNCT
aiua-9512	20	27	free	free	ADJ
aiua-9512	20	28	survival	survival	NOUN
aiua-9512	20	29	(	(	PUNCT
aiua-9512	20	30	rfs	rfs	PROPN
aiua-9512	20	31	)	)	PUNCT
aiua-9512	20	32	and	and	CCONJ
aiua-9512	20	33	progression	progression	NOUN
aiua-9512	20	34	-	-	PUNCT
aiua-9512	20	35	free	free	ADJ
aiua-9512	20	36	survival	survival	NOUN
aiua-9512	20	37	(	(	PUNCT
aiua-9512	20	38	pfs	pfs	PROPN
aiua-9512	20	39	)	)	PUNCT
aiua-9512	20	40	.	.	PUNCT
aiua-9512	21	1	results	result	NOUN
aiua-9512	21	2	:	:	PUNCT
aiua-9512	21	3	et-1	et-1	X
aiua-9512	21	4	associates	associate	NOUN
aiua-9512	21	5	significantly	significantly	ADV
aiua-9512	21	6	with	with	ADP
aiua-9512	21	7	recurrence	recurrence	NOUN
aiua-9512	21	8	(	(	PUNCT
aiua-9512	21	9	p	p	X
aiua-9512	21	10	=	=	NOUN
aiua-9512	21	11	0.000	0.000	NUM
aiua-9512	21	12	)	)	PUNCT
aiua-9512	21	13	,	,	PUNCT
aiua-9512	21	14	progression	progression	NOUN
aiua-9512	21	15	(	(	PUNCT
aiua-9512	21	16	p	p	X
aiua-9512	21	17	=	=	NOUN
aiua-9512	21	18	0.000	0.000	NUM
aiua-9512	21	19	)	)	PUNCT
aiua-9512	21	20	,	,	PUNCT
aiua-9512	21	21	rfs	rfs	X
aiua-9512	21	22	(	(	PUNCT
aiua-9512	21	23	p	p	X
aiua-9512	21	24	=	=	NOUN
aiua-9512	21	25	0.000	0.000	NUM
aiua-9512	21	26	)	)	PUNCT
aiua-9512	21	27	and	and	CCONJ
aiua-9512	21	28	pfs	pfs	PROPN
aiua-9512	21	29	(	(	PUNCT
aiua-9512	21	30	p	p	X
aiua-9512	21	31	=	=	NOUN
aiua-9512	21	32	0.000	0.000	NUM
aiua-9512	21	33	)	)	PUNCT
aiua-9512	21	34	.	.	PUNCT
aiua-9512	22	1	the	the	DET
aiua-9512	22	2	patient	patient	NOUN
aiua-9512	22	3	’s	’s	PART
aiua-9512	22	4	age	age	NOUN
aiua-9512	22	5	is	be	AUX
aiua-9512	22	6	also	also	ADV
aiua-9512	22	7	significant	significant	ADJ
aiua-9512	22	8	for	for	ADP
aiua-9512	22	9	recurrence	recurrence	NOUN
aiua-9512	22	10	(	(	PUNCT
aiua-9512	22	11	p	p	X
aiua-9512	22	12	=	=	NOUN
aiua-9512	22	13	0.003	0.003	NUM
aiua-9512	22	14	,	,	PUNCT
aiua-9512	22	15	or	or	CCONJ
aiua-9512	22	16	=	=	NOUN
aiua-9512	22	17	1.273	1.273	NUM
aiua-9512	22	18	95	95	NUM
aiua-9512	22	19	%	%	NOUN
aiua-9512	22	20	ci	ci	NOUN
aiua-9512	22	21	:	:	PUNCT
aiua-9512	22	22	1.086	1.086	NUM
aiua-9512	22	23	-	-	SYM
aiua-9512	22	24	1.492	1.492	NUM
aiua-9512	22	25	)	)	PUNCT
aiua-9512	22	26	and	and	CCONJ
aiua-9512	22	27	rfs	rfs	X
aiua-9512	22	28	(	(	PUNCT
aiua-9512	22	29	p	p	X
aiua-9512	22	30	=	=	NOUN
aiua-9512	22	31	0.013	0.013	NUM
aiua-9512	22	32	)	)	PUNCT
aiua-9512	22	33	.	.	PUNCT
aiua-9512	23	1	conclusions	conclusion	NOUN
aiua-9512	23	2	:	:	PUNCT
aiua-9512	23	3	et-1	et-1	NUM
aiua-9512	23	4	seems	seem	VERB
aiua-9512	23	5	to	to	PART
aiua-9512	23	6	deteriorate	deteriorate	VERB
aiua-9512	23	7	prognosis	prognosis	NOUN
aiua-9512	23	8	in	in	ADP
aiua-9512	23	9	patients	patient	NOUN
aiua-9512	23	10	suffering	suffer	VERB
aiua-9512	23	11	from	from	ADP
aiua-9512	23	12	primary	primary	ADJ
aiua-9512	23	13	high	high	ADJ
aiua-9512	23	14	-	-	PUNCT
aiua-9512	23	15	grade	grade	NOUN
aiua-9512	23	16	non	non	ADJ
aiua-9512	23	17	-	-	ADJ
aiua-9512	23	18	muscle	muscle	ADJ
aiua-9512	23	19	-	-	PUNCT
aiua-9512	23	20	invasive	invasive	ADJ
aiua-9512	23	21	urothelial	urothelial	ADJ
aiua-9512	23	22	bladder	bladder	NOUN
aiua-9512	23	23	cancer	cancer	NOUN
aiua-9512	23	24	,	,	PUNCT
aiua-9512	23	25	who	who	PRON
aiua-9512	23	26	are	be	AUX
aiua-9512	23	27	treated	treat	VERB
aiua-9512	23	28	with	with	ADP
aiua-9512	23	29	adjuvant	adjuvant	ADJ
aiua-9512	23	30	bcg	bcg	PROPN
aiua-9512	23	31	instillations	instillation	NOUN
aiua-9512	23	32	.	.	PUNCT
aiua-9512	24	1	furthermore	furthermore	ADV
aiua-9512	24	2	,	,	PUNCT
aiua-9512	24	3	the	the	DET
aiua-9512	24	4	patient	patient	NOUN
aiua-9512	24	5	’s	’s	PART
aiua-9512	24	6	age	age	NOUN
aiua-9512	24	7	associates	associate	NOUN
aiua-9512	24	8	with	with	ADP
aiua-9512	24	9	an	an	DET
aiua-9512	24	10	increased	increase	VERB
aiua-9512	24	11	likelihood	likelihood	NOUN
aiua-9512	24	12	for	for	ADP
aiua-9512	24	13	recurrence	recurrence	NOUN
aiua-9512	24	14	.	.	PUNCT
aiua-9512	25	1	key	key	ADJ
aiua-9512	25	2	words	word	NOUN
aiua-9512	25	3	:	:	PUNCT
aiua-9512	25	4	et-1	et-1	NUM
aiua-9512	25	5	;	;	PUNCT
aiua-9512	25	6	high	high	ADJ
aiua-9512	25	7	-	-	PUNCT
aiua-9512	25	8	grade	grade	NOUN
aiua-9512	25	9	;	;	PUNCT
aiua-9512	25	10	non	non	ADJ
aiua-9512	25	11	-	-	ADJ
aiua-9512	25	12	muscle	muscle	ADJ
aiua-9512	25	13	-	-	PUNCT
aiua-9512	25	14	invasive	invasive	ADJ
aiua-9512	25	15	bladder	bladder	NOUN
aiua-9512	25	16	cancer	cancer	NOUN
aiua-9512	25	17	;	;	PUNCT
aiua-9512	25	18	prognosis	prognosis	NOUN
aiua-9512	25	19	.	.	PUNCT
aiua-9512	25	20	submitted	submit	VERB
aiua-9512	25	21	17	17	NUM
aiua-9512	25	22	november	november	PROPN
aiua-9512	25	23	2020	2020	NUM
aiua-9512	25	24	;	;	PUNCT
aiua-9512	25	25	accepted	accept	VERB
aiua-9512	25	26	25	25	NUM
aiua-9512	25	27	january	january	PROPN
aiua-9512	25	28	2021	2021	NUM
aiua-9512	25	29	introduction	introduction	NOUN
aiua-9512	25	30	in	in	ADP
aiua-9512	25	31	urothelial	urothelial	ADJ
aiua-9512	25	32	bladder	bladder	NOUN
aiua-9512	25	33	cancer	cancer	NOUN
aiua-9512	25	34	about	about	ADV
aiua-9512	25	35	75	75	NUM
aiua-9512	25	36	%	%	NOUN
aiua-9512	25	37	of	of	ADP
aiua-9512	25	38	new	new	ADJ
aiua-9512	25	39	patients	patient	NOUN
aiua-9512	25	40	are	be	AUX
aiua-9512	25	41	diagnosed	diagnose	VERB
aiua-9512	25	42	with	with	ADP
aiua-9512	25	43	a	a	DET
aiua-9512	25	44	non	non	ADJ
aiua-9512	25	45	-	-	ADJ
aiua-9512	25	46	muscle	muscle	ADJ
aiua-9512	25	47	-	-	PUNCT
aiua-9512	25	48	invasive	invasive	ADJ
aiua-9512	25	49	tumor	tumor	NOUN
aiua-9512	25	50	.	.	PUNCT
aiua-9512	26	1	the	the	DET
aiua-9512	26	2	most	most	ADV
aiua-9512	26	3	effective	effective	ADJ
aiua-9512	26	4	adjuvant	adjuvant	ADJ
aiua-9512	26	5	treatment	treatment	NOUN
aiua-9512	26	6	for	for	ADP
aiua-9512	26	7	high	high	ADJ
aiua-9512	26	8	-	-	PUNCT
aiua-9512	26	9	grade	grade	NOUN
aiua-9512	26	10	nonmuscle	nonmuscle	NOUN
aiua-9512	26	11	-	-	PUNCT
aiua-9512	26	12	invasive	invasive	ADJ
aiua-9512	26	13	urothelial	urothelial	ADJ
aiua-9512	26	14	bladder	bladder	NOUN
aiua-9512	26	15	cancer	cancer	NOUN
aiua-9512	26	16	(	(	PUNCT
aiua-9512	26	17	hgnmiubc	hgnmiubc	PROPN
aiua-9512	26	18	)	)	PUNCT
aiua-9512	26	19	is	be	AUX
aiua-9512	26	20	the	the	DET
aiua-9512	26	21	use	use	NOUN
aiua-9512	26	22	of	of	ADP
aiua-9512	26	23	intravesical	intravesical	ADJ
aiua-9512	26	24	instillations	instillation	NOUN
aiua-9512	26	25	of	of	ADP
aiua-9512	26	26	bacillus	bacillus	NOUN
aiua-9512	26	27	calmetteguérin	calmetteguérin	NOUN
aiua-9512	26	28	(	(	PUNCT
aiua-9512	26	29	bcg	bcg	PROPN
aiua-9512	26	30	)	)	PUNCT
aiua-9512	26	31	(	(	PUNCT
aiua-9512	26	32	1	1	NUM
aiua-9512	26	33	)	)	PUNCT
aiua-9512	26	34	.	.	PUNCT
aiua-9512	27	1	unfortunately	unfortunately	ADV
aiua-9512	27	2	,	,	PUNCT
aiua-9512	27	3	recurrence	recurrence	NOUN
aiua-9512	27	4	and	and	CCONJ
aiua-9512	27	5	progression	progression	NOUN
aiua-9512	27	6	are	be	AUX
aiua-9512	27	7	documented	document	VERB
aiua-9512	27	8	in	in	ADP
aiua-9512	27	9	about	about	ADV
aiua-9512	27	10	30	30	NUM
aiua-9512	27	11	%	%	NOUN
aiua-9512	27	12	and	and	CCONJ
aiua-9512	27	13	12	12	NUM
aiua-9512	27	14	%	%	NOUN
aiua-9512	27	15	(	(	PUNCT
aiua-9512	27	16	0	0	NUM
aiua-9512	27	17	-	-	SYM
aiua-9512	27	18	35	35	NUM
aiua-9512	27	19	%	%	NOUN
aiua-9512	27	20	)	)	PUNCT
aiua-9512	27	21	of	of	ADP
aiua-9512	27	22	these	these	DET
aiua-9512	27	23	patients	patient	NOUN
aiua-9512	27	24	(	(	PUNCT
aiua-9512	27	25	2	2	NUM
aiua-9512	27	26	)	)	PUNCT
aiua-9512	27	27	.	.	PUNCT
aiua-9512	28	1	furthermore	furthermore	ADV
aiua-9512	28	2	,	,	PUNCT
aiua-9512	28	3	pt1g3	pt1g3	NOUN
aiua-9512	28	4	patients	patient	NOUN
aiua-9512	28	5	have	have	VERB
aiua-9512	28	6	a	a	DET
aiua-9512	28	7	5	5	NUM
aiua-9512	28	8	-	-	PUNCT
aiua-9512	28	9	year	year	NOUN
aiua-9512	28	10	disease	disease	NOUN
aiua-9512	28	11	progression	progression	NOUN
aiua-9512	28	12	rate	rate	NOUN
aiua-9512	28	13	of	of	ADP
aiua-9512	28	14	19.8	19.8	NUM
aiua-9512	28	15	%	%	NOUN
aiua-9512	28	16	and	and	CCONJ
aiua-9512	28	17	a	a	DET
aiua-9512	28	18	5	5	NUM
aiua-9512	28	19	-	-	PUNCT
aiua-9512	28	20	year	year	NOUN
aiua-9512	28	21	disease	disease	NOUN
aiua-9512	28	22	-	-	PUNCT
aiua-9512	28	23	specific	specific	ADJ
aiua-9512	28	24	death	death	NOUN
aiua-9512	28	25	rate	rate	NOUN
aiua-9512	28	26	of	of	ADP
aiua-9512	28	27	11.3	11.3	NUM
aiua-9512	28	28	%	%	NOUN
aiua-9512	28	29	,	,	PUNCT
aiua-9512	28	30	which	which	PRON
aiua-9512	28	31	proves	prove	VERB
aiua-9512	28	32	a	a	DET
aiua-9512	28	33	poor	poor	ADJ
aiua-9512	28	34	prognosis	prognosis	NOUN
aiua-9512	28	35	(	(	PUNCT
aiua-9512	28	36	3	3	NUM
aiua-9512	28	37	)	)	PUNCT
aiua-9512	28	38	.	.	PUNCT
aiua-9512	29	1	radical	radical	ADJ
aiua-9512	29	2	cystectomy	cystectomy	NOUN
aiua-9512	29	3	is	be	AUX
aiua-9512	29	4	the	the	DET
aiua-9512	29	5	chosen	choose	VERB
aiua-9512	29	6	treatment	treatment	NOUN
aiua-9512	29	7	in	in	ADP
aiua-9512	29	8	cases	case	NOUN
aiua-9512	29	9	of	of	ADP
aiua-9512	29	10	failure	failure	NOUN
aiua-9512	29	11	of	of	ADP
aiua-9512	29	12	bcg	bcg	NOUN
aiua-9512	29	13	therapy	therapy	NOUN
aiua-9512	29	14	.	.	PUNCT
aiua-9512	30	1	therefore	therefore	ADV
aiua-9512	30	2	,	,	PUNCT
aiua-9512	30	3	the	the	DET
aiua-9512	30	4	early	early	ADJ
aiua-9512	30	5	idenendothelin-1	idenendothelin-1	NUM
aiua-9512	30	6	indicates	indicate	VERB
aiua-9512	30	7	unfavorable	unfavorable	ADJ
aiua-9512	30	8	prognosis	prognosis	NOUN
aiua-9512	30	9	in	in	ADP
aiua-9512	30	10	primary	primary	ADJ
aiua-9512	30	11	high	high	ADJ
aiua-9512	30	12	-	-	PUNCT
aiua-9512	30	13	grade	grade	NOUN
aiua-9512	30	14	non	non	ADJ
aiua-9512	30	15	-	-	ADJ
aiua-9512	30	16	muscle	muscle	ADJ
aiua-9512	30	17	-	-	PUNCT
aiua-9512	30	18	invasive	invasive	ADJ
aiua-9512	30	19	urothelial	urothelial	ADJ
aiua-9512	30	20	bladder	bladder	NOUN
aiua-9512	30	21	cancer	cancer	NOUN
aiua-9512	30	22	lampros	lampro	VERB
aiua-9512	30	23	mitrakas	mitrakas	NOUN
aiua-9512	30	24	1	1	NUM
aiua-9512	30	25	,	,	PUNCT
aiua-9512	30	26	stavros	stavros	PROPN
aiua-9512	30	27	gravas	gravas	PROPN
aiua-9512	30	28	1	1	NUM
aiua-9512	30	29	,	,	PUNCT
aiua-9512	30	30	foteini	foteini	NOUN
aiua-9512	30	31	karasavvidou	karasavvidou	PROPN
aiua-9512	30	32	2	2	NUM
aiua-9512	30	33	,	,	PUNCT
aiua-9512	30	34	ioannis	ioannis	PROPN
aiua-9512	30	35	zachos	zachos	PROPN
aiua-9512	30	36	1	1	NUM
aiua-9512	30	37	,	,	PUNCT
aiua-9512	30	38	anastasios	anastasio	NOUN
aiua-9512	30	39	karatzas	karatzas	NOUN
aiua-9512	30	40	1	1	NUM
aiua-9512	30	41	,	,	PUNCT
aiua-9512	30	42	athanasios	athanasio	VERB
aiua-9512	30	43	oeconomou	oeconomou	ADV
aiua-9512	30	44	1	1	NUM
aiua-9512	30	45	,	,	PUNCT
aiua-9512	30	46	georgios	georgios	PROPN
aiua-9512	30	47	koukoulis	koukouli	VERB
aiua-9512	30	48	2	2	NUM
aiua-9512	30	49	,	,	PUNCT
aiua-9512	30	50	vasilios	vasilio	VERB
aiua-9512	30	51	tzortzis	tzortzi	NOUN
aiua-9512	30	52	1	1	NUM
aiua-9512	30	53	,	,	PUNCT
aiua-9512	30	54	christos	christo	NOUN
aiua-9512	30	55	papandreou	papandreou	PROPN
aiua-9512	30	56	3	3	NUM
aiua-9512	30	57	1	1	NUM
aiua-9512	30	58	department	department	NOUN
aiua-9512	30	59	of	of	ADP
aiua-9512	30	60	urology	urology	NOUN
aiua-9512	30	61	,	,	PUNCT
aiua-9512	30	62	faculty	faculty	NOUN
aiua-9512	30	63	of	of	ADP
aiua-9512	30	64	medicine	medicine	NOUN
aiua-9512	30	65	-	-	PUNCT
aiua-9512	30	66	school	school	NOUN
aiua-9512	30	67	of	of	ADP
aiua-9512	30	68	health	health	PROPN
aiua-9512	30	69	sciences	sciences	PROPN
aiua-9512	30	70	-	-	PUNCT
aiua-9512	30	71	university	university	PROPN
aiua-9512	30	72	of	of	ADP
aiua-9512	30	73	thessaly	thessaly	PROPN
aiua-9512	30	74	,	,	PUNCT
aiua-9512	30	75	university	university	NOUN
aiua-9512	30	76	hospital	hospital	NOUN
aiua-9512	30	77	of	of	ADP
aiua-9512	30	78	larissa	larissa	PROPN
aiua-9512	30	79	,	,	PUNCT
aiua-9512	30	80	greece	greece	PROPN
aiua-9512	30	81	;	;	PUNCT
aiua-9512	30	82	2	2	NUM
aiua-9512	30	83	department	department	NOUN
aiua-9512	30	84	of	of	ADP
aiua-9512	30	85	pathology	pathology	PROPN
aiua-9512	30	86	and	and	CCONJ
aiua-9512	30	87	cytology	cytology	NOUN
aiua-9512	30	88	,	,	PUNCT
aiua-9512	30	89	faculty	faculty	NOUN
aiua-9512	30	90	of	of	ADP
aiua-9512	30	91	medicine	medicine	NOUN
aiua-9512	30	92	-	-	PUNCT
aiua-9512	30	93	school	school	NOUN
aiua-9512	30	94	of	of	ADP
aiua-9512	30	95	health	health	PROPN
aiua-9512	30	96	sciences	sciences	PROPN
aiua-9512	30	97	-	-	PUNCT
aiua-9512	30	98	university	university	PROPN
aiua-9512	30	99	of	of	ADP
aiua-9512	30	100	thessaly	thessaly	PROPN
aiua-9512	30	101	,	,	PUNCT
aiua-9512	30	102	university	university	NOUN
aiua-9512	30	103	hospital	hospital	NOUN
aiua-9512	30	104	of	of	ADP
aiua-9512	30	105	larissa	larissa	PROPN
aiua-9512	30	106	,	,	PUNCT
aiua-9512	30	107	greece	greece	PROPN
aiua-9512	30	108	;	;	PUNCT
aiua-9512	30	109	3	3	NUM
aiua-9512	30	110	department	department	NOUN
aiua-9512	30	111	of	of	ADP
aiua-9512	30	112	oncology	oncology	NOUN
aiua-9512	30	113	,	,	PUNCT
aiua-9512	30	114	school	school	NOUN
aiua-9512	30	115	of	of	ADP
aiua-9512	30	116	medicine	medicine	NOUN
aiua-9512	30	117	,	,	PUNCT
aiua-9512	30	118	aristotle	aristotle	PROPN
aiua-9512	30	119	university	university	PROPN
aiua-9512	30	120	of	of	ADP
aiua-9512	30	121	thessaloniki	thessaloniki	PROPN
aiua-9512	30	122	,	,	PUNCT
aiua-9512	30	123	“	"	PUNCT
aiua-9512	30	124	n.papageorgiou	n.papageorgiou	ADJ
aiua-9512	30	125	”	"	PUNCT
aiua-9512	30	126	hospital	hospital	NOUN
aiua-9512	30	127	of	of	ADP
aiua-9512	30	128	thessaloniki	thessaloniki	PROPN
aiua-9512	30	129	,	,	PUNCT
aiua-9512	30	130	ring	ring	NOUN
aiua-9512	30	131	road	road	NOUN
aiua-9512	30	132	of	of	ADP
aiua-9512	30	133	thessaloniki	thessaloniki	PROPN
aiua-9512	30	134	,	,	PUNCT
aiua-9512	30	135	greece	greece	PROPN
aiua-9512	30	136	.	.	PUNCT
aiua-9512	31	1	doi	doi	PROPN
aiua-9512	31	2	:	:	PUNCT
aiua-9512	31	3	10.4081	10.4081	NUM
aiua-9512	31	4	/	/	SYM
aiua-9512	31	5	aiua.2021.2.143	aiua.2021.2.143	NOUN
aiua-9512	31	6	summary	summary	NOUN
aiua-9512	31	7	archivio	archivio	NOUN
aiua-9512	31	8	italiano	italiano	X
aiua-9512	31	9	di	di	X
aiua-9512	31	10	urologia	urologia	PROPN
aiua-9512	31	11	e	e	PROPN
aiua-9512	31	12	andrologia	andrologia	NOUN
aiua-9512	31	13	2021	2021	NUM
aiua-9512	31	14	;	;	PUNCT
aiua-9512	31	15	93	93	NUM
aiua-9512	31	16	,	,	PUNCT
aiua-9512	31	17	2	2	NUM
aiua-9512	31	18	l.	l.	PROPN
aiua-9512	31	19	mitrakas	mitrakas	PROPN
aiua-9512	31	20	,	,	PUNCT
aiua-9512	31	21	s.	s.	PROPN
aiua-9512	31	22	gravas	gravas	PROPN
aiua-9512	31	23	,	,	PUNCT
aiua-9512	31	24	f.	f.	PROPN
aiua-9512	31	25	karasavvidou	karasavvidou	PROPN
aiua-9512	31	26	,	,	PUNCT
aiua-9512	31	27	i.	i.	PROPN
aiua-9512	31	28	zachos	zachos	PROPN
aiua-9512	31	29	,	,	PUNCT
aiua-9512	31	30	a.	a.	PROPN
aiua-9512	31	31	karatzas	karatzas	PROPN
aiua-9512	31	32	,	,	PUNCT
aiua-9512	31	33	a.	a.	NOUN
aiua-9512	31	34	oeconomou	oeconomou	PROPN
aiua-9512	31	35	,	,	PUNCT
aiua-9512	31	36	g.	g.	PROPN
aiua-9512	31	37	koukoulis	koukoulis	PROPN
aiua-9512	31	38	,	,	PUNCT
aiua-9512	31	39	v.	v.	ADP
aiua-9512	31	40	tzortzis	tzortzi	NOUN
aiua-9512	31	41	,	,	PUNCT
aiua-9512	31	42	c.	c.	PROPN
aiua-9512	31	43	papandreou	papandreou	PROPN
aiua-9512	31	44	144	144	NUM
aiua-9512	31	45	association	association	NOUN
aiua-9512	31	46	of	of	ADP
aiua-9512	31	47	urology	urology	NOUN
aiua-9512	31	48	/	/	SYM
aiua-9512	31	49	eau	eau	PROPN
aiua-9512	31	50	(	(	PUNCT
aiua-9512	31	51	geau	geau	PROPN
aiua-9512	31	52	)	)	PUNCT
aiua-9512	31	53	(	(	PUNCT
aiua-9512	31	54	7	7	NUM
aiua-9512	31	55	)	)	PUNCT
aiua-9512	31	56	.	.	PUNCT
aiua-9512	32	1	histologically	histologically	PROPN
aiua-9512	32	2	proven	prove	VERB
aiua-9512	32	3	urothelial	urothelial	ADJ
aiua-9512	32	4	carcinoma	carcinoma	NOUN
aiua-9512	32	5	after	after	SCONJ
aiua-9512	32	6	transurethral	transurethral	ADJ
aiua-9512	32	7	resection	resection	NOUN
aiua-9512	32	8	of	of	ADP
aiua-9512	32	9	any	any	DET
aiua-9512	32	10	cystoscopic	cystoscopic	NOUN
aiua-9512	32	11	lesion	lesion	NOUN
aiua-9512	32	12	found	find	VERB
aiua-9512	32	13	during	during	ADP
aiua-9512	32	14	the	the	DET
aiua-9512	32	15	follow	follow	NOUN
aiua-9512	32	16	-	-	PUNCT
aiua-9512	32	17	up	up	NOUN
aiua-9512	32	18	period	period	NOUN
aiua-9512	32	19	was	be	AUX
aiua-9512	32	20	set	set	VERB
aiua-9512	32	21	as	as	ADP
aiua-9512	32	22	“	"	PUNCT
aiua-9512	32	23	disease	disease	NOUN
aiua-9512	32	24	recurrence	recurrence	NOUN
aiua-9512	32	25	”	"	PUNCT
aiua-9512	32	26	.	.	PUNCT
aiua-9512	33	1	any	any	DET
aiua-9512	33	2	change	change	NOUN
aiua-9512	33	3	from	from	ADP
aiua-9512	33	4	pta	pta	NOUN
aiua-9512	33	5	to	to	ADP
aiua-9512	33	6	at	at	ADP
aiua-9512	33	7	least	least	ADJ
aiua-9512	33	8	pt1	pt1	PROPN
aiua-9512	33	9	and	and	CCONJ
aiua-9512	33	10	from	from	ADP
aiua-9512	33	11	pt1	pt1	PROPN
aiua-9512	33	12	to	to	ADP
aiua-9512	33	13	at	at	ADV
aiua-9512	33	14	least	least	ADJ
aiua-9512	33	15	pt2	pt2	NOUN
aiua-9512	33	16	stage	stage	NOUN
aiua-9512	33	17	was	be	AUX
aiua-9512	33	18	set	set	VERB
aiua-9512	33	19	as	as	ADP
aiua-9512	33	20	“	"	PUNCT
aiua-9512	33	21	disease	disease	NOUN
aiua-9512	33	22	progression	progression	NOUN
aiua-9512	33	23	”	"	PUNCT
aiua-9512	33	24	.	.	PUNCT
aiua-9512	34	1	our	our	PRON
aiua-9512	34	2	further	further	ADJ
aiua-9512	34	3	treatment	treatment	NOUN
aiua-9512	34	4	decisions	decision	NOUN
aiua-9512	34	5	concerning	concern	VERB
aiua-9512	34	6	recurrence	recurrence	NOUN
aiua-9512	34	7	and	and	CCONJ
aiua-9512	34	8	progression	progression	NOUN
aiua-9512	34	9	were	be	AUX
aiua-9512	34	10	based	base	VERB
aiua-9512	34	11	on	on	ADP
aiua-9512	34	12	the	the	DET
aiua-9512	34	13	recommendations	recommendation	NOUN
aiua-9512	34	14	made	make	VERB
aiua-9512	34	15	by	by	ADP
aiua-9512	34	16	the	the	DET
aiua-9512	34	17	geau	geau	PROPN
aiua-9512	34	18	(	(	PUNCT
aiua-9512	34	19	7	7	NUM
aiua-9512	34	20	)	)	PUNCT
aiua-9512	34	21	.	.	PUNCT
aiua-9512	35	1	group	group	PROPN
aiua-9512	35	2	a	a	DET
aiua-9512	35	3	consists	consist	NOUN
aiua-9512	35	4	of	of	ADP
aiua-9512	35	5	40	40	NUM
aiua-9512	35	6	consecutive	consecutive	ADJ
aiua-9512	35	7	patients	patient	NOUN
aiua-9512	35	8	with	with	ADP
aiua-9512	35	9	disease	disease	NOUN
aiua-9512	35	10	recurrence	recurrence	NOUN
aiua-9512	35	11	±	±	NUM
aiua-9512	35	12	progression	progression	NOUN
aiua-9512	35	13	.	.	PUNCT
aiua-9512	36	1	a	a	DET
aiua-9512	36	2	patient	patient	NOUN
aiua-9512	36	3	was	be	AUX
aiua-9512	36	4	allocated	allocate	VERB
aiua-9512	36	5	in	in	ADP
aiua-9512	36	6	group	group	NOUN
aiua-9512	36	7	a	a	PRON
aiua-9512	36	8	as	as	ADV
aiua-9512	36	9	soon	soon	ADV
aiua-9512	36	10	as	as	SCONJ
aiua-9512	36	11	recurrence	recurrence	NOUN
aiua-9512	36	12	was	be	AUX
aiua-9512	36	13	initially	initially	ADV
aiua-9512	36	14	documented	document	VERB
aiua-9512	36	15	in	in	ADP
aiua-9512	36	16	the	the	DET
aiua-9512	36	17	follow	follow	NOUN
aiua-9512	36	18	-	-	PUNCT
aiua-9512	36	19	up	up	NOUN
aiua-9512	36	20	period	period	NOUN
aiua-9512	36	21	.	.	PUNCT
aiua-9512	37	1	apparently	apparently	ADV
aiua-9512	37	2	,	,	PUNCT
aiua-9512	37	3	there	there	PRON
aiua-9512	37	4	can	can	AUX
aiua-9512	37	5	be	be	AUX
aiua-9512	37	6	no	no	DET
aiua-9512	37	7	progression	progression	NOUN
aiua-9512	37	8	without	without	ADP
aiua-9512	37	9	the	the	DET
aiua-9512	37	10	event	event	NOUN
aiua-9512	37	11	of	of	ADP
aiua-9512	37	12	recurrence	recurrence	NOUN
aiua-9512	37	13	,	,	PUNCT
aiua-9512	37	14	but	but	CCONJ
aiua-9512	37	15	it	it	PRON
aiua-9512	37	16	is	be	AUX
aiua-9512	37	17	not	not	PART
aiua-9512	37	18	for	for	ADP
aiua-9512	37	19	sure	sure	ADJ
aiua-9512	37	20	that	that	SCONJ
aiua-9512	37	21	every	every	DET
aiua-9512	37	22	patient	patient	NOUN
aiua-9512	37	23	with	with	ADP
aiua-9512	37	24	recurrence	recurrence	NOUN
aiua-9512	37	25	will	will	AUX
aiua-9512	37	26	end	end	VERB
aiua-9512	37	27	up	up	ADP
aiua-9512	37	28	in	in	ADP
aiua-9512	37	29	having	have	VERB
aiua-9512	37	30	progression	progression	NOUN
aiua-9512	37	31	.	.	PUNCT
aiua-9512	38	1	group	group	PROPN
aiua-9512	38	2	b	b	PROPN
aiua-9512	38	3	includes	include	VERB
aiua-9512	38	4	20	20	NUM
aiua-9512	38	5	consecutive	consecutive	ADJ
aiua-9512	38	6	patients	patient	NOUN
aiua-9512	38	7	who	who	PRON
aiua-9512	38	8	had	have	VERB
aiua-9512	38	9	neither	neither	CCONJ
aiua-9512	38	10	recurrence	recurrence	NOUN
aiua-9512	38	11	nor	nor	CCONJ
aiua-9512	38	12	progression	progression	NOUN
aiua-9512	38	13	.	.	PUNCT
aiua-9512	39	1	taking	take	VERB
aiua-9512	39	2	into	into	ADP
aiua-9512	39	3	account	account	NOUN
aiua-9512	39	4	the	the	DET
aiua-9512	39	5	predefined	predefine	VERB
aiua-9512	39	6	size	size	NOUN
aiua-9512	39	7	of	of	ADP
aiua-9512	39	8	group	group	PROPN
aiua-9512	39	9	a	a	PROPN
aiua-9512	39	10	,	,	PUNCT
aiua-9512	39	11	this	this	DET
aiua-9512	39	12	size	size	NOUN
aiua-9512	39	13	of	of	ADP
aiua-9512	39	14	group	group	NOUN
aiua-9512	39	15	b	b	PROPN
aiua-9512	39	16	is	be	AUX
aiua-9512	39	17	the	the	DET
aiua-9512	39	18	minimum	minimum	ADJ
aiua-9512	39	19	numerical	numerical	ADJ
aiua-9512	39	20	value	value	NOUN
aiua-9512	39	21	allowing	allow	VERB
aiua-9512	39	22	a	a	DET
aiua-9512	39	23	reliable	reliable	ADJ
aiua-9512	39	24	statistical	statistical	ADJ
aiua-9512	39	25	analysis	analysis	NOUN
aiua-9512	39	26	within	within	ADP
aiua-9512	39	27	a	a	DET
aiua-9512	39	28	prospective	prospective	ADJ
aiua-9512	39	29	framework	framework	NOUN
aiua-9512	39	30	.	.	PUNCT
aiua-9512	40	1	all	all	PRON
aiua-9512	40	2	included	include	VERB
aiua-9512	40	3	patients	patient	NOUN
aiua-9512	40	4	provided	provide	VERB
aiua-9512	40	5	their	their	PRON
aiua-9512	40	6	consent	consent	NOUN
aiua-9512	40	7	.	.	PUNCT
aiua-9512	41	1	the	the	DET
aiua-9512	41	2	pathology	pathology	NOUN
aiua-9512	41	3	staging	staging	NOUN
aiua-9512	41	4	was	be	AUX
aiua-9512	41	5	done	do	VERB
aiua-9512	41	6	according	accord	VERB
aiua-9512	41	7	to	to	ADP
aiua-9512	41	8	the	the	DET
aiua-9512	41	9	2009	2009	NUM
aiua-9512	41	10	tnm	tnm	NOUN
aiua-9512	41	11	classification	classification	NOUN
aiua-9512	41	12	approved	approve	VERB
aiua-9512	41	13	by	by	ADP
aiua-9512	41	14	the	the	DET
aiua-9512	41	15	union	union	PROPN
aiua-9512	41	16	international	international	ADJ
aiua-9512	41	17	contre	contre	X
aiua-9512	41	18	le	le	X
aiua-9512	41	19	cancer	cancer	NOUN
aiua-9512	41	20	(	(	PUNCT
aiua-9512	41	21	uicc	uicc	NOUN
aiua-9512	41	22	)	)	PUNCT
aiua-9512	41	23	which	which	PRON
aiua-9512	41	24	was	be	AUX
aiua-9512	41	25	updated	update	VERB
aiua-9512	41	26	in	in	ADP
aiua-9512	41	27	2017	2017	NUM
aiua-9512	41	28	(	(	PUNCT
aiua-9512	41	29	8th	8th	NOUN
aiua-9512	41	30	edition	edition	NOUN
aiua-9512	41	31	)	)	PUNCT
aiua-9512	41	32	and	and	CCONJ
aiua-9512	41	33	grading	grading	NOUN
aiua-9512	41	34	was	be	AUX
aiua-9512	41	35	estimated	estimate	VERB
aiua-9512	41	36	according	accord	VERB
aiua-9512	41	37	to	to	ADP
aiua-9512	41	38	the	the	DET
aiua-9512	41	39	2004	2004	NUM
aiua-9512	41	40	who	who	PRON
aiua-9512	41	41	grading	grade	VERB
aiua-9512	41	42	system	system	NOUN
aiua-9512	41	43	.	.	PUNCT
aiua-9512	42	1	a	a	DET
aiua-9512	42	2	central	central	ADJ
aiua-9512	42	3	pathology	pathology	NOUN
aiua-9512	42	4	review	review	NOUN
aiua-9512	42	5	was	be	AUX
aiua-9512	42	6	applied	apply	VERB
aiua-9512	42	7	for	for	ADP
aiua-9512	42	8	the	the	DET
aiua-9512	42	9	grading	grading	NOUN
aiua-9512	42	10	of	of	ADP
aiua-9512	42	11	the	the	DET
aiua-9512	42	12	immunohistochemical	immunohistochemical	ADJ
aiua-9512	42	13	staining	stain	VERB
aiua-9512	42	14	(	(	PUNCT
aiua-9512	42	15	ihc	ihc	PROPN
aiua-9512	42	16	)	)	PUNCT
aiua-9512	42	17	.	.	PUNCT
aiua-9512	43	1	representative	representative	ADJ
aiua-9512	43	2	samples	sample	NOUN
aiua-9512	43	3	of	of	ADP
aiua-9512	43	4	good	good	ADJ
aiua-9512	43	5	morphology	morphology	NOUN
aiua-9512	43	6	and	and	CCONJ
aiua-9512	43	7	antigenicity	antigenicity	NOUN
aiua-9512	43	8	of	of	ADP
aiua-9512	43	9	the	the	DET
aiua-9512	43	10	primary	primary	ADJ
aiua-9512	43	11	tumors	tumor	NOUN
aiua-9512	43	12	were	be	AUX
aiua-9512	43	13	obtained	obtain	VERB
aiua-9512	43	14	for	for	ADP
aiua-9512	43	15	staining	stain	VERB
aiua-9512	43	16	.	.	PUNCT
aiua-9512	44	1	staining	stain	VERB
aiua-9512	44	2	was	be	AUX
aiua-9512	44	3	performed	perform	VERB
aiua-9512	44	4	in	in	ADP
aiua-9512	44	5	a	a	DET
aiua-9512	44	6	single	single	ADJ
aiua-9512	44	7	run	run	NOUN
aiua-9512	44	8	and	and	CCONJ
aiua-9512	44	9	by	by	ADP
aiua-9512	44	10	applying	apply	VERB
aiua-9512	44	11	mouse	mouse	NOUN
aiua-9512	44	12	monoclonal	monoclonal	NOUN
aiua-9512	44	13	antibody	antibody	NOUN
aiua-9512	44	14	for	for	ADP
aiua-9512	44	15	et-1	et-1	X
aiua-9512	44	16	(	(	PUNCT
aiua-9512	44	17	clone	clone	NOUN
aiua-9512	44	18	tr.et.48.5	tr.et.48.5	NOUN
aiua-9512	44	19	,	,	PUNCT
aiua-9512	44	20	dilution	dilution	NOUN
aiua-9512	44	21	1:250	1:250	NUM
aiua-9512	44	22	,	,	PUNCT
aiua-9512	44	23	novus	novus	NOUN
aiua-9512	44	24	biologicals	biological	NOUN
aiua-9512	44	25	,	,	PUNCT
aiua-9512	44	26	littleton	littleton	PROPN
aiua-9512	44	27	,	,	PUNCT
aiua-9512	44	28	colorado	colorado	PROPN
aiua-9512	44	29	,	,	PUNCT
aiua-9512	44	30	usa	usa	PROPN
aiua-9512	44	31	)	)	PUNCT
aiua-9512	44	32	.	.	PUNCT
aiua-9512	45	1	staining	stain	VERB
aiua-9512	45	2	intensity	intensity	NOUN
aiua-9512	45	3	(	(	PUNCT
aiua-9512	45	4	si	si	NOUN
aiua-9512	45	5	)	)	PUNCT
aiua-9512	45	6	of	of	ADP
aiua-9512	45	7	et-1	et-1	NUM
aiua-9512	45	8	on	on	ADP
aiua-9512	45	9	a	a	DET
aiua-9512	45	10	highpower	highpower	NOUN
aiua-9512	45	11	field	field	NOUN
aiua-9512	45	12	(	(	PUNCT
aiua-9512	45	13	figure	figure	NOUN
aiua-9512	45	14	1	1	NUM
aiua-9512	45	15	)	)	PUNCT
aiua-9512	45	16	was	be	AUX
aiua-9512	45	17	classified	classify	VERB
aiua-9512	45	18	according	accord	VERB
aiua-9512	45	19	to	to	ADP
aiua-9512	45	20	an	an	DET
aiua-9512	45	21	arbitrary	arbitrary	ADJ
aiua-9512	45	22	four	four	NUM
aiua-9512	45	23	-	-	PUNCT
aiua-9512	45	24	tiered	tiere	VERB
aiua-9512	45	25	scale	scale	NOUN
aiua-9512	45	26	(	(	PUNCT
aiua-9512	45	27	no	no	DET
aiua-9512	45	28	staining	stain	VERB
aiua-9512	45	29	=	=	NOUN
aiua-9512	45	30	0	0	NUM
aiua-9512	45	31	,	,	PUNCT
aiua-9512	45	32	mild	mild	ADJ
aiua-9512	45	33	=	=	SYM
aiua-9512	45	34	1	1	NUM
aiua-9512	45	35	,	,	PUNCT
aiua-9512	45	36	moderate	moderate	ADJ
aiua-9512	45	37	=	=	SYM
aiua-9512	45	38	2	2	NUM
aiua-9512	45	39	,	,	PUNCT
aiua-9512	45	40	strong	strong	ADJ
aiua-9512	45	41	=	=	ADJ
aiua-9512	45	42	3	3	X
aiua-9512	45	43	)	)	PUNCT
aiua-9512	45	44	in	in	ADP
aiua-9512	45	45	a	a	DET
aiua-9512	45	46	manner	manner	NOUN
aiua-9512	45	47	consistent	consistent	ADJ
aiua-9512	45	48	with	with	ADP
aiua-9512	45	49	previous	previous	ADJ
aiua-9512	45	50	investigations	investigation	NOUN
aiua-9512	45	51	(	(	PUNCT
aiua-9512	45	52	5	5	NUM
aiua-9512	45	53	)	)	PUNCT
aiua-9512	45	54	.	.	PUNCT
aiua-9512	46	1	epidemiological	epidemiological	ADJ
aiua-9512	46	2	(	(	PUNCT
aiua-9512	46	3	age	age	NOUN
aiua-9512	46	4	,	,	PUNCT
aiua-9512	46	5	gender	gender	NOUN
aiua-9512	46	6	,	,	PUNCT
aiua-9512	46	7	smoking	smoking	NOUN
aiua-9512	46	8	)	)	PUNCT
aiua-9512	46	9	,	,	PUNCT
aiua-9512	46	10	pathological	pathological	ADJ
aiua-9512	46	11	(	(	PUNCT
aiua-9512	46	12	stage	stage	NOUN
aiua-9512	46	13	t	t	PROPN
aiua-9512	46	14	,	,	PUNCT
aiua-9512	46	15	concomitant	concomitant	ADJ
aiua-9512	46	16	carcinoma	carcinoma	NOUN
aiua-9512	46	17	in	in	ADP
aiua-9512	46	18	situ	situ	PROPN
aiua-9512	46	19	/	/	SYM
aiua-9512	46	20	tis	tis	PROPN
aiua-9512	46	21	)	)	PUNCT
aiua-9512	46	22	and	and	CCONJ
aiua-9512	46	23	clinical	clinical	ADJ
aiua-9512	46	24	parameters	parameter	NOUN
aiua-9512	46	25	(	(	PUNCT
aiua-9512	46	26	number	number	NOUN
aiua-9512	46	27	of	of	ADP
aiua-9512	46	28	tumors	tumor	NOUN
aiua-9512	46	29	,	,	PUNCT
aiua-9512	46	30	tumor	tumor	NOUN
aiua-9512	46	31	size	size	NOUN
aiua-9512	46	32	,	,	PUNCT
aiua-9512	46	33	patient	patient	NOUN
aiua-9512	46	34	group	group	NOUN
aiua-9512	46	35	)	)	PUNCT
aiua-9512	46	36	,	,	PUNCT
aiua-9512	46	37	and	and	CCONJ
aiua-9512	46	38	et-1	et-1	CCONJ
aiua-9512	46	39	expression	expression	NOUN
aiua-9512	46	40	were	be	AUX
aiua-9512	46	41	statistically	statistically	ADV
aiua-9512	46	42	analyzed	analyze	VERB
aiua-9512	46	43	.	.	PUNCT
aiua-9512	47	1	univariate	univariate	ADJ
aiua-9512	47	2	analysis	analysis	NOUN
aiua-9512	47	3	for	for	ADP
aiua-9512	47	4	recurrence	recurrence	NOUN
aiua-9512	47	5	(	(	PUNCT
aiua-9512	47	6	rec	rec	NOUN
aiua-9512	47	7	)	)	PUNCT
aiua-9512	47	8	and	and	CCONJ
aiua-9512	47	9	progression	progression	NOUN
aiua-9512	47	10	(	(	PUNCT
aiua-9512	47	11	pr	pr	NOUN
aiua-9512	47	12	)	)	PUNCT
aiua-9512	47	13	was	be	AUX
aiua-9512	47	14	performed	perform	VERB
aiua-9512	47	15	using	use	VERB
aiua-9512	47	16	chi	chi	ADJ
aiua-9512	47	17	-	-	PUNCT
aiua-9512	47	18	square	square	NOUN
aiua-9512	47	19	or	or	CCONJ
aiua-9512	47	20	fisher	fisher	NOUN
aiua-9512	47	21	’s	’s	PART
aiua-9512	47	22	exact	exact	ADJ
aiua-9512	47	23	test	test	NOUN
aiua-9512	47	24	and	and	CCONJ
aiua-9512	47	25	multivariate	multivariate	VERB
aiua-9512	47	26	analysis	analysis	NOUN
aiua-9512	47	27	using	use	VERB
aiua-9512	47	28	multiple	multiple	ADJ
aiua-9512	47	29	logistic	logistic	ADJ
aiua-9512	47	30	regression	regression	NOUN
aiua-9512	47	31	.	.	PUNCT
aiua-9512	48	1	univariate	univariate	ADJ
aiua-9512	48	2	analysis	analysis	NOUN
aiua-9512	48	3	for	for	ADP
aiua-9512	48	4	recurrence	recurrence	NOUN
aiua-9512	48	5	-	-	PUNCT
aiua-9512	48	6	free	free	ADJ
aiua-9512	48	7	survival	survival	NOUN
aiua-9512	48	8	(	(	PUNCT
aiua-9512	48	9	rfs	rfs	PROPN
aiua-9512	48	10	)	)	PUNCT
aiua-9512	48	11	and	and	CCONJ
aiua-9512	48	12	progression	progression	NOUN
aiua-9512	48	13	-	-	PUNCT
aiua-9512	48	14	free	free	ADJ
aiua-9512	48	15	survival	survival	NOUN
aiua-9512	48	16	(	(	PUNCT
aiua-9512	48	17	pfs	pfs	PROPN
aiua-9512	48	18	)	)	PUNCT
aiua-9512	48	19	was	be	AUX
aiua-9512	48	20	performed	perform	VERB
aiua-9512	48	21	using	use	VERB
aiua-9512	48	22	log	log	NOUN
aiua-9512	48	23	-	-	PUNCT
aiua-9512	48	24	rank	rank	NOUN
aiua-9512	48	25	test	test	NOUN
aiua-9512	48	26	for	for	ADP
aiua-9512	48	27	categorical	categorical	ADJ
aiua-9512	48	28	variables	variable	NOUN
aiua-9512	48	29	and	and	CCONJ
aiua-9512	48	30	cox	cox	PROPN
aiua-9512	48	31	regression	regression	NOUN
aiua-9512	48	32	for	for	ADP
aiua-9512	48	33	scale	scale	NOUN
aiua-9512	48	34	variables	variable	NOUN
aiua-9512	48	35	.	.	PUNCT
aiua-9512	49	1	multivariate	multivariate	VERB
aiua-9512	49	2	analysis	analysis	NOUN
aiua-9512	49	3	for	for	ADP
aiua-9512	49	4	rfs	rfs	PRON
aiua-9512	49	5	and	and	CCONJ
aiua-9512	49	6	pfs	pfs	PROPN
aiua-9512	49	7	was	be	AUX
aiua-9512	49	8	assessed	assess	VERB
aiua-9512	49	9	using	use	VERB
aiua-9512	49	10	cox	cox	PROPN
aiua-9512	49	11	regression	regression	NOUN
aiua-9512	49	12	analysis	analysis	NOUN
aiua-9512	49	13	after	after	ADP
aiua-9512	49	14	checking	check	VERB
aiua-9512	49	15	the	the	DET
aiua-9512	49	16	proportional	proportional	ADJ
aiua-9512	49	17	hazards	hazard	NOUN
aiua-9512	49	18	assumption	assumption	NOUN
aiua-9512	49	19	.	.	PUNCT
aiua-9512	50	1	the	the	DET
aiua-9512	50	2	level	level	NOUN
aiua-9512	50	3	of	of	ADP
aiua-9512	50	4	statistical	statistical	ADJ
aiua-9512	50	5	significance	significance	NOUN
aiua-9512	50	6	was	be	AUX
aiua-9512	50	7	set	set	VERB
aiua-9512	50	8	as	as	ADP
aiua-9512	50	9	p	p	NOUN
aiua-9512	50	10	≤	≤	NOUN
aiua-9512	50	11	0.05	0.05	NUM
aiua-9512	50	12	.	.	PUNCT
aiua-9512	51	1	all	all	DET
aiua-9512	51	2	analyses	analysis	NOUN
aiua-9512	51	3	were	be	AUX
aiua-9512	51	4	performed	perform	VERB
aiua-9512	51	5	with	with	ADP
aiua-9512	51	6	the	the	DET
aiua-9512	51	7	use	use	NOUN
aiua-9512	51	8	of	of	ADP
aiua-9512	51	9	ibm	ibm	PROPN
aiua-9512	51	10	spss	spss	PROPN
aiua-9512	51	11	statistics	statistics	PROPN
aiua-9512	51	12	version	version	PROPN
aiua-9512	51	13	21	21	NUM
aiua-9512	51	14	software	software	NOUN
aiua-9512	51	15	.	.	PUNCT
aiua-9512	52	1	the	the	DET
aiua-9512	52	2	study	study	NOUN
aiua-9512	52	3	was	be	AUX
aiua-9512	52	4	approved	approve	VERB
aiua-9512	52	5	by	by	ADP
aiua-9512	52	6	the	the	DET
aiua-9512	52	7	ethics	ethic	NOUN
aiua-9512	52	8	committeescientific	committeescientific	PROPN
aiua-9512	52	9	board	board	PROPN
aiua-9512	52	10	of	of	ADP
aiua-9512	52	11	the	the	DET
aiua-9512	52	12	university	university	NOUN
aiua-9512	52	13	hospital	hospital	NOUN
aiua-9512	52	14	of	of	ADP
aiua-9512	52	15	larissa	larissa	PROPN
aiua-9512	52	16	and	and	CCONJ
aiua-9512	52	17	it	it	PRON
aiua-9512	52	18	conforms	conform	VERB
aiua-9512	52	19	to	to	ADP
aiua-9512	52	20	the	the	DET
aiua-9512	52	21	provisions	provision	NOUN
aiua-9512	52	22	of	of	ADP
aiua-9512	52	23	the	the	DET
aiua-9512	52	24	declaration	declaration	NOUN
aiua-9512	52	25	of	of	ADP
aiua-9512	52	26	helsinki	helsinki	PROPN
aiua-9512	52	27	(	(	PUNCT
aiua-9512	52	28	as	as	SCONJ
aiua-9512	52	29	revised	revise	VERB
aiua-9512	52	30	in	in	ADP
aiua-9512	52	31	tokyo	tokyo	PROPN
aiua-9512	52	32	2008	2008	NUM
aiua-9512	52	33	)	)	PUNCT
aiua-9512	52	34	.	.	PUNCT
aiua-9512	53	1	results	result	NOUN
aiua-9512	53	2	we	we	PRON
aiua-9512	53	3	totally	totally	ADV
aiua-9512	53	4	included	include	VERB
aiua-9512	53	5	60	60	NUM
aiua-9512	53	6	patients	patient	NOUN
aiua-9512	53	7	,	,	PUNCT
aiua-9512	53	8	40	40	NUM
aiua-9512	53	9	patients	patient	NOUN
aiua-9512	53	10	in	in	ADP
aiua-9512	53	11	group	group	PROPN
aiua-9512	53	12	a	a	PRON
aiua-9512	53	13	and	and	CCONJ
aiua-9512	53	14	20	20	NUM
aiua-9512	53	15	patients	patient	NOUN
aiua-9512	53	16	in	in	ADP
aiua-9512	53	17	group	group	PROPN
aiua-9512	53	18	b.	b.	PROPN
aiua-9512	53	19	median	median	PROPN
aiua-9512	53	20	follow	follow	NOUN
aiua-9512	53	21	-	-	PUNCT
aiua-9512	53	22	up	up	NOUN
aiua-9512	53	23	was	be	AUX
aiua-9512	53	24	63.2	63.2	NUM
aiua-9512	53	25	months	month	NOUN
aiua-9512	53	26	for	for	ADP
aiua-9512	53	27	group	group	NOUN
aiua-9512	53	28	a	a	X
aiua-9512	53	29	(	(	PUNCT
aiua-9512	53	30	n	n	NOUN
aiua-9512	53	31	=	=	NUM
aiua-9512	53	32	40	40	NUM
aiua-9512	53	33	)	)	PUNCT
aiua-9512	53	34	and	and	CCONJ
aiua-9512	53	35	87.8	87.8	NUM
aiua-9512	53	36	months	month	NOUN
aiua-9512	53	37	for	for	ADP
aiua-9512	53	38	group	group	NOUN
aiua-9512	53	39	b	b	PROPN
aiua-9512	53	40	(	(	PUNCT
aiua-9512	53	41	n	n	NOUN
aiua-9512	53	42	=	=	NUM
aiua-9512	53	43	20	20	NUM
aiua-9512	53	44	)	)	PUNCT
aiua-9512	53	45	.	.	PUNCT
aiua-9512	54	1	baseline	baseline	PROPN
aiua-9512	54	2	characteristics	characteristic	NOUN
aiua-9512	54	3	for	for	ADP
aiua-9512	54	4	the	the	DET
aiua-9512	54	5	total	total	ADJ
aiua-9512	54	6	number	number	NOUN
aiua-9512	54	7	of	of	ADP
aiua-9512	54	8	patients	patient	NOUN
aiua-9512	54	9	as	as	ADV
aiua-9512	54	10	well	well	ADV
aiua-9512	54	11	as	as	ADP
aiua-9512	54	12	for	for	ADP
aiua-9512	54	13	the	the	DET
aiua-9512	54	14	patients	patient	NOUN
aiua-9512	54	15	of	of	ADP
aiua-9512	54	16	groups	group	NOUN
aiua-9512	54	17	a	a	PRON
aiua-9512	54	18	and	and	CCONJ
aiua-9512	54	19	b	b	NOUN
aiua-9512	54	20	are	be	AUX
aiua-9512	54	21	shown	show	VERB
aiua-9512	54	22	in	in	ADP
aiua-9512	54	23	table	table	NOUN
aiua-9512	54	24	1	1	NUM
aiua-9512	54	25	.	.	PUNCT
aiua-9512	55	1	the	the	DET
aiua-9512	55	2	results	result	NOUN
aiua-9512	55	3	of	of	ADP
aiua-9512	55	4	the	the	DET
aiua-9512	55	5	ihc	ihc	PROPN
aiua-9512	55	6	for	for	ADP
aiua-9512	55	7	both	both	DET
aiua-9512	55	8	groups	group	NOUN
aiua-9512	55	9	are	be	AUX
aiua-9512	55	10	summarized	summarize	VERB
aiua-9512	55	11	in	in	ADP
aiua-9512	55	12	table	table	NOUN
aiua-9512	55	13	2	2	NUM
aiua-9512	55	14	and	and	CCONJ
aiua-9512	55	15	the	the	DET
aiua-9512	55	16	detailed	detailed	ADJ
aiua-9512	55	17	results	result	NOUN
aiua-9512	55	18	of	of	ADP
aiua-9512	55	19	the	the	DET
aiua-9512	55	20	ihc	ihc	PROPN
aiua-9512	55	21	regarding	regard	VERB
aiua-9512	55	22	rec	rec	NOUN
aiua-9512	55	23	and	and	CCONJ
aiua-9512	55	24	pr	pr	NOUN
aiua-9512	55	25	for	for	ADP
aiua-9512	55	26	group	group	NOUN
aiua-9512	55	27	a	a	PROPN
aiua-9512	55	28	are	be	AUX
aiua-9512	55	29	presented	present	VERB
aiua-9512	55	30	in	in	ADP
aiua-9512	55	31	table	table	NOUN
aiua-9512	55	32	3	3	NUM
aiua-9512	55	33	.	.	PUNCT
aiua-9512	56	1	in	in	ADP
aiua-9512	56	2	group	group	PROPN
aiua-9512	56	3	a	a	PROPN
aiua-9512	56	4	,	,	PUNCT
aiua-9512	56	5	27	27	NUM
aiua-9512	56	6	patients	patient	NOUN
aiua-9512	56	7	had	have	VERB
aiua-9512	56	8	recurrence	recurrence	NOUN
aiua-9512	56	9	(	(	PUNCT
aiua-9512	56	10	27/40	27/40	NUM
aiua-9512	56	11	,	,	PUNCT
aiua-9512	56	12	67.5	67.5	NUM
aiua-9512	56	13	%	%	NOUN
aiua-9512	56	14	)	)	PUNCT
aiua-9512	56	15	and	and	CCONJ
aiua-9512	56	16	the	the	DET
aiua-9512	56	17	median	median	ADJ
aiua-9512	56	18	rfs	rfs	PROPN
aiua-9512	56	19	was	be	AUX
aiua-9512	56	20	11.3	11.3	NUM
aiua-9512	56	21	months	month	NOUN
aiua-9512	56	22	.	.	PUNCT
aiua-9512	57	1	moreover	moreover	ADV
aiua-9512	57	2	,	,	PUNCT
aiua-9512	57	3	13	13	NUM
aiua-9512	57	4	patients	patient	NOUN
aiua-9512	57	5	had	have	VERB
aiua-9512	57	6	recurrence	recurrence	NOUN
aiua-9512	57	7	and	and	CCONJ
aiua-9512	57	8	progression	progression	NOUN
aiua-9512	57	9	(	(	PUNCT
aiua-9512	57	10	13/40	13/40	NUM
aiua-9512	57	11	,	,	PUNCT
aiua-9512	57	12	32.5	32.5	NUM
aiua-9512	57	13	%	%	NOUN
aiua-9512	57	14	)	)	PUNCT
aiua-9512	57	15	and	and	CCONJ
aiua-9512	57	16	the	the	DET
aiua-9512	57	17	median	median	ADJ
aiua-9512	57	18	pfs	pfs	PROPN
aiua-9512	57	19	was	be	AUX
aiua-9512	57	20	38.9	38.9	NUM
aiua-9512	57	21	months	month	NOUN
aiua-9512	57	22	.	.	PUNCT
aiua-9512	58	1	the	the	DET
aiua-9512	58	2	patients	patient	NOUN
aiua-9512	58	3	of	of	ADP
aiua-9512	58	4	table	table	NOUN
aiua-9512	58	5	1	1	NUM
aiua-9512	58	6	.	.	PUNCT
aiua-9512	58	7	baseline	baseline	PROPN
aiua-9512	58	8	characteristics	characteristic	NOUN
aiua-9512	58	9	of	of	ADP
aiua-9512	58	10	patients	patient	NOUN
aiua-9512	58	11	in	in	ADP
aiua-9512	58	12	group	group	PROPN
aiua-9512	58	13	a	a	PROPN
aiua-9512	58	14	and	and	CCONJ
aiua-9512	58	15	b.	b.	PROPN
aiua-9512	58	16	patients	patients	PROPN
aiua-9512	58	17	’	'	PUNCT
aiua-9512	58	18	baseline	baseline	PROPN
aiua-9512	58	19	characteristics	characteristic	NOUN
aiua-9512	58	20	total	total	NOUN
aiua-9512	58	21	(	(	PUNCT
aiua-9512	58	22	n	n	NOUN
aiua-9512	58	23	=	=	SYM
aiua-9512	58	24	60	60	NUM
aiua-9512	58	25	)	)	PUNCT
aiua-9512	58	26	group	group	NOUN
aiua-9512	58	27	a	a	X
aiua-9512	58	28	(	(	PUNCT
aiua-9512	58	29	n	n	NOUN
aiua-9512	58	30	=	=	SYM
aiua-9512	58	31	40	40	NUM
aiua-9512	58	32	)	)	PUNCT
aiua-9512	58	33	group	group	NOUN
aiua-9512	58	34	b	b	PROPN
aiua-9512	58	35	(	(	PUNCT
aiua-9512	58	36	n	n	NOUN
aiua-9512	58	37	=	=	NUM
aiua-9512	58	38	20	20	NUM
aiua-9512	58	39	)	)	PUNCT
aiua-9512	58	40	p	p	NOUN
aiua-9512	58	41	value	value	NOUN
aiua-9512	58	42	median	median	ADJ
aiua-9512	58	43	age	age	NOUN
aiua-9512	58	44	(	(	PUNCT
aiua-9512	58	45	years	year	NOUN
aiua-9512	58	46	)	)	PUNCT
aiua-9512	58	47	67.3	67.3	NUM
aiua-9512	58	48	±	±	NUM
aiua-9512	58	49	8.4	8.4	NUM
aiua-9512	58	50	(	(	PUNCT
aiua-9512	58	51	38	38	NUM
aiua-9512	58	52	-	-	SYM
aiua-9512	58	53	87	87	NUM
aiua-9512	58	54	)	)	PUNCT
aiua-9512	58	55	68.7	68.7	NUM
aiua-9512	58	56	±	±	NUM
aiua-9512	58	57	7.4	7.4	NUM
aiua-9512	58	58	(	(	PUNCT
aiua-9512	58	59	58	58	NUM
aiua-9512	58	60	-	-	SYM
aiua-9512	58	61	87	87	NUM
aiua-9512	58	62	)	)	PUNCT
aiua-9512	58	63	64.3	64.3	NUM
aiua-9512	58	64	±	±	NUM
aiua-9512	58	65	9.1	9.1	NUM
aiua-9512	58	66	(	(	PUNCT
aiua-9512	58	67	38	38	NUM
aiua-9512	58	68	-	-	SYM
aiua-9512	58	69	77	77	NUM
aiua-9512	58	70	)	)	PUNCT
aiua-9512	58	71	0.749	0.749	NUM
aiua-9512	58	72	(	(	PUNCT
aiua-9512	58	73	*	*	NOUN
aiua-9512	58	74	)	)	PUNCT
aiua-9512	58	75	gender	gender	NOUN
aiua-9512	58	76	(	(	PUNCT
aiua-9512	58	77	♂	♂	NOUN
aiua-9512	58	78	/	/	SYM
aiua-9512	58	79	♀	♀	X
aiua-9512	58	80	)	)	PUNCT
aiua-9512	59	1	50/10	50/10	NUM
aiua-9512	59	2	(	(	PUNCT
aiua-9512	59	3	83.3%/16.7	83.3%/16.7	NUM
aiua-9512	59	4	%	%	NOUN
aiua-9512	59	5	)	)	PUNCT
aiua-9512	60	1	34/6	34/6	NUM
aiua-9512	60	2	(	(	PUNCT
aiua-9512	60	3	85%/15	85%/15	NUM
aiua-9512	60	4	%	%	NOUN
aiua-9512	60	5	)	)	PUNCT
aiua-9512	60	6	16/4	16/4	PROPN
aiua-9512	60	7	(	(	PUNCT
aiua-9512	60	8	80%/20	80%/20	NUM
aiua-9512	60	9	%	%	NOUN
aiua-9512	60	10	)	)	PUNCT
aiua-9512	60	11	0.356	0.356	NUM
aiua-9512	60	12	(	(	PUNCT
aiua-9512	60	13	^	^	NOUN
aiua-9512	60	14	)	)	PUNCT
aiua-9512	60	15	smoker	smoker	NOUN
aiua-9512	60	16	(	(	PUNCT
aiua-9512	60	17	yes	yes	INTJ
aiua-9512	60	18	/	/	SYM
aiua-9512	60	19	no	no	NOUN
aiua-9512	60	20	/	/	SYM
aiua-9512	60	21	ex	ex	NOUN
aiua-9512	60	22	)	)	PUNCT
aiua-9512	60	23	30/9/21	30/9/21	NUM
aiua-9512	60	24	(	(	PUNCT
aiua-9512	60	25	50%/15%/35	50%/15%/35	NUM
aiua-9512	60	26	%	%	NOUN
aiua-9512	60	27	)	)	PUNCT
aiua-9512	60	28	20/5/15	20/5/15	NUM
aiua-9512	61	1	(	(	PUNCT
aiua-9512	61	2	50%/12.5%/37.5	50%/12.5%/37.5	NUM
aiua-9512	61	3	%	%	NOUN
aiua-9512	61	4	)	)	PUNCT
aiua-9512	61	5	10/4/6	10/4/6	NUM
aiua-9512	61	6	(	(	PUNCT
aiua-9512	61	7	50%/20%/30	50%/20%/30	NUM
aiua-9512	61	8	%	%	NOUN
aiua-9512	61	9	)	)	PUNCT
aiua-9512	61	10	0.112	0.112	NUM
aiua-9512	61	11	(	(	PUNCT
aiua-9512	61	12	^	^	NOUN
aiua-9512	61	13	)	)	PUNCT
aiua-9512	61	14	number	number	NOUN
aiua-9512	61	15	of	of	ADP
aiua-9512	61	16	tumors	tumor	NOUN
aiua-9512	61	17	(	(	PUNCT
aiua-9512	61	18	single	single	ADJ
aiua-9512	61	19	/	/	SYM
aiua-9512	61	20	multiple	multiple	NOUN
aiua-9512	61	21	)	)	PUNCT
aiua-9512	61	22	31/29	31/29	NUM
aiua-9512	61	23	(	(	PUNCT
aiua-9512	61	24	51.7%/48.3	51.7%/48.3	NUM
aiua-9512	61	25	%	%	NOUN
aiua-9512	61	26	)	)	PUNCT
aiua-9512	61	27	20/20	20/20	NUM
aiua-9512	61	28	(	(	PUNCT
aiua-9512	61	29	50%/50	50%/50	NUM
aiua-9512	61	30	%	%	NOUN
aiua-9512	61	31	)	)	PUNCT
aiua-9512	61	32	11/9	11/9	NUM
aiua-9512	61	33	(	(	PUNCT
aiua-9512	61	34	55%/45	55%/45	NUM
aiua-9512	61	35	%	%	NOUN
aiua-9512	61	36	)	)	PUNCT
aiua-9512	61	37	0.471	0.471	NUM
aiua-9512	61	38	(	(	PUNCT
aiua-9512	61	39	^	^	NOUN
aiua-9512	61	40	)	)	PUNCT
aiua-9512	61	41	tumor	tumor	NOUN
aiua-9512	61	42	size	size	NOUN
aiua-9512	61	43	(	(	PUNCT
aiua-9512	61	44	>	>	X
aiua-9512	61	45	3	3	NUM
aiua-9512	61	46	cm/	cm/	NOUN
aiua-9512	61	47	<	<	X
aiua-9512	61	48	3	3	NUM
aiua-9512	61	49	cm	cm	NOUN
aiua-9512	61	50	)	)	PUNCT
aiua-9512	61	51	30/30	30/30	NUM
aiua-9512	61	52	(	(	PUNCT
aiua-9512	61	53	50%/50	50%/50	NUM
aiua-9512	61	54	%	%	NOUN
aiua-9512	61	55	)	)	PUNCT
aiua-9512	61	56	21/19	21/19	NUM
aiua-9512	61	57	(	(	PUNCT
aiua-9512	61	58	52.5%/47.5	52.5%/47.5	NUM
aiua-9512	61	59	%	%	NOUN
aiua-9512	61	60	)	)	PUNCT
aiua-9512	61	61	9/11	9/11	NOUN
aiua-9512	61	62	(	(	PUNCT
aiua-9512	61	63	45%/55	45%/55	NOUN
aiua-9512	61	64	%	%	NOUN
aiua-9512	61	65	)	)	PUNCT
aiua-9512	61	66	0.355	0.355	NUM
aiua-9512	61	67	(	(	PUNCT
aiua-9512	61	68	^	^	NOUN
aiua-9512	61	69	)	)	PUNCT
aiua-9512	61	70	concomitant	concomitant	ADJ
aiua-9512	61	71	carcinoma	carcinoma	NOUN
aiua-9512	61	72	in	in	ADP
aiua-9512	61	73	situ	situ	NOUN
aiua-9512	61	74	(	(	PUNCT
aiua-9512	61	75	yes	yes	INTJ
aiua-9512	61	76	/	/	SYM
aiua-9512	61	77	no	no	NOUN
aiua-9512	61	78	)	)	PUNCT
aiua-9512	61	79	12/48	12/48	NUM
aiua-9512	61	80	(	(	PUNCT
aiua-9512	61	81	20%/80	20%/80	NUM
aiua-9512	61	82	%	%	NOUN
aiua-9512	61	83	)	)	PUNCT
aiua-9512	61	84	8/32	8/32	NUM
aiua-9512	61	85	(	(	PUNCT
aiua-9512	61	86	20%/80	20%/80	NUM
aiua-9512	61	87	%	%	NOUN
aiua-9512	61	88	)	)	PUNCT
aiua-9512	62	1	4/16	4/16	NUM
aiua-9512	62	2	(	(	PUNCT
aiua-9512	62	3	20%/80	20%/80	NUM
aiua-9512	62	4	%	%	NOUN
aiua-9512	62	5	)	)	PUNCT
aiua-9512	62	6	0.642	0.642	NUM
aiua-9512	62	7	(	(	PUNCT
aiua-9512	62	8	^	^	NOUN
aiua-9512	62	9	)	)	PUNCT
aiua-9512	62	10	tumor	tumor	NOUN
aiua-9512	62	11	stage	stage	NOUN
aiua-9512	62	12	t	t	PROPN
aiua-9512	62	13	(	(	PUNCT
aiua-9512	62	14	ta	ta	PART
aiua-9512	62	15	/	/	SYM
aiua-9512	62	16	t1	t1	NOUN
aiua-9512	62	17	)	)	PUNCT
aiua-9512	62	18	15/45	15/45	NUM
aiua-9512	62	19	(	(	PUNCT
aiua-9512	62	20	25%/75	25%/75	NUM
aiua-9512	62	21	%	%	NOUN
aiua-9512	62	22	)	)	PUNCT
aiua-9512	62	23	11/29	11/29	NUM
aiua-9512	62	24	(	(	PUNCT
aiua-9512	62	25	27.5%/72.5	27.5%/72.5	NUM
aiua-9512	62	26	%	%	NOUN
aiua-9512	62	27	)	)	PUNCT
aiua-9512	63	1	4/16	4/16	NUM
aiua-9512	63	2	(	(	PUNCT
aiua-9512	63	3	20%/80	20%/80	NUM
aiua-9512	63	4	%	%	NOUN
aiua-9512	63	5	)	)	PUNCT
aiua-9512	63	6	0.490	0.490	NUM
aiua-9512	63	7	(	(	PUNCT
aiua-9512	63	8	^	^	NUM
aiua-9512	63	9	)	)	PUNCT
aiua-9512	63	10	(	(	PUNCT
aiua-9512	63	11	^	^	NOUN
aiua-9512	63	12	):	):	PUNCT
aiua-9512	63	13	pearson	pearson	PROPN
aiua-9512	63	14	chi	chi	PROPN
aiua-9512	63	15	-	-	PUNCT
aiua-9512	63	16	square	square	PROPN
aiua-9512	63	17	test	test	NOUN
aiua-9512	63	18	;	;	PUNCT
aiua-9512	63	19	(	(	PUNCT
aiua-9512	63	20	*	*	PUNCT
aiua-9512	63	21	)	)	PUNCT
aiua-9512	63	22	:	:	PUNCT
aiua-9512	63	23	t	t	NOUN
aiua-9512	63	24	-	-	PUNCT
aiua-9512	63	25	test	test	NOUN
aiua-9512	63	26	,	,	PUNCT
aiua-9512	63	27	statistical	statistical	ADJ
aiua-9512	63	28	significance	significance	NOUN
aiua-9512	63	29	was	be	AUX
aiua-9512	63	30	set	set	VERB
aiua-9512	63	31	as	as	ADP
aiua-9512	63	32	p	p	NOUN
aiua-9512	63	33	≤	≤	NUM
aiua-9512	63	34	0.05	0.05	NUM
aiua-9512	63	35	.	.	PUNCT
aiua-9512	64	1	figure	figure	NOUN
aiua-9512	64	2	1	1	NUM
aiua-9512	64	3	.	.	PUNCT
aiua-9512	64	4	high	high	ADJ
aiua-9512	64	5	-	-	PUNCT
aiua-9512	64	6	grade	grade	NOUN
aiua-9512	64	7	nonmuscle	nonmuscle	NOUN
aiua-9512	64	8	invasive	invasive	ADJ
aiua-9512	64	9	urothelial	urothelial	ADJ
aiua-9512	64	10	carcinoma	carcinoma	NOUN
aiua-9512	64	11	,	,	PUNCT
aiua-9512	64	12	stage	stage	NOUN
aiua-9512	64	13	pt1	pt1	PROPN
aiua-9512	64	14	.	.	PUNCT
aiua-9512	64	15	strong	strong	ADJ
aiua-9512	64	16	cytoplasmic	cytoplasmic	ADJ
aiua-9512	64	17	immunostaining	immunostaine	VERB
aiua-9512	64	18	for	for	ADP
aiua-9512	64	19	et-1	et-1	X
aiua-9512	64	20	(	(	PUNCT
aiua-9512	64	21	x400	x400	PROPN
aiua-9512	64	22	)	)	PUNCT
aiua-9512	64	23	.	.	PUNCT
aiua-9512	65	1	positive	positive	ADJ
aiua-9512	65	2	marker	marker	NOUN
aiua-9512	65	3	the	the	DET
aiua-9512	65	4	vascular	vascular	ADJ
aiua-9512	65	5	endothelium	endothelium	NOUN
aiua-9512	65	6	(	(	PUNCT
aiua-9512	65	7	arrows	arrow	NOUN
aiua-9512	65	8	)	)	PUNCT
aiua-9512	65	9	.	.	PUNCT
aiua-9512	66	1	table	table	NOUN
aiua-9512	66	2	2	2	NUM
aiua-9512	66	3	.	.	NUM
aiua-9512	66	4	summarized	summarize	VERB
aiua-9512	66	5	results	result	NOUN
aiua-9512	66	6	of	of	ADP
aiua-9512	66	7	the	the	DET
aiua-9512	66	8	immunohistochemical	immunohistochemical	ADJ
aiua-9512	66	9	staining	stain	VERB
aiua-9512	66	10	(	(	PUNCT
aiua-9512	66	11	ihcs	ihc	NOUN
aiua-9512	66	12	)	)	PUNCT
aiua-9512	66	13	for	for	ADP
aiua-9512	66	14	groups	group	NOUN
aiua-9512	66	15	a	a	PRON
aiua-9512	66	16	and	and	CCONJ
aiua-9512	66	17	b.	b.	PROPN
aiua-9512	66	18	ihcs	ihcs	PROPN
aiua-9512	66	19	grading	grade	VERB
aiua-9512	66	20	of	of	ADP
aiua-9512	66	21	ihcs	ihcs	NOUN
aiua-9512	66	22	patients	patient	NOUN
aiua-9512	66	23	’	'	PUNCT
aiua-9512	66	24	group	group	NOUN
aiua-9512	66	25	0	0	NUM
aiua-9512	66	26	1	1	NUM
aiua-9512	66	27	(	(	PUNCT
aiua-9512	66	28	mild	mild	ADJ
aiua-9512	66	29	)	)	PUNCT
aiua-9512	66	30	2	2	NUM
aiua-9512	66	31	(	(	PUNCT
aiua-9512	66	32	moderate	moderate	ADJ
aiua-9512	66	33	)	)	PUNCT
aiua-9512	66	34	3	3	NUM
aiua-9512	66	35	(	(	PUNCT
aiua-9512	66	36	strong	strong	ADJ
aiua-9512	66	37	)	)	PUNCT
aiua-9512	66	38	et-1	et-1	NUM
aiua-9512	66	39	1	1	NUM
aiua-9512	66	40	(	(	PUNCT
aiua-9512	66	41	2.5	2.5	NUM
aiua-9512	66	42	%	%	NOUN
aiua-9512	66	43	)	)	PUNCT
aiua-9512	66	44	18	18	NUM
aiua-9512	66	45	(	(	PUNCT
aiua-9512	66	46	45	45	NUM
aiua-9512	66	47	%	%	NOUN
aiua-9512	66	48	)	)	PUNCT
aiua-9512	66	49	15	15	NUM
aiua-9512	66	50	(	(	PUNCT
aiua-9512	66	51	37.5	37.5	NUM
aiua-9512	66	52	%	%	NOUN
aiua-9512	66	53	)	)	PUNCT
aiua-9512	66	54	6	6	NUM
aiua-9512	66	55	(	(	PUNCT
aiua-9512	66	56	15	15	NUM
aiua-9512	66	57	%	%	NOUN
aiua-9512	66	58	)	)	PUNCT
aiua-9512	66	59	a	a	DET
aiua-9512	66	60	(	(	PUNCT
aiua-9512	66	61	n	n	NOUN
aiua-9512	66	62	=	=	SYM
aiua-9512	66	63	40	40	NUM
aiua-9512	66	64	)	)	PUNCT
aiua-9512	66	65	et-1	et-1	NUM
aiua-9512	66	66	5	5	NUM
aiua-9512	66	67	(	(	PUNCT
aiua-9512	66	68	25	25	NUM
aiua-9512	66	69	%	%	NOUN
aiua-9512	66	70	)	)	PUNCT
aiua-9512	66	71	12	12	NUM
aiua-9512	66	72	(	(	PUNCT
aiua-9512	66	73	60	60	NUM
aiua-9512	66	74	%	%	NOUN
aiua-9512	66	75	)	)	PUNCT
aiua-9512	66	76	2	2	NUM
aiua-9512	66	77	(	(	PUNCT
aiua-9512	66	78	10	10	NUM
aiua-9512	66	79	%	%	NOUN
aiua-9512	66	80	)	)	PUNCT
aiua-9512	66	81	1	1	NUM
aiua-9512	66	82	(	(	PUNCT
aiua-9512	66	83	5	5	NUM
aiua-9512	66	84	%	%	NOUN
aiua-9512	66	85	)	)	PUNCT
aiua-9512	66	86	b	b	NOUN
aiua-9512	66	87	(	(	PUNCT
aiua-9512	66	88	n	n	NOUN
aiua-9512	66	89	=	=	SYM
aiua-9512	66	90	20	20	NUM
aiua-9512	66	91	)	)	PUNCT
aiua-9512	66	92	group	group	NOUN
aiua-9512	66	93	b	b	PROPN
aiua-9512	66	94	had	have	VERB
aiua-9512	66	95	neither	neither	CCONJ
aiua-9512	66	96	recurrence	recurrence	NOUN
aiua-9512	66	97	nor	nor	CCONJ
aiua-9512	66	98	progression	progression	NOUN
aiua-9512	66	99	.	.	PUNCT
aiua-9512	67	1	median	median	ADJ
aiua-9512	67	2	rfs	rfs	PROPN
aiua-9512	67	3	and	and	CCONJ
aiua-9512	67	4	median	median	ADJ
aiua-9512	67	5	pfs	pfs	PROPN
aiua-9512	67	6	were	be	AUX
aiua-9512	67	7	87.8	87.8	NUM
aiua-9512	67	8	months	month	NOUN
aiua-9512	67	9	.	.	PUNCT
aiua-9512	68	1	recurrence	recurrence	NOUN
aiua-9512	68	2	:	:	PUNCT
aiua-9512	68	3	in	in	ADP
aiua-9512	68	4	univariate	univariate	ADJ
aiua-9512	68	5	analysis	analysis	NOUN
aiua-9512	68	6	,	,	PUNCT
aiua-9512	68	7	et-1	et-1	X
aiua-9512	68	8	(	(	PUNCT
aiua-9512	68	9	p	p	X
aiua-9512	68	10	=	=	NOUN
aiua-9512	68	11	0.000	0.000	NUM
aiua-9512	68	12	)	)	PUNCT
aiua-9512	68	13	and	and	CCONJ
aiua-9512	68	14	age	age	NOUN
aiua-9512	68	15	(	(	PUNCT
aiua-9512	68	16	p	p	NOUN
aiua-9512	68	17	=	=	NOUN
aiua-9512	68	18	0.001	0.001	NUM
aiua-9512	68	19	,	,	PUNCT
aiua-9512	68	20	t	t	NOUN
aiua-9512	68	21	-	-	PUNCT
aiua-9512	68	22	test	test	NOUN
aiua-9512	68	23	)	)	PUNCT
aiua-9512	68	24	were	be	AUX
aiua-9512	68	25	statistically	statistically	ADV
aiua-9512	68	26	significant	significant	ADJ
aiua-9512	68	27	.	.	PUNCT
aiua-9512	69	1	specifically	specifically	ADV
aiua-9512	69	2	,	,	PUNCT
aiua-9512	69	3	among	among	ADP
aiua-9512	69	4	the	the	DET
aiua-9512	69	5	patients	patient	NOUN
aiua-9512	69	6	of	of	ADP
aiua-9512	69	7	group	group	PROPN
aiua-9512	69	8	a	a	PRON
aiua-9512	69	9	who	who	PRON
aiua-9512	69	10	had	have	VERB
aiua-9512	69	11	recurrence	recurrence	NOUN
aiua-9512	69	12	(	(	PUNCT
aiua-9512	69	13	n	n	NOUN
aiua-9512	69	14	=	=	NOUN
aiua-9512	69	15	27/40	27/40	NUM
aiua-9512	69	16	)	)	PUNCT
aiua-9512	69	17	,	,	PUNCT
aiua-9512	69	18	26	26	NUM
aiua-9512	69	19	of	of	ADP
aiua-9512	69	20	them	they	PRON
aiua-9512	69	21	(	(	PUNCT
aiua-9512	69	22	26/27	26/27	NUM
aiua-9512	69	23	,	,	PUNCT
aiua-9512	69	24	96.3	96.3	NUM
aiua-9512	69	25	%	%	NOUN
aiua-9512	69	26	)	)	PUNCT
aiua-9512	69	27	showed	show	VERB
aiua-9512	69	28	et-1	et-1	CCONJ
aiua-9512	69	29	expression	expression	NOUN
aiua-9512	69	30	in	in	ADP
aiua-9512	69	31	the	the	DET
aiua-9512	69	32	ihc	ihc	PROPN
aiua-9512	69	33	.	.	PUNCT
aiua-9512	70	1	the	the	DET
aiua-9512	70	2	multivariate	multivariate	NOUN
aiua-9512	70	3	analysis	analysis	NOUN
aiua-9512	70	4	showed	show	VERB
aiua-9512	70	5	significance	significance	NOUN
aiua-9512	70	6	only	only	ADV
aiua-9512	70	7	for	for	ADP
aiua-9512	70	8	the	the	DET
aiua-9512	70	9	patient	patient	NOUN
aiua-9512	70	10	’s	’s	PART
aiua-9512	70	11	age	age	NOUN
aiua-9512	70	12	(	(	PUNCT
aiua-9512	70	13	p	p	X
aiua-9512	70	14	=	=	NOUN
aiua-9512	70	15	0.003	0.003	NUM
aiua-9512	70	16	,	,	PUNCT
aiua-9512	70	17	or	or	CCONJ
aiua-9512	70	18	=	=	NOUN
aiua-9512	70	19	1.273	1.273	NUM
aiua-9512	70	20	,	,	PUNCT
aiua-9512	70	21	95	95	NUM
aiua-9512	70	22	%	%	NOUN
aiua-9512	70	23	ci	ci	NOUN
aiua-9512	70	24	:	:	PUNCT
aiua-9512	70	25	1.086	1.086	NUM
aiua-9512	70	26	-	-	SYM
aiua-9512	70	27	1.492	1.492	NUM
aiua-9512	70	28	)	)	PUNCT
aiua-9512	70	29	.	.	PUNCT
aiua-9512	71	1	progression	progression	NOUN
aiua-9512	71	2	:	:	PUNCT
aiua-9512	71	3	in	in	ADP
aiua-9512	71	4	univariate	univariate	ADJ
aiua-9512	71	5	analysis	analysis	NOUN
aiua-9512	71	6	,	,	PUNCT
aiua-9512	71	7	et-1	et-1	X
aiua-9512	71	8	(	(	PUNCT
aiua-9512	71	9	p	p	X
aiua-9512	71	10	=	=	NOUN
aiua-9512	71	11	0.000	0.000	NUM
aiua-9512	71	12	)	)	PUNCT
aiua-9512	71	13	was	be	AUX
aiua-9512	71	14	significant	significant	ADJ
aiua-9512	71	15	.	.	PUNCT
aiua-9512	72	1	notably	notably	ADV
aiua-9512	72	2	,	,	PUNCT
aiua-9512	72	3	among	among	ADP
aiua-9512	72	4	the	the	DET
aiua-9512	72	5	patients	patient	NOUN
aiua-9512	72	6	of	of	ADP
aiua-9512	72	7	group	group	PROPN
aiua-9512	72	8	a	a	PRON
aiua-9512	72	9	who	who	PRON
aiua-9512	72	10	had	have	VERB
aiua-9512	72	11	progression	progression	NOUN
aiua-9512	72	12	(	(	PUNCT
aiua-9512	72	13	n	n	NOUN
aiua-9512	72	14	=	=	SYM
aiua-9512	72	15	13/40	13/40	NUM
aiua-9512	72	16	)	)	PUNCT
aiua-9512	72	17	,	,	PUNCT
aiua-9512	72	18	13	13	NUM
aiua-9512	72	19	of	of	ADP
aiua-9512	72	20	them	they	PRON
aiua-9512	72	21	(	(	PUNCT
aiua-9512	72	22	13/13	13/13	NUM
aiua-9512	72	23	,	,	PUNCT
aiua-9512	72	24	100	100	NUM
aiua-9512	72	25	%	%	NOUN
aiua-9512	72	26	)	)	PUNCT
aiua-9512	72	27	showed	show	VERB
aiua-9512	72	28	et-1	et-1	CCONJ
aiua-9512	72	29	expression	expression	NOUN
aiua-9512	72	30	in	in	ADP
aiua-9512	72	31	the	the	DET
aiua-9512	72	32	ihc	ihc	PROPN
aiua-9512	72	33	.	.	PUNCT
aiua-9512	73	1	no	no	DET
aiua-9512	73	2	parameter	parameter	NOUN
aiua-9512	73	3	showed	show	VERB
aiua-9512	73	4	significance	significance	NOUN
aiua-9512	73	5	in	in	ADP
aiua-9512	73	6	multivariate	multivariate	NOUN
aiua-9512	73	7	analysis	analysis	NOUN
aiua-9512	73	8	.	.	PUNCT
aiua-9512	74	1	recurrence	recurrence	NOUN
aiua-9512	74	2	-	-	PUNCT
aiua-9512	74	3	free	free	ADJ
aiua-9512	74	4	survival	survival	NOUN
aiua-9512	74	5	(	(	PUNCT
aiua-9512	74	6	rfs	rfs	PROPN
aiua-9512	74	7	):	):	PUNCT
aiua-9512	74	8	in	in	ADP
aiua-9512	74	9	univariate	univariate	ADJ
aiua-9512	74	10	model	model	NOUN
aiua-9512	74	11	,	,	PUNCT
aiua-9512	74	12	et-1	et-1	PUNCT
aiua-9512	74	13	was	be	AUX
aiua-9512	74	14	importantly	importantly	ADV
aiua-9512	74	15	associated	associate	VERB
aiua-9512	74	16	with	with	ADP
aiua-9512	74	17	rfs	rfs	PROPN
aiua-9512	74	18	(	(	PUNCT
aiua-9512	74	19	p	p	X
aiua-9512	74	20	=	=	NOUN
aiua-9512	74	21	0.000	0.000	NUM
aiua-9512	74	22	)	)	PUNCT
aiua-9512	74	23	,	,	PUNCT
aiua-9512	74	24	which	which	PRON
aiua-9512	74	25	is	be	AUX
aiua-9512	74	26	illustrated	illustrate	VERB
aiua-9512	74	27	in	in	ADP
aiua-9512	74	28	the	the	DET
aiua-9512	74	29	kaplan	kaplan	PROPN
aiua-9512	74	30	-	-	PUNCT
aiua-9512	74	31	meier	meier	PROPN
aiua-9512	74	32	curves	curve	NOUN
aiua-9512	74	33	(	(	PUNCT
aiua-9512	74	34	figure	figure	NOUN
aiua-9512	74	35	2	2	NUM
aiua-9512	74	36	)	)	PUNCT
aiua-9512	74	37	.	.	PUNCT
aiua-9512	75	1	age	age	NOUN
aiua-9512	75	2	is	be	AUX
aiua-9512	75	3	significant	significant	ADJ
aiua-9512	75	4	too	too	ADV
aiua-9512	75	5	(	(	PUNCT
aiua-9512	75	6	p	p	X
aiua-9512	75	7	=	=	NOUN
aiua-9512	75	8	0.013	0.013	NUM
aiua-9512	75	9	,	,	PUNCT
aiua-9512	75	10	cox	cox	PROPN
aiua-9512	75	11	regression	regression	PROPN
aiua-9512	75	12	)	)	PUNCT
aiua-9512	75	13	.	.	PUNCT
aiua-9512	76	1	the	the	DET
aiua-9512	76	2	multivariate	multivariate	NOUN
aiua-9512	76	3	model	model	NOUN
aiua-9512	76	4	provided	provide	VERB
aiua-9512	76	5	no	no	DET
aiua-9512	76	6	significant	significant	ADJ
aiua-9512	76	7	finding	finding	NOUN
aiua-9512	76	8	.	.	PUNCT
aiua-9512	77	1	progression	progression	NOUN
aiua-9512	77	2	-	-	PUNCT
aiua-9512	77	3	free	free	ADJ
aiua-9512	77	4	survival	survival	NOUN
aiua-9512	77	5	(	(	PUNCT
aiua-9512	77	6	pfs	pfs	PROPN
aiua-9512	77	7	):	):	PUNCT
aiua-9512	77	8	as	as	SCONJ
aiua-9512	77	9	it	it	PRON
aiua-9512	77	10	is	be	AUX
aiua-9512	77	11	shown	show	VERB
aiua-9512	77	12	by	by	ADP
aiua-9512	77	13	kaplan	kaplan	PROPN
aiua-9512	77	14	-	-	PUNCT
aiua-9512	77	15	meier	meier	PROPN
aiua-9512	77	16	curves	curve	NOUN
aiua-9512	77	17	(	(	PUNCT
aiua-9512	77	18	figure	figure	NOUN
aiua-9512	77	19	3	3	NUM
aiua-9512	77	20	)	)	PUNCT
aiua-9512	77	21	,	,	PUNCT
aiua-9512	77	22	the	the	DET
aiua-9512	77	23	univariate	univariate	ADJ
aiua-9512	77	24	analysis	analysis	NOUN
aiua-9512	77	25	revealed	reveal	VERB
aiua-9512	77	26	the	the	DET
aiua-9512	77	27	significance	significance	NOUN
aiua-9512	77	28	of	of	ADP
aiua-9512	77	29	et-1	et-1	X
aiua-9512	77	30	(	(	PUNCT
aiua-9512	77	31	p	p	X
aiua-9512	77	32	=	=	NOUN
aiua-9512	77	33	0.000	0.000	NUM
aiua-9512	77	34	)	)	PUNCT
aiua-9512	77	35	.	.	PUNCT
aiua-9512	78	1	no	no	DET
aiua-9512	78	2	parameter	parameter	NOUN
aiua-9512	78	3	proved	prove	VERB
aiua-9512	78	4	to	to	PART
aiua-9512	78	5	be	be	AUX
aiua-9512	78	6	significant	significant	ADJ
aiua-9512	78	7	in	in	ADP
aiua-9512	78	8	multivariate	multivariate	NOUN
aiua-9512	78	9	analysis	analysis	NOUN
aiua-9512	78	10	.	.	PUNCT
aiua-9512	79	1	discussion	discussion	NOUN
aiua-9512	79	2	the	the	DET
aiua-9512	79	3	two	two	NUM
aiua-9512	79	4	major	major	ADJ
aiua-9512	79	5	events	event	NOUN
aiua-9512	79	6	in	in	ADP
aiua-9512	79	7	the	the	DET
aiua-9512	79	8	natural	natural	ADJ
aiua-9512	79	9	history	history	NOUN
aiua-9512	79	10	of	of	ADP
aiua-9512	79	11	hgnmiubc	hgnmiubc	PROPN
aiua-9512	79	12	are	be	AUX
aiua-9512	79	13	recurrence	recurrence	NOUN
aiua-9512	79	14	and	and	CCONJ
aiua-9512	79	15	progression	progression	NOUN
aiua-9512	79	16	to	to	ADP
aiua-9512	79	17	muscle	muscle	NOUN
aiua-9512	79	18	-	-	PUNCT
aiua-9512	79	19	invasiveness	invasiveness	ADJ
aiua-9512	79	20	,	,	PUNCT
aiua-9512	79	21	despite	despite	SCONJ
aiua-9512	79	22	the	the	DET
aiua-9512	79	23	initial	initial	ADJ
aiua-9512	79	24	high	high	ADJ
aiua-9512	79	25	response	response	NOUN
aiua-9512	79	26	-	-	PUNCT
aiua-9512	79	27	rate	rate	NOUN
aiua-9512	79	28	to	to	ADP
aiua-9512	79	29	postoperative	postoperative	ADJ
aiua-9512	79	30	intravesical	intravesical	ADJ
aiua-9512	79	31	bcg	bcg	PROPN
aiua-9512	79	32	treatment	treatment	NOUN
aiua-9512	79	33	(	(	PUNCT
aiua-9512	79	34	8)	8)	NUM
aiua-9512	79	35	.	.	PUNCT
aiua-9512	79	36	from	from	ADP
aiua-9512	79	37	a	a	DET
aiua-9512	79	38	clinical	clinical	ADJ
aiua-9512	79	39	point	point	NOUN
aiua-9512	79	40	of	of	ADP
aiua-9512	79	41	view	view	NOUN
aiua-9512	79	42	it	it	PRON
aiua-9512	79	43	is	be	AUX
aiua-9512	79	44	difficult	difficult	ADJ
aiua-9512	79	45	and	and	CCONJ
aiua-9512	79	46	of	of	ADP
aiua-9512	79	47	value	value	NOUN
aiua-9512	79	48	to	to	PART
aiua-9512	79	49	identify	identify	VERB
aiua-9512	79	50	on	on	ADP
aiua-9512	79	51	time	time	NOUN
aiua-9512	79	52	and	and	CCONJ
aiua-9512	79	53	correctly	correctly	ADV
aiua-9512	79	54	those	those	DET
aiua-9512	79	55	patients	patient	NOUN
aiua-9512	79	56	who	who	PRON
aiua-9512	79	57	will	will	AUX
aiua-9512	79	58	experience	experience	VERB
aiua-9512	79	59	a	a	DET
aiua-9512	79	60	failure	failure	NOUN
aiua-9512	79	61	of	of	ADP
aiua-9512	79	62	bcg	bcg	NOUN
aiua-9512	79	63	-	-	PUNCT
aiua-9512	79	64	therapy	therapy	NOUN
aiua-9512	79	65	and	and	CCONJ
aiua-9512	79	66	consequently	consequently	ADV
aiua-9512	79	67	recurrence	recurrence	NOUN
aiua-9512	79	68	and/or	and/or	CCONJ
aiua-9512	79	69	progression	progression	NOUN
aiua-9512	79	70	.	.	PUNCT
aiua-9512	80	1	of	of	ADP
aiua-9512	80	2	course	course	NOUN
aiua-9512	80	3	,	,	PUNCT
aiua-9512	80	4	the	the	DET
aiua-9512	80	5	heterogeneity	heterogeneity	NOUN
aiua-9512	80	6	of	of	ADP
aiua-9512	80	7	the	the	DET
aiua-9512	80	8	tumor	tumor	NOUN
aiua-9512	80	9	does	do	AUX
aiua-9512	80	10	not	not	PART
aiua-9512	80	11	facilitate	facilitate	VERB
aiua-9512	80	12	a	a	DET
aiua-9512	80	13	safe	safe	ADJ
aiua-9512	80	14	prognosis	prognosis	NOUN
aiua-9512	80	15	.	.	PUNCT
aiua-9512	81	1	risk	risk	NOUN
aiua-9512	81	2	tables	table	NOUN
aiua-9512	81	3	for	for	ADP
aiua-9512	81	4	predicting	predict	VERB
aiua-9512	81	5	recurrence	recurrence	NOUN
aiua-9512	81	6	and	and	CCONJ
aiua-9512	81	7	progression	progression	NOUN
aiua-9512	81	8	,	,	PUNCT
aiua-9512	81	9	based	base	VERB
aiua-9512	81	10	on	on	ADP
aiua-9512	81	11	the	the	DET
aiua-9512	81	12	six	six	NUM
aiua-9512	81	13	most	most	ADV
aiua-9512	81	14	significant	significant	ADJ
aiua-9512	81	15	clinical	clinical	ADJ
aiua-9512	81	16	and	and	CCONJ
aiua-9512	81	17	pathological	pathological	ADJ
aiua-9512	81	18	factors	factor	NOUN
aiua-9512	81	19	,	,	PUNCT
aiua-9512	81	20	were	be	AUX
aiua-9512	81	21	developed	develop	VERB
aiua-9512	81	22	by	by	ADP
aiua-9512	81	23	the	the	DET
aiua-9512	81	24	european	european	PROPN
aiua-9512	81	25	organization	organization	PROPN
aiua-9512	81	26	for	for	ADP
aiua-9512	81	27	145archivio	145archivio	PROPN
aiua-9512	81	28	italiano	italiano	NOUN
aiua-9512	81	29	di	di	X
aiua-9512	81	30	urologia	urologia	PROPN
aiua-9512	81	31	e	e	PROPN
aiua-9512	81	32	andrologia	andrologia	NOUN
aiua-9512	81	33	2021	2021	NUM
aiua-9512	81	34	;	;	PUNCT
aiua-9512	81	35	93	93	NUM
aiua-9512	81	36	,	,	PUNCT
aiua-9512	81	37	2	2	NUM
aiua-9512	81	38	et-1	et-1	X
aiua-9512	81	39	worsens	worsen	VERB
aiua-9512	81	40	prognosis	prognosis	NOUN
aiua-9512	81	41	in	in	ADP
aiua-9512	81	42	bladder	bladder	NOUN
aiua-9512	81	43	cancer	cancer	NOUN
aiua-9512	81	44	table	table	NOUN
aiua-9512	81	45	3	3	NUM
aiua-9512	81	46	.	.	PUNCT
aiua-9512	81	47	detailed	detailed	ADJ
aiua-9512	81	48	results	result	NOUN
aiua-9512	81	49	of	of	ADP
aiua-9512	81	50	the	the	DET
aiua-9512	81	51	immunohistochemical	immunohistochemical	ADJ
aiua-9512	81	52	(	(	PUNCT
aiua-9512	81	53	ihc	ihc	PROPN
aiua-9512	81	54	)	)	PUNCT
aiua-9512	81	55	staining	stain	VERB
aiua-9512	81	56	for	for	ADP
aiua-9512	81	57	group	group	NOUN
aiua-9512	81	58	a	a	PRON
aiua-9512	81	59	regarding	regard	VERB
aiua-9512	81	60	recurrence	recurrence	NOUN
aiua-9512	81	61	and	and	CCONJ
aiua-9512	81	62	progression	progression	NOUN
aiua-9512	81	63	.	.	PUNCT
aiua-9512	82	1	figure	figure	NOUN
aiua-9512	82	2	3	3	NUM
aiua-9512	82	3	.	.	PUNCT
aiua-9512	83	1	the	the	DET
aiua-9512	83	2	expression	expression	NOUN
aiua-9512	83	3	of	of	ADP
aiua-9512	83	4	et-1	et-1	NUM
aiua-9512	83	5	in	in	ADP
aiua-9512	83	6	primary	primary	ADJ
aiua-9512	83	7	high	high	ADJ
aiua-9512	83	8	-	-	PUNCT
aiua-9512	83	9	grade	grade	NOUN
aiua-9512	83	10	non	non	ADJ
aiua-9512	83	11	-	-	ADJ
aiua-9512	83	12	muscle	muscle	ADJ
aiua-9512	83	13	-	-	PUNCT
aiua-9512	83	14	invasive	invasive	ADJ
aiua-9512	83	15	urothelial	urothelial	ADJ
aiua-9512	83	16	bladder	bladder	NOUN
aiua-9512	83	17	cancer	cancer	NOUN
aiua-9512	83	18	(	(	PUNCT
aiua-9512	83	19	hgnmiubc	hgnmiubc	NOUN
aiua-9512	83	20	)	)	PUNCT
aiua-9512	83	21	significantly	significantly	ADV
aiua-9512	83	22	associates	associate	VERB
aiua-9512	83	23	with	with	ADP
aiua-9512	83	24	progression	progression	NOUN
aiua-9512	83	25	-	-	PUNCT
aiua-9512	83	26	free	free	ADJ
aiua-9512	83	27	survival	survival	NOUN
aiua-9512	83	28	/	/	SYM
aiua-9512	83	29	pfs	pfs	PROPN
aiua-9512	83	30	(	(	PUNCT
aiua-9512	83	31	ihc	ihc	PROPN
aiua-9512	83	32	:	:	PUNCT
aiua-9512	83	33	immunohistochemical	immunohistochemical	ADJ
aiua-9512	83	34	staining	staining	NOUN
aiua-9512	83	35	)	)	PUNCT
aiua-9512	83	36	.	.	PUNCT
aiua-9512	84	1	figure	figure	NOUN
aiua-9512	84	2	2	2	NUM
aiua-9512	84	3	.	.	PUNCT
aiua-9512	85	1	the	the	DET
aiua-9512	85	2	expression	expression	NOUN
aiua-9512	85	3	of	of	ADP
aiua-9512	85	4	et-1	et-1	NUM
aiua-9512	85	5	in	in	ADP
aiua-9512	85	6	primary	primary	ADJ
aiua-9512	85	7	high	high	ADJ
aiua-9512	85	8	-	-	PUNCT
aiua-9512	85	9	grade	grade	NOUN
aiua-9512	85	10	non	non	ADJ
aiua-9512	85	11	-	-	ADJ
aiua-9512	85	12	muscle	muscle	ADJ
aiua-9512	85	13	-	-	PUNCT
aiua-9512	85	14	invasive	invasive	ADJ
aiua-9512	85	15	urothelial	urothelial	ADJ
aiua-9512	85	16	bladder	bladder	NOUN
aiua-9512	85	17	cancer	cancer	NOUN
aiua-9512	85	18	(	(	PUNCT
aiua-9512	85	19	hgnmiubc	hgnmiubc	NOUN
aiua-9512	85	20	)	)	PUNCT
aiua-9512	85	21	significantly	significantly	ADV
aiua-9512	85	22	associates	associate	VERB
aiua-9512	85	23	with	with	ADP
aiua-9512	85	24	recurrence	recurrence	NOUN
aiua-9512	85	25	-	-	PUNCT
aiua-9512	85	26	free	free	ADJ
aiua-9512	85	27	survival	survival	NOUN
aiua-9512	85	28	/	/	SYM
aiua-9512	85	29	rfs	rfs	PROPN
aiua-9512	85	30	(	(	PUNCT
aiua-9512	85	31	ihc	ihc	PROPN
aiua-9512	85	32	:	:	PUNCT
aiua-9512	85	33	immunohistochemical	immunohistochemical	ADJ
aiua-9512	85	34	staining	staining	NOUN
aiua-9512	85	35	)	)	PUNCT
aiua-9512	85	36	.	.	PUNCT
aiua-9512	86	1	ihc	ihc	PROPN
aiua-9512	86	2	grading	grading	PROPN
aiua-9512	86	3	of	of	ADP
aiua-9512	86	4	ihc	ihc	PROPN
aiua-9512	86	5	group	group	PROPN
aiua-9512	86	6	a	a	DET
aiua-9512	86	7	p	p	NOUN
aiua-9512	86	8	value	value	NOUN
aiua-9512	86	9	0	0	NUM
aiua-9512	86	10	1	1	NUM
aiua-9512	86	11	(	(	PUNCT
aiua-9512	86	12	mild	mild	ADJ
aiua-9512	86	13	)	)	PUNCT
aiua-9512	86	14	2	2	NUM
aiua-9512	86	15	(	(	PUNCT
aiua-9512	86	16	moderate	moderate	ADJ
aiua-9512	86	17	)	)	PUNCT
aiua-9512	86	18	3	3	NUM
aiua-9512	86	19	(	(	PUNCT
aiua-9512	86	20	strong	strong	ADJ
aiua-9512	86	21	)	)	PUNCT
aiua-9512	86	22	rec	rec	X
aiua-9512	86	23	rfs	rfs	PROPN
aiua-9512	86	24	pr	pr	PROPN
aiua-9512	86	25	pfs	pfs	PROPN
aiua-9512	86	26	et-1	et-1	NUM
aiua-9512	86	27	1/1	1/1	NUM
aiua-9512	86	28	(	(	PUNCT
aiua-9512	86	29	100	100	NUM
aiua-9512	86	30	%	%	NOUN
aiua-9512	86	31	)	)	PUNCT
aiua-9512	87	1	6/18	6/18	NUM
aiua-9512	87	2	(	(	PUNCT
aiua-9512	87	3	33.3	33.3	NUM
aiua-9512	87	4	%	%	NOUN
aiua-9512	87	5	)	)	PUNCT
aiua-9512	87	6	14/15	14/15	NUM
aiua-9512	87	7	(	(	PUNCT
aiua-9512	87	8	93.3	93.3	NUM
aiua-9512	87	9	%	%	NOUN
aiua-9512	87	10	)	)	PUNCT
aiua-9512	87	11	6/6	6/6	NUM
aiua-9512	87	12	(	(	PUNCT
aiua-9512	87	13	100	100	NUM
aiua-9512	87	14	%	%	NOUN
aiua-9512	87	15	)	)	PUNCT
aiua-9512	87	16	recurrence	recurrence	NOUN
aiua-9512	87	17	n	n	NOUN
aiua-9512	87	18	=	=	SYM
aiua-9512	87	19	27/40	27/40	NUM
aiua-9512	87	20	(	(	PUNCT
aiua-9512	87	21	67.5	67.5	NUM
aiua-9512	87	22	%	%	NOUN
aiua-9512	87	23	)	)	PUNCT
aiua-9512	88	1	0.000	0.000	NUM
aiua-9512	89	1	*	*	PUNCT
aiua-9512	89	2	0.000	0.000	NUM
aiua-9512	89	3	^	^	SYM
aiua-9512	89	4	et-1	et-1	NUM
aiua-9512	89	5	0/1	0/1	NUM
aiua-9512	89	6	(	(	PUNCT
aiua-9512	89	7	0	0	NUM
aiua-9512	89	8	%	%	NOUN
aiua-9512	89	9	)	)	PUNCT
aiua-9512	89	10	2/18	2/18	NUM
aiua-9512	89	11	(	(	PUNCT
aiua-9512	89	12	11.1	11.1	NUM
aiua-9512	89	13	%	%	NOUN
aiua-9512	89	14	)	)	PUNCT
aiua-9512	90	1	7/15	7/15	NUM
aiua-9512	90	2	(	(	PUNCT
aiua-9512	90	3	46.7	46.7	NUM
aiua-9512	90	4	%	%	NOUN
aiua-9512	90	5	)	)	PUNCT
aiua-9512	90	6	4/6	4/6	NUM
aiua-9512	90	7	(	(	PUNCT
aiua-9512	90	8	66.7	66.7	NUM
aiua-9512	90	9	%	%	NOUN
aiua-9512	90	10	)	)	PUNCT
aiua-9512	90	11	recurrence	recurrence	NOUN
aiua-9512	90	12	&	&	CCONJ
aiua-9512	90	13	progression	progression	PROPN
aiua-9512	90	14	n	n	PROPN
aiua-9512	90	15	=	=	SYM
aiua-9512	90	16	13/40	13/40	NUM
aiua-9512	90	17	(	(	PUNCT
aiua-9512	90	18	32.5	32.5	NUM
aiua-9512	90	19	%	%	NOUN
aiua-9512	90	20	)	)	PUNCT
aiua-9512	90	21	0.000	0.000	NUM
aiua-9512	91	1	*	*	PUNCT
aiua-9512	91	2	0.000	0.000	NUM
aiua-9512	91	3	^	^	PUNCT
aiua-9512	91	4	*	*	PUNCT
aiua-9512	91	5	:	:	PUNCT
aiua-9512	91	6	chi	chi	PROPN
aiua-9512	91	7	square	square	PROPN
aiua-9512	91	8	-	-	PUNCT
aiua-9512	91	9	fisher	fisher	PROPN
aiua-9512	91	10	’s	’s	PART
aiua-9512	91	11	exact	exact	ADJ
aiua-9512	91	12	test	test	NOUN
aiua-9512	91	13	;	;	PUNCT
aiua-9512	91	14	^	^	PUNCT
aiua-9512	91	15	:	:	PUNCT
aiua-9512	91	16	log	log	VERB
aiua-9512	91	17	rank	rank	NOUN
aiua-9512	91	18	test	test	NOUN
aiua-9512	91	19	,	,	PUNCT
aiua-9512	91	20	statistical	statistical	ADJ
aiua-9512	91	21	significance	significance	NOUN
aiua-9512	91	22	was	be	AUX
aiua-9512	91	23	set	set	VERB
aiua-9512	91	24	as	as	ADP
aiua-9512	91	25	p	p	NOUN
aiua-9512	91	26	≤	≤	NOUN
aiua-9512	91	27	0.05	0.05	NUM
aiua-9512	91	28	;	;	PUNCT
aiua-9512	91	29	rec	rec	X
aiua-9512	91	30	:	:	PUNCT
aiua-9512	91	31	recurrence	recurrence	NOUN
aiua-9512	91	32	;	;	PUNCT
aiua-9512	91	33	pr	pr	NOUN
aiua-9512	91	34	:	:	PUNCT
aiua-9512	91	35	progression	progression	NOUN
aiua-9512	91	36	;	;	PUNCT
aiua-9512	91	37	rfs	rf	NOUN
aiua-9512	91	38	:	:	PUNCT
aiua-9512	91	39	recurrence	recurrence	NOUN
aiua-9512	91	40	-	-	PUNCT
aiua-9512	91	41	free	free	ADJ
aiua-9512	91	42	survival	survival	NOUN
aiua-9512	91	43	;	;	PUNCT
aiua-9512	91	44	pfs	pfs	PROPN
aiua-9512	91	45	:	:	PUNCT
aiua-9512	91	46	progression	progression	NOUN
aiua-9512	91	47	-	-	PUNCT
aiua-9512	91	48	free	free	ADJ
aiua-9512	91	49	survival	survival	NOUN
aiua-9512	91	50	.	.	PUNCT
aiua-9512	92	1	archivio	archivio	NOUN
aiua-9512	92	2	italiano	italiano	PROPN
aiua-9512	92	3	di	di	X
aiua-9512	92	4	urologia	urologia	PROPN
aiua-9512	92	5	e	e	PROPN
aiua-9512	92	6	andrologia	andrologia	NOUN
aiua-9512	92	7	2021	2021	NUM
aiua-9512	92	8	;	;	PUNCT
aiua-9512	92	9	93	93	NUM
aiua-9512	92	10	,	,	PUNCT
aiua-9512	92	11	2	2	NUM
aiua-9512	92	12	l.	l.	PROPN
aiua-9512	92	13	mitrakas	mitrakas	PROPN
aiua-9512	92	14	,	,	PUNCT
aiua-9512	92	15	s.	s.	PROPN
aiua-9512	92	16	gravas	gravas	PROPN
aiua-9512	92	17	,	,	PUNCT
aiua-9512	92	18	f.	f.	PROPN
aiua-9512	92	19	karasavvidou	karasavvidou	PROPN
aiua-9512	92	20	,	,	PUNCT
aiua-9512	92	21	i.	i.	PROPN
aiua-9512	92	22	zachos	zachos	PROPN
aiua-9512	92	23	,	,	PUNCT
aiua-9512	92	24	a.	a.	PROPN
aiua-9512	92	25	karatzas	karatzas	PROPN
aiua-9512	92	26	,	,	PUNCT
aiua-9512	92	27	a.	a.	NOUN
aiua-9512	92	28	oeconomou	oeconomou	PROPN
aiua-9512	92	29	,	,	PUNCT
aiua-9512	92	30	g.	g.	PROPN
aiua-9512	92	31	koukoulis	koukoulis	PROPN
aiua-9512	92	32	,	,	PUNCT
aiua-9512	92	33	v.	v.	ADP
aiua-9512	92	34	tzortzis	tzortzi	NOUN
aiua-9512	92	35	,	,	PUNCT
aiua-9512	92	36	c.	c.	PROPN
aiua-9512	92	37	papandreou	papandreou	PROPN
aiua-9512	92	38	146	146	NUM
aiua-9512	92	39	research	research	NOUN
aiua-9512	92	40	and	and	CCONJ
aiua-9512	92	41	treatment	treatment	NOUN
aiua-9512	92	42	of	of	ADP
aiua-9512	92	43	cancer	cancer	NOUN
aiua-9512	92	44	(	(	PUNCT
aiua-9512	92	45	eortc	eortc	VERB
aiua-9512	92	46	)	)	PUNCT
aiua-9512	92	47	and	and	CCONJ
aiua-9512	92	48	represent	represent	VERB
aiua-9512	92	49	a	a	DET
aiua-9512	92	50	means	mean	NOUN
aiua-9512	92	51	whose	whose	DET
aiua-9512	92	52	prognostic	prognostic	ADJ
aiua-9512	92	53	value	value	NOUN
aiua-9512	92	54	was	be	AUX
aiua-9512	92	55	confirmed	confirm	VERB
aiua-9512	92	56	by	by	ADP
aiua-9512	92	57	data	datum	NOUN
aiua-9512	92	58	from	from	ADP
aiua-9512	92	59	other	other	ADJ
aiua-9512	92	60	studies	study	NOUN
aiua-9512	92	61	(	(	PUNCT
aiua-9512	92	62	7	7	NUM
aiua-9512	92	63	,	,	PUNCT
aiua-9512	92	64	9	9	NUM
aiua-9512	92	65	)	)	PUNCT
aiua-9512	92	66	.	.	PUNCT
aiua-9512	93	1	the	the	DET
aiua-9512	93	2	eortc	eortc	ADJ
aiua-9512	93	3	scoring	scoring	NOUN
aiua-9512	93	4	system	system	NOUN
aiua-9512	93	5	has	have	AUX
aiua-9512	93	6	not	not	PART
aiua-9512	93	7	achieved	achieve	VERB
aiua-9512	93	8	a	a	DET
aiua-9512	93	9	universal	universal	ADJ
aiua-9512	93	10	and	and	CCONJ
aiua-9512	93	11	unanimous	unanimous	ADJ
aiua-9512	93	12	acceptance	acceptance	NOUN
aiua-9512	93	13	though	though	ADV
aiua-9512	93	14	.	.	PUNCT
aiua-9512	94	1	one	one	NUM
aiua-9512	94	2	of	of	ADP
aiua-9512	94	3	the	the	DET
aiua-9512	94	4	main	main	ADJ
aiua-9512	94	5	reasons	reason	NOUN
aiua-9512	94	6	for	for	ADP
aiua-9512	94	7	this	this	DET
aiua-9512	94	8	fact	fact	NOUN
aiua-9512	94	9	is	be	AUX
aiua-9512	94	10	that	that	SCONJ
aiua-9512	94	11	none	none	NOUN
aiua-9512	94	12	of	of	ADP
aiua-9512	94	13	the	the	DET
aiua-9512	94	14	included	include	VERB
aiua-9512	94	15	patients	patient	NOUN
aiua-9512	94	16	received	receive	VERB
aiua-9512	94	17	maintenance	maintenance	NOUN
aiua-9512	94	18	therapy	therapy	NOUN
aiua-9512	94	19	with	with	ADP
aiua-9512	94	20	bcg	bcg	PROPN
aiua-9512	94	21	,	,	PUNCT
aiua-9512	94	22	which	which	PRON
aiua-9512	94	23	is	be	AUX
aiua-9512	94	24	currently	currently	ADV
aiua-9512	94	25	recommended	recommend	VERB
aiua-9512	94	26	for	for	ADP
aiua-9512	94	27	all	all	DET
aiua-9512	94	28	the	the	DET
aiua-9512	94	29	high	high	ADJ
aiua-9512	94	30	-	-	PUNCT
aiua-9512	94	31	risk	risk	NOUN
aiua-9512	94	32	patients	patient	NOUN
aiua-9512	94	33	(	(	PUNCT
aiua-9512	94	34	3	3	NUM
aiua-9512	94	35	)	)	PUNCT
aiua-9512	94	36	.	.	PUNCT
aiua-9512	95	1	another	another	DET
aiua-9512	95	2	prognostic	prognostic	ADJ
aiua-9512	95	3	model	model	NOUN
aiua-9512	95	4	was	be	AUX
aiua-9512	95	5	proposed	propose	VERB
aiua-9512	95	6	from	from	ADP
aiua-9512	95	7	the	the	DET
aiua-9512	95	8	club	club	NOUN
aiua-9512	95	9	urológico	urológico	PROPN
aiua-9512	95	10	español	español	PROPN
aiua-9512	95	11	de	de	PROPN
aiua-9512	95	12	tratamiento	tratamiento	PROPN
aiua-9512	95	13	oncológico	oncológico	NOUN
aiua-9512	95	14	(	(	PUNCT
aiua-9512	95	15	cueto	cueto	PROPN
aiua-9512	95	16	)	)	PUNCT
aiua-9512	95	17	.	.	PUNCT
aiua-9512	96	1	in	in	ADP
aiua-9512	96	2	this	this	DET
aiua-9512	96	3	study	study	NOUN
aiua-9512	96	4	,	,	PUNCT
aiua-9512	96	5	patients	patient	NOUN
aiua-9512	96	6	were	be	AUX
aiua-9512	96	7	stratified	stratify	VERB
aiua-9512	96	8	according	accord	VERB
aiua-9512	96	9	to	to	ADP
aiua-9512	96	10	the	the	DET
aiua-9512	96	11	risk	risk	NOUN
aiua-9512	96	12	of	of	ADP
aiua-9512	96	13	recurrence	recurrence	NOUN
aiua-9512	96	14	and	and	CCONJ
aiua-9512	96	15	progression	progression	NOUN
aiua-9512	96	16	,	,	PUNCT
aiua-9512	96	17	which	which	PRON
aiua-9512	96	18	also	also	ADV
aiua-9512	96	19	stratified	stratify	VERB
aiua-9512	96	20	a	a	DET
aiua-9512	96	21	patient	patient	NOUN
aiua-9512	96	22	’s	’s	PART
aiua-9512	96	23	risk	risk	NOUN
aiua-9512	96	24	of	of	ADP
aiua-9512	96	25	recurrence	recurrence	NOUN
aiua-9512	96	26	after	after	ADP
aiua-9512	96	27	bcg	bcg	PROPN
aiua-9512	96	28	plus	plus	CCONJ
aiua-9512	96	29	interferon	interferon	PROPN
aiua-9512	96	30	-	-	PUNCT
aiua-9512	96	31	a	a	DET
aiua-9512	96	32	therapy	therapy	NOUN
aiua-9512	96	33	(	(	PUNCT
aiua-9512	96	34	3	3	NUM
aiua-9512	96	35	)	)	PUNCT
aiua-9512	96	36	.	.	PUNCT
aiua-9512	97	1	the	the	DET
aiua-9512	97	2	maintenance	maintenance	NOUN
aiua-9512	97	3	scheme	scheme	NOUN
aiua-9512	97	4	lasted	last	VERB
aiua-9512	97	5	for	for	ADP
aiua-9512	97	6	5	5	NUM
aiua-9512	97	7	-	-	SYM
aiua-9512	97	8	6	6	NUM
aiua-9512	97	9	months	month	NOUN
aiua-9512	97	10	,	,	PUNCT
aiua-9512	97	11	which	which	PRON
aiua-9512	97	12	is	be	AUX
aiua-9512	97	13	considerably	considerably	ADV
aiua-9512	97	14	shorter	short	ADJ
aiua-9512	97	15	than	than	ADP
aiua-9512	97	16	the	the	DET
aiua-9512	97	17	actually	actually	ADV
aiua-9512	97	18	recommended	recommend	VERB
aiua-9512	97	19	one	one	NUM
aiua-9512	97	20	by	by	ADP
aiua-9512	97	21	the	the	DET
aiua-9512	97	22	eau	eau	PROPN
aiua-9512	97	23	(	(	PUNCT
aiua-9512	97	24	3	3	NUM
aiua-9512	97	25	)	)	PUNCT
aiua-9512	97	26	.	.	PUNCT
aiua-9512	98	1	except	except	SCONJ
aiua-9512	98	2	for	for	ADP
aiua-9512	98	3	these	these	DET
aiua-9512	98	4	two	two	NUM
aiua-9512	98	5	widespread	widespread	ADJ
aiua-9512	98	6	prognostic	prognostic	ADJ
aiua-9512	98	7	tools	tool	NOUN
aiua-9512	98	8	,	,	PUNCT
aiua-9512	98	9	there	there	PRON
aiua-9512	98	10	are	be	VERB
aiua-9512	98	11	numerous	numerous	ADJ
aiua-9512	98	12	studies	study	NOUN
aiua-9512	98	13	,	,	PUNCT
aiua-9512	98	14	which	which	PRON
aiua-9512	98	15	propose	propose	VERB
aiua-9512	98	16	different	different	ADJ
aiua-9512	98	17	prognostic	prognostic	ADJ
aiua-9512	98	18	factors	factor	NOUN
aiua-9512	98	19	,	,	PUNCT
aiua-9512	98	20	including	include	VERB
aiua-9512	98	21	molecular	molecular	ADJ
aiua-9512	98	22	ones	one	NOUN
aiua-9512	98	23	,	,	PUNCT
aiua-9512	98	24	for	for	ADP
aiua-9512	98	25	categorizing	categorize	VERB
aiua-9512	98	26	patients	patient	NOUN
aiua-9512	98	27	in	in	ADP
aiua-9512	98	28	terms	term	NOUN
aiua-9512	98	29	of	of	ADP
aiua-9512	98	30	clinical	clinical	ADJ
aiua-9512	98	31	course	course	NOUN
aiua-9512	98	32	and	and	CCONJ
aiua-9512	98	33	outcome	outcome	NOUN
aiua-9512	98	34	(	(	PUNCT
aiua-9512	98	35	4	4	NUM
aiua-9512	98	36	)	)	PUNCT
aiua-9512	98	37	.	.	PUNCT
aiua-9512	99	1	for	for	ADP
aiua-9512	99	2	example	example	NOUN
aiua-9512	99	3	,	,	PUNCT
aiua-9512	99	4	cambier	cambier	PROPN
aiua-9512	99	5	et	et	PROPN
aiua-9512	99	6	al	al	PROPN
aiua-9512	99	7	.	.	PROPN
aiua-9512	99	8	studied	study	VERB
aiua-9512	99	9	a	a	DET
aiua-9512	99	10	total	total	NOUN
aiua-9512	99	11	of	of	ADP
aiua-9512	99	12	1812	1812	NUM
aiua-9512	99	13	ta	ta	PROPN
aiua-9512	99	14	-	-	PUNCT
aiua-9512	99	15	t1	t1	NOUN
aiua-9512	99	16	patients	patient	NOUN
aiua-9512	99	17	from	from	ADP
aiua-9512	99	18	eortc	eortc	ADJ
aiua-9512	99	19	studies	study	NOUN
aiua-9512	99	20	30962	30962	NUM
aiua-9512	99	21	and	and	CCONJ
aiua-9512	99	22	30911	30911	NUM
aiua-9512	99	23	(	(	PUNCT
aiua-9512	99	24	3	3	NUM
aiua-9512	99	25	)	)	PUNCT
aiua-9512	99	26	.	.	PUNCT
aiua-9512	100	1	patients	patient	NOUN
aiua-9512	100	2	were	be	AUX
aiua-9512	100	3	allocated	allocate	VERB
aiua-9512	100	4	either	either	CCONJ
aiua-9512	100	5	to	to	ADP
aiua-9512	100	6	3	3	NUM
aiua-9512	100	7	years	year	NOUN
aiua-9512	100	8	of	of	ADP
aiua-9512	100	9	maintenance	maintenance	NOUN
aiua-9512	100	10	bcg	bcg	NOUN
aiua-9512	100	11	or	or	CCONJ
aiua-9512	100	12	1	1	NUM
aiua-9512	100	13	year	year	NOUN
aiua-9512	100	14	of	of	ADP
aiua-9512	100	15	maintenance	maintenance	NOUN
aiua-9512	100	16	.	.	PUNCT
aiua-9512	101	1	the	the	DET
aiua-9512	101	2	prior	prior	ADJ
aiua-9512	101	3	recurrence	recurrence	NOUN
aiua-9512	101	4	rate	rate	NOUN
aiua-9512	101	5	and	and	CCONJ
aiua-9512	101	6	the	the	DET
aiua-9512	101	7	number	number	NOUN
aiua-9512	101	8	of	of	ADP
aiua-9512	101	9	tumors	tumor	NOUN
aiua-9512	101	10	were	be	AUX
aiua-9512	101	11	identified	identify	VERB
aiua-9512	101	12	by	by	ADP
aiua-9512	101	13	multivariable	multivariable	ADJ
aiua-9512	101	14	analyses	analysis	NOUN
aiua-9512	101	15	as	as	ADP
aiua-9512	101	16	statistically	statistically	ADV
aiua-9512	101	17	significant	significant	ADJ
aiua-9512	101	18	prognostic	prognostic	ADJ
aiua-9512	101	19	factors	factor	NOUN
aiua-9512	101	20	for	for	ADP
aiua-9512	101	21	recurrence	recurrence	NOUN
aiua-9512	101	22	(	(	PUNCT
aiua-9512	101	23	3	3	NUM
aiua-9512	101	24	)	)	PUNCT
aiua-9512	101	25	.	.	PUNCT
aiua-9512	102	1	tumor	tumor	NOUN
aiua-9512	102	2	stage	stage	NOUN
aiua-9512	102	3	and	and	CCONJ
aiua-9512	102	4	grade	grade	NOUN
aiua-9512	102	5	were	be	AUX
aiua-9512	102	6	found	find	VERB
aiua-9512	102	7	to	to	PART
aiua-9512	102	8	be	be	AUX
aiua-9512	102	9	important	important	ADJ
aiua-9512	102	10	for	for	ADP
aiua-9512	102	11	progression	progression	NOUN
aiua-9512	102	12	and	and	CCONJ
aiua-9512	102	13	death	death	NOUN
aiua-9512	102	14	caused	cause	VERB
aiua-9512	102	15	by	by	ADP
aiua-9512	102	16	bladder	bladder	NOUN
aiua-9512	102	17	cancer	cancer	NOUN
aiua-9512	102	18	(	(	PUNCT
aiua-9512	102	19	3	3	NUM
aiua-9512	102	20	)	)	PUNCT
aiua-9512	102	21	.	.	PUNCT
aiua-9512	103	1	this	this	DET
aiua-9512	103	2	study	study	NOUN
aiua-9512	103	3	had	have	AUX
aiua-9512	103	4	also	also	ADV
aiua-9512	103	5	limitations	limitation	NOUN
aiua-9512	103	6	(	(	PUNCT
aiua-9512	103	7	no	no	DET
aiua-9512	103	8	patients	patient	NOUN
aiua-9512	103	9	with	with	ADP
aiua-9512	103	10	tis	tis	PROPN
aiua-9512	103	11	were	be	AUX
aiua-9512	103	12	included	include	VERB
aiua-9512	103	13	,	,	PUNCT
aiua-9512	103	14	routine	routine	ADJ
aiua-9512	103	15	repeat	repeat	NOUN
aiua-9512	103	16	tur	tur	X
aiua-9512	103	17	resection	resection	NOUN
aiua-9512	103	18	was	be	AUX
aiua-9512	103	19	not	not	PART
aiua-9512	103	20	performed	perform	VERB
aiua-9512	103	21	in	in	ADP
aiua-9512	103	22	high	high	ADJ
aiua-9512	103	23	-	-	PUNCT
aiua-9512	103	24	risk	risk	NOUN
aiua-9512	103	25	patients	patient	NOUN
aiua-9512	103	26	,	,	PUNCT
aiua-9512	103	27	there	there	PRON
aiua-9512	103	28	was	be	VERB
aiua-9512	103	29	no	no	DET
aiua-9512	103	30	central	central	ADJ
aiua-9512	103	31	pathology	pathology	NOUN
aiua-9512	103	32	review	review	NOUN
aiua-9512	103	33	,	,	PUNCT
aiua-9512	103	34	upper	upper	ADJ
aiua-9512	103	35	urinary	urinary	ADJ
aiua-9512	103	36	tract	tract	NOUN
aiua-9512	103	37	was	be	AUX
aiua-9512	103	38	not	not	PART
aiua-9512	103	39	investigated	investigate	VERB
aiua-9512	103	40	upon	upon	SCONJ
aiua-9512	103	41	recurrence	recurrence	NOUN
aiua-9512	103	42	or	or	CCONJ
aiua-9512	103	43	progression	progression	NOUN
aiua-9512	103	44	,	,	PUNCT
aiua-9512	103	45	no	no	DET
aiua-9512	103	46	use	use	NOUN
aiua-9512	103	47	of	of	ADP
aiua-9512	103	48	biomarker	biomarker	NOUN
aiua-9512	103	49	)	)	PUNCT
aiua-9512	103	50	.	.	PUNCT
aiua-9512	104	1	furthermore	furthermore	ADV
aiua-9512	104	2	,	,	PUNCT
aiua-9512	104	3	palou	palou	AUX
aiua-9512	104	4	et	et	PROPN
aiua-9512	104	5	al	al	PROPN
aiua-9512	104	6	.	.	PROPN
aiua-9512	104	7	documented	document	VERB
aiua-9512	104	8	that	that	SCONJ
aiua-9512	104	9	female	female	ADJ
aiua-9512	104	10	gender	gender	NOUN
aiua-9512	104	11	and	and	CCONJ
aiua-9512	104	12	carcinoma	carcinoma	NOUN
aiua-9512	104	13	in	in	ADP
aiua-9512	104	14	situ	situ	NOUN
aiua-9512	104	15	in	in	ADP
aiua-9512	104	16	the	the	DET
aiua-9512	104	17	prostatic	prostatic	ADJ
aiua-9512	104	18	urethra	urethra	NOUN
aiua-9512	104	19	are	be	AUX
aiua-9512	104	20	negative	negative	ADJ
aiua-9512	104	21	prognostic	prognostic	ADJ
aiua-9512	104	22	factors	factor	NOUN
aiua-9512	104	23	for	for	ADP
aiua-9512	104	24	recurrence	recurrence	NOUN
aiua-9512	104	25	(	(	PUNCT
aiua-9512	104	26	p	p	X
aiua-9512	104	27	=	=	SYM
aiua-9512	104	28	0.0003	0.0003	NUM
aiua-9512	104	29	,	,	PUNCT
aiua-9512	104	30	hr:2.53	hr:2.53	NOUN
aiua-9512	104	31	)	)	PUNCT
aiua-9512	104	32	,	,	PUNCT
aiua-9512	104	33	progression	progression	NOUN
aiua-9512	104	34	(	(	PUNCT
aiua-9512	104	35	p	p	NOUN
aiua-9512	104	36	=	=	NOUN
aiua-9512	104	37	0.001	0.001	NUM
aiua-9512	104	38	,	,	PUNCT
aiua-9512	104	39	hr	hr	NOUN
aiua-9512	104	40	:	:	PUNCT
aiua-9512	104	41	359	359	NUM
aiua-9512	104	42	)	)	PUNCT
aiua-9512	104	43	and	and	CCONJ
aiua-9512	104	44	disease	disease	NOUN
aiua-9512	104	45	specific	specific	ADJ
aiua-9512	104	46	mortality	mortality	NOUN
aiua-9512	104	47	(	(	PUNCT
aiua-9512	104	48	p	p	NOUN
aiua-9512	104	49	=	=	NOUN
aiua-9512	104	50	0.004	0.004	NUM
aiua-9512	104	51	,	,	PUNCT
aiua-9512	104	52	hr	hr	NOUN
aiua-9512	104	53	:	:	PUNCT
aiua-9512	104	54	3.53	3.53	NUM
aiua-9512	104	55	)	)	PUNCT
aiua-9512	104	56	in	in	ADP
aiua-9512	104	57	pt1g3	pt1g3	NOUN
aiua-9512	104	58	bladder	bladder	NOUN
aiua-9512	104	59	cancer	cancer	NOUN
aiua-9512	104	60	patients	patient	NOUN
aiua-9512	104	61	treated	treat	VERB
aiua-9512	104	62	with	with	ADP
aiua-9512	104	63	bcg	bcg	PROPN
aiua-9512	104	64	(	(	PUNCT
aiua-9512	104	65	10	10	NUM
aiua-9512	104	66	)	)	PUNCT
aiua-9512	104	67	.	.	PUNCT
aiua-9512	105	1	another	another	DET
aiua-9512	105	2	interesting	interesting	ADJ
aiua-9512	105	3	study	study	NOUN
aiua-9512	105	4	from	from	ADP
aiua-9512	105	5	gontero	gontero	PROPN
aiua-9512	105	6	et	et	PROPN
aiua-9512	105	7	al	al	PROPN
aiua-9512	105	8	.	.	PROPN
aiua-9512	105	9	,	,	PUNCT
aiua-9512	105	10	showed	show	VERB
aiua-9512	105	11	that	that	SCONJ
aiua-9512	105	12	pt1g3	pt1g3	NOUN
aiua-9512	105	13	patients	patient	NOUN
aiua-9512	105	14	≥	≥	NOUN
aiua-9512	105	15	70	70	NUM
aiua-9512	105	16	years	year	NOUN
aiua-9512	105	17	old	old	ADJ
aiua-9512	105	18	with	with	ADP
aiua-9512	105	19	tumors	tumor	NOUN
aiua-9512	105	20	≥	≥	VERB
aiua-9512	105	21	3	3	NUM
aiua-9512	105	22	cm	cm	NOUN
aiua-9512	105	23	and	and	CCONJ
aiua-9512	105	24	concomitant	concomitant	ADJ
aiua-9512	105	25	carcinoma	carcinoma	NOUN
aiua-9512	105	26	in	in	ADP
aiua-9512	105	27	situ	situ	NOUN
aiua-9512	105	28	should	should	AUX
aiua-9512	105	29	be	be	AUX
aiua-9512	105	30	handled	handle	VERB
aiua-9512	105	31	aggressively	aggressively	ADV
aiua-9512	105	32	because	because	SCONJ
aiua-9512	105	33	of	of	ADP
aiua-9512	105	34	the	the	DET
aiua-9512	105	35	high	high	ADJ
aiua-9512	105	36	risk	risk	NOUN
aiua-9512	105	37	of	of	ADP
aiua-9512	105	38	progression	progression	NOUN
aiua-9512	105	39	(	(	PUNCT
aiua-9512	105	40	11	11	NUM
aiua-9512	105	41	)	)	PUNCT
aiua-9512	105	42	.	.	PUNCT
aiua-9512	106	1	recently	recently	ADV
aiua-9512	106	2	,	,	PUNCT
aiua-9512	106	3	sahan	sahan	PROPN
aiua-9512	106	4	et	et	PROPN
aiua-9512	106	5	al	al	PROPN
aiua-9512	106	6	.	.	PROPN
aiua-9512	106	7	found	find	VERB
aiua-9512	106	8	in	in	ADP
aiua-9512	106	9	a	a	DET
aiua-9512	106	10	retrospective	retrospective	ADJ
aiua-9512	106	11	cohort	cohort	NOUN
aiua-9512	106	12	of	of	ADP
aiua-9512	106	13	pt1	pt1	PROPN
aiua-9512	106	14	bladder	bladder	NOUN
aiua-9512	106	15	urothelial	urothelial	ADJ
aiua-9512	106	16	carcinoma	carcinoma	NOUN
aiua-9512	106	17	patients	patient	NOUN
aiua-9512	106	18	treated	treat	VERB
aiua-9512	106	19	postoperatively	postoperatively	ADV
aiua-9512	106	20	with	with	ADP
aiua-9512	106	21	intravesical	intravesical	ADJ
aiua-9512	106	22	bcg	bcg	NOUN
aiua-9512	106	23	,	,	PUNCT
aiua-9512	106	24	for	for	ADP
aiua-9512	106	25	at	at	ADV
aiua-9512	106	26	least	least	ADV
aiua-9512	106	27	1	1	NUM
aiua-9512	106	28	year	year	NOUN
aiua-9512	106	29	,	,	PUNCT
aiua-9512	106	30	that	that	SCONJ
aiua-9512	106	31	the	the	DET
aiua-9512	106	32	tumor	tumor	NOUN
aiua-9512	106	33	invasion	invasion	NOUN
aiua-9512	106	34	to	to	ADP
aiua-9512	106	35	the	the	DET
aiua-9512	106	36	muscularis	muscularis	NOUN
aiua-9512	106	37	mucosaevascular	mucosaevascular	ADJ
aiua-9512	106	38	plexus	plexus	NOUN
aiua-9512	106	39	significantly	significantly	ADV
aiua-9512	106	40	associates	associate	NOUN
aiua-9512	106	41	with	with	ADP
aiua-9512	106	42	recurrence	recurrence	NOUN
aiua-9512	106	43	(	(	PUNCT
aiua-9512	106	44	12	12	NUM
aiua-9512	106	45	)	)	PUNCT
aiua-9512	106	46	.	.	PUNCT
aiua-9512	107	1	in	in	ADP
aiua-9512	107	2	closing	closing	NOUN
aiua-9512	107	3	,	,	PUNCT
aiua-9512	107	4	no	no	DET
aiua-9512	107	5	molecule	molecule	NOUN
aiua-9512	107	6	is	be	AUX
aiua-9512	107	7	turned	turn	VERB
aiua-9512	107	8	to	to	PART
aiua-9512	107	9	be	be	AUX
aiua-9512	107	10	a	a	DET
aiua-9512	107	11	marker	marker	NOUN
aiua-9512	107	12	until	until	ADP
aiua-9512	107	13	today	today	NOUN
aiua-9512	107	14	.	.	PUNCT
aiua-9512	108	1	the	the	DET
aiua-9512	108	2	available	available	ADJ
aiua-9512	108	3	data	datum	NOUN
aiua-9512	108	4	regarding	regard	VERB
aiua-9512	108	5	the	the	DET
aiua-9512	108	6	expression	expression	NOUN
aiua-9512	108	7	of	of	ADP
aiua-9512	108	8	et	et	NOUN
aiua-9512	108	9	axis	axis	NOUN
aiua-9512	108	10	in	in	ADP
aiua-9512	108	11	bladder	bladder	NOUN
aiua-9512	108	12	cancer	cancer	NOUN
aiua-9512	108	13	does	do	AUX
aiua-9512	108	14	not	not	PART
aiua-9512	108	15	give	give	VERB
aiua-9512	108	16	a	a	DET
aiua-9512	108	17	clear	clear	ADJ
aiua-9512	108	18	end	end	NOUN
aiua-9512	108	19	result	result	NOUN
aiua-9512	108	20	.	.	PUNCT
aiua-9512	109	1	eltze	eltze	PROPN
aiua-9512	109	2	et	et	PROPN
aiua-9512	109	3	al	al	PROPN
aiua-9512	109	4	.	.	PROPN
aiua-9512	109	5	examined	examine	VERB
aiua-9512	109	6	retrospectively	retrospectively	ADV
aiua-9512	109	7	the	the	DET
aiua-9512	109	8	expression	expression	NOUN
aiua-9512	109	9	of	of	ADP
aiua-9512	109	10	the	the	DET
aiua-9512	109	11	endothelin	endothelin	PROPN
aiua-9512	109	12	axis	axis	NOUN
aiua-9512	109	13	in	in	ADP
aiua-9512	109	14	154	154	NUM
aiua-9512	109	15	patients	patient	NOUN
aiua-9512	109	16	with	with	ADP
aiua-9512	109	17	primary	primary	ADJ
aiua-9512	109	18	bladder	bladder	NOUN
aiua-9512	109	19	cancer	cancer	NOUN
aiua-9512	109	20	(	(	PUNCT
aiua-9512	109	21	pta	pta	NOUN
aiua-9512	109	22	-	-	PUNCT
aiua-9512	109	23	pt2	pt2	NOUN
aiua-9512	109	24	)	)	PUNCT
aiua-9512	109	25	.	.	PUNCT
aiua-9512	110	1	they	they	PRON
aiua-9512	110	2	ascertain	ascertain	VERB
aiua-9512	110	3	that	that	SCONJ
aiua-9512	110	4	both	both	DET
aiua-9512	110	5	lack	lack	NOUN
aiua-9512	110	6	of	of	ADP
aiua-9512	110	7	et-1	et-1	PUNCT
aiua-9512	110	8	and	and	CCONJ
aiua-9512	110	9	etar	etar	PROPN
aiua-9512	110	10	have	have	VERB
aiua-9512	110	11	a	a	DET
aiua-9512	110	12	negative	negative	ADJ
aiua-9512	110	13	prognostic	prognostic	ADJ
aiua-9512	110	14	impact	impact	NOUN
aiua-9512	110	15	(	(	PUNCT
aiua-9512	110	16	13	13	NUM
aiua-9512	110	17	)	)	PUNCT
aiua-9512	110	18	.	.	PUNCT
aiua-9512	111	1	moreover	moreover	ADV
aiua-9512	111	2	,	,	PUNCT
aiua-9512	111	3	an	an	DET
aiua-9512	111	4	ihc	ihc	PROPN
aiua-9512	111	5	study	study	NOUN
aiua-9512	111	6	of	of	ADP
aiua-9512	111	7	157	157	NUM
aiua-9512	111	8	radical	radical	ADJ
aiua-9512	111	9	cystectomy	cystectomy	NOUN
aiua-9512	111	10	samples	sample	NOUN
aiua-9512	111	11	demonstrated	demonstrate	VERB
aiua-9512	111	12	an	an	DET
aiua-9512	111	13	overexpression	overexpression	NOUN
aiua-9512	111	14	of	of	ADP
aiua-9512	111	15	the	the	DET
aiua-9512	111	16	entire	entire	ADJ
aiua-9512	111	17	et	et	NOUN
aiua-9512	111	18	axis	axis	NOUN
aiua-9512	111	19	.	.	PUNCT
aiua-9512	112	1	a	a	DET
aiua-9512	112	2	survival	survival	NOUN
aiua-9512	112	3	benefit	benefit	NOUN
aiua-9512	112	4	(	(	PUNCT
aiua-9512	112	5	disease	disease	NOUN
aiua-9512	112	6	-	-	PUNCT
aiua-9512	112	7	free	free	ADJ
aiua-9512	112	8	survival	survival	NOUN
aiua-9512	112	9	,	,	PUNCT
aiua-9512	112	10	overall	overall	ADJ
aiua-9512	112	11	survival	survival	NOUN
aiua-9512	112	12	)	)	PUNCT
aiua-9512	112	13	was	be	AUX
aiua-9512	112	14	established	establish	VERB
aiua-9512	112	15	only	only	ADV
aiua-9512	112	16	for	for	ADP
aiua-9512	112	17	etbr	etbr	NOUN
aiua-9512	112	18	(	(	PUNCT
aiua-9512	112	19	+	+	NOUN
aiua-9512	112	20	)	)	PUNCT
aiua-9512	112	21	tumors	tumor	NOUN
aiua-9512	112	22	(	(	PUNCT
aiua-9512	112	23	14	14	NUM
aiua-9512	112	24	)	)	PUNCT
aiua-9512	112	25	.	.	PUNCT
aiua-9512	113	1	two	two	NUM
aiua-9512	113	2	experimental	experimental	ADJ
aiua-9512	113	3	studies	study	NOUN
aiua-9512	113	4	,	,	PUNCT
aiua-9512	113	5	in	in	ADP
aiua-9512	113	6	which	which	PRON
aiua-9512	113	7	ku-19	ku-19	ADV
aiua-9512	113	8	-	-	PUNCT
aiua-9512	113	9	19	19	NUM
aiua-9512	113	10	bladder	bladder	NOUN
aiua-9512	113	11	cancer	cancer	NOUN
aiua-9512	113	12	cells	cell	NOUN
aiua-9512	113	13	were	be	AUX
aiua-9512	113	14	implanted	implant	VERB
aiua-9512	113	15	in	in	ADP
aiua-9512	113	16	mice	mouse	NOUN
aiua-9512	113	17	,	,	PUNCT
aiua-9512	113	18	showed	show	VERB
aiua-9512	113	19	that	that	SCONJ
aiua-9512	113	20	the	the	DET
aiua-9512	113	21	administration	administration	NOUN
aiua-9512	113	22	of	of	ADP
aiua-9512	113	23	atrasentan	atrasentan	PROPN
aiua-9512	113	24	,	,	PUNCT
aiua-9512	113	25	a	a	DET
aiua-9512	113	26	selective	selective	ADJ
aiua-9512	113	27	etar	etar	NOUN
aiua-9512	113	28	antagonist	antagonist	NOUN
aiua-9512	113	29	,	,	PUNCT
aiua-9512	113	30	lead	lead	VERB
aiua-9512	113	31	to	to	ADP
aiua-9512	113	32	a	a	DET
aiua-9512	113	33	diminished	diminished	ADJ
aiua-9512	113	34	tumor	tumor	NOUN
aiua-9512	113	35	-	-	PUNCT
aiua-9512	113	36	growth	growth	NOUN
aiua-9512	113	37	rate	rate	NOUN
aiua-9512	113	38	with	with	ADP
aiua-9512	113	39	an	an	DET
aiua-9512	113	40	increased	increase	VERB
aiua-9512	113	41	necrosis	necrosis	NOUN
aiua-9512	113	42	in	in	ADP
aiua-9512	113	43	the	the	DET
aiua-9512	113	44	tumor	tumor	NOUN
aiua-9512	113	45	tissue	tissue	NOUN
aiua-9512	113	46	,	,	PUNCT
aiua-9512	113	47	no	no	DET
aiua-9512	113	48	significant	significant	ADJ
aiua-9512	113	49	cytoreduction	cytoreduction	NOUN
aiua-9512	113	50	and	and	CCONJ
aiua-9512	113	51	increased	increase	VERB
aiua-9512	113	52	etar	etar	NOUN
aiua-9512	113	53	expression	expression	NOUN
aiua-9512	113	54	,	,	PUNCT
aiua-9512	113	55	implying	imply	VERB
aiua-9512	113	56	an	an	DET
aiua-9512	113	57	escape	escape	NOUN
aiua-9512	113	58	mechanism	mechanism	NOUN
aiua-9512	113	59	to	to	PART
aiua-9512	113	60	overcome	overcome	VERB
aiua-9512	113	61	the	the	DET
aiua-9512	113	62	antiproliferative	antiproliferative	ADJ
aiua-9512	113	63	effect	effect	NOUN
aiua-9512	113	64	caused	cause	VERB
aiua-9512	113	65	by	by	ADP
aiua-9512	113	66	targeting	target	VERB
aiua-9512	113	67	etar	etar	NOUN
aiua-9512	113	68	(	(	PUNCT
aiua-9512	113	69	15	15	NUM
aiua-9512	113	70	,	,	PUNCT
aiua-9512	113	71	16	16	NUM
aiua-9512	113	72	)	)	PUNCT
aiua-9512	113	73	.	.	PUNCT
aiua-9512	114	1	in	in	ADP
aiua-9512	114	2	another	another	DET
aiua-9512	114	3	ihc	ihc	PROPN
aiua-9512	114	4	retrospective	retrospective	ADJ
aiua-9512	114	5	study	study	NOUN
aiua-9512	114	6	,	,	PUNCT
aiua-9512	114	7	et-1	et-1	PUNCT
aiua-9512	114	8	and	and	CCONJ
aiua-9512	114	9	the	the	DET
aiua-9512	114	10	microvessel	microvessel	NOUN
aiua-9512	114	11	density	density	NOUN
aiua-9512	114	12	(	(	PUNCT
aiua-9512	114	13	mvd	mvd	PROPN
aiua-9512	114	14	)	)	PUNCT
aiua-9512	114	15	seemed	seem	VERB
aiua-9512	114	16	to	to	PART
aiua-9512	114	17	be	be	AUX
aiua-9512	114	18	“	"	PUNCT
aiua-9512	114	19	good	good	ADJ
aiua-9512	114	20	prognostic	prognostic	ADJ
aiua-9512	114	21	factors	factor	NOUN
aiua-9512	114	22	”	"	PUNCT
aiua-9512	114	23	,	,	PUNCT
aiua-9512	114	24	cause	cause	VERB
aiua-9512	114	25	the	the	DET
aiua-9512	114	26	et-1	et-1	NUM
aiua-9512	114	27	overexpression	overexpression	NOUN
aiua-9512	114	28	was	be	AUX
aiua-9512	114	29	importantly	importantly	ADV
aiua-9512	114	30	associated	associate	VERB
aiua-9512	114	31	with	with	ADP
aiua-9512	114	32	increased	increase	VERB
aiua-9512	114	33	mvd	mvd	PROPN
aiua-9512	114	34	and	and	CCONJ
aiua-9512	114	35	organ	organ	NOUN
aiua-9512	114	36	-	-	PUNCT
aiua-9512	114	37	confined	confine	VERB
aiua-9512	114	38	disease	disease	NOUN
aiua-9512	114	39	(	(	PUNCT
aiua-9512	114	40	17	17	NUM
aiua-9512	114	41	)	)	PUNCT
aiua-9512	114	42	.	.	PUNCT
aiua-9512	115	1	coming	come	VERB
aiua-9512	115	2	to	to	ADP
aiua-9512	115	3	an	an	DET
aiua-9512	115	4	end	end	NOUN
aiua-9512	115	5	,	,	PUNCT
aiua-9512	115	6	a	a	DET
aiua-9512	115	7	prospective	prospective	ADJ
aiua-9512	115	8	study	study	NOUN
aiua-9512	115	9	of	of	ADP
aiua-9512	115	10	2015	2015	NUM
aiua-9512	115	11	,	,	PUNCT
aiua-9512	115	12	based	base	VERB
aiua-9512	115	13	on	on	ADP
aiua-9512	115	14	ihc	ihc	PROPN
aiua-9512	115	15	,	,	PUNCT
aiua-9512	115	16	recorded	record	VERB
aiua-9512	115	17	that	that	SCONJ
aiua-9512	115	18	the	the	DET
aiua-9512	115	19	overexpression	overexpression	NOUN
aiua-9512	115	20	of	of	ADP
aiua-9512	115	21	et-1	et-1	PUNCT
aiua-9512	115	22	was	be	AUX
aiua-9512	115	23	remarkably	remarkably	ADV
aiua-9512	115	24	correlated	correlate	VERB
aiua-9512	115	25	with	with	ADP
aiua-9512	115	26	an	an	DET
aiua-9512	115	27	increased	increase	VERB
aiua-9512	115	28	hazard	hazard	NOUN
aiua-9512	115	29	ratio	ratio	NOUN
aiua-9512	115	30	of	of	ADP
aiua-9512	115	31	progression	progression	NOUN
aiua-9512	115	32	and	and	CCONJ
aiua-9512	115	33	death	death	NOUN
aiua-9512	115	34	(	(	PUNCT
aiua-9512	115	35	5	5	NUM
aiua-9512	115	36	)	)	PUNCT
aiua-9512	115	37	.	.	PUNCT
aiua-9512	116	1	in	in	ADP
aiua-9512	116	2	this	this	DET
aiua-9512	116	3	case	case	NOUN
aiua-9512	116	4	,	,	PUNCT
aiua-9512	116	5	the	the	DET
aiua-9512	116	6	included	include	VERB
aiua-9512	116	7	patients	patient	NOUN
aiua-9512	116	8	suffered	suffer	VERB
aiua-9512	116	9	from	from	ADP
aiua-9512	116	10	non	non	ADJ
aiua-9512	116	11	-	-	ADJ
aiua-9512	116	12	metastatic	metastatic	ADJ
aiua-9512	116	13	muscle	muscle	NOUN
aiua-9512	116	14	-	-	PUNCT
aiua-9512	116	15	invasive	invasive	ADJ
aiua-9512	116	16	bladder	bladder	NOUN
aiua-9512	116	17	cancer	cancer	NOUN
aiua-9512	116	18	.	.	PUNCT
aiua-9512	117	1	we	we	PRON
aiua-9512	117	2	found	find	VERB
aiua-9512	117	3	that	that	SCONJ
aiua-9512	117	4	the	the	DET
aiua-9512	117	5	expression	expression	NOUN
aiua-9512	117	6	of	of	ADP
aiua-9512	117	7	et-1	et-1	NUM
aiua-9512	117	8	indicates	indicate	VERB
aiua-9512	117	9	a	a	DET
aiua-9512	117	10	higher	high	ADJ
aiua-9512	117	11	risk	risk	NOUN
aiua-9512	117	12	for	for	ADP
aiua-9512	117	13	disease	disease	NOUN
aiua-9512	117	14	recurrence	recurrence	NOUN
aiua-9512	117	15	and	and	CCONJ
aiua-9512	117	16	progression	progression	NOUN
aiua-9512	117	17	.	.	PUNCT
aiua-9512	118	1	regarding	regard	VERB
aiua-9512	118	2	the	the	DET
aiua-9512	118	3	relative	relative	ADJ
aiua-9512	118	4	survival	survival	NOUN
aiua-9512	118	5	estimations	estimation	NOUN
aiua-9512	118	6	(	(	PUNCT
aiua-9512	118	7	rfs	rfs	PROPN
aiua-9512	118	8	,	,	PUNCT
aiua-9512	118	9	pfs	pf	NOUN
aiua-9512	118	10	)	)	PUNCT
aiua-9512	118	11	,	,	PUNCT
aiua-9512	118	12	this	this	DET
aiua-9512	118	13	higher	high	ADJ
aiua-9512	118	14	risk	risk	NOUN
aiua-9512	118	15	remains	remains	AUX
aiua-9512	118	16	documented	document	VERB
aiua-9512	118	17	.	.	PUNCT
aiua-9512	118	18	et-1	et-1	PUNCT
aiua-9512	118	19	could	could	AUX
aiua-9512	118	20	make	make	VERB
aiua-9512	118	21	us	we	PRON
aiua-9512	118	22	alert	alert	VERB
aiua-9512	118	23	,	,	PUNCT
aiua-9512	118	24	in	in	ADP
aiua-9512	118	25	order	order	NOUN
aiua-9512	118	26	to	to	PART
aiua-9512	118	27	recognize	recognize	VERB
aiua-9512	118	28	the	the	DET
aiua-9512	118	29	patients	patient	NOUN
aiua-9512	118	30	with	with	ADP
aiua-9512	118	31	primary	primary	ADJ
aiua-9512	118	32	hgnmiubc	hgnmiubc	NOUN
aiua-9512	118	33	who	who	PRON
aiua-9512	118	34	are	be	AUX
aiua-9512	118	35	at	at	ADP
aiua-9512	118	36	risk	risk	NOUN
aiua-9512	118	37	for	for	ADP
aiua-9512	118	38	a	a	DET
aiua-9512	118	39	bad	bad	ADJ
aiua-9512	118	40	clinical	clinical	ADJ
aiua-9512	118	41	outcome	outcome	NOUN
aiua-9512	118	42	,	,	PUNCT
aiua-9512	118	43	taking	take	VERB
aiua-9512	118	44	into	into	ADP
aiua-9512	118	45	consideration	consideration	NOUN
aiua-9512	118	46	that	that	SCONJ
aiua-9512	118	47	we	we	PRON
aiua-9512	118	48	can	can	AUX
aiua-9512	118	49	accurately	accurately	ADV
aiua-9512	118	50	identify	identify	VERB
aiua-9512	118	51	patients	patient	NOUN
aiua-9512	118	52	who	who	PRON
aiua-9512	118	53	will	will	AUX
aiua-9512	118	54	not	not	PART
aiua-9512	118	55	progress	progress	VERB
aiua-9512	118	56	or	or	CCONJ
aiua-9512	118	57	die	die	VERB
aiua-9512	118	58	due	due	ADP
aiua-9512	118	59	to	to	ADP
aiua-9512	118	60	bladder	bladder	NOUN
aiua-9512	118	61	cancer	cancer	NOUN
aiua-9512	118	62	(	(	PUNCT
aiua-9512	118	63	ptag1	ptag1	NOUN
aiua-9512	118	64	)	)	PUNCT
aiua-9512	118	65	,	,	PUNCT
aiua-9512	118	66	but	but	CCONJ
aiua-9512	118	67	we	we	PRON
aiua-9512	118	68	can	can	AUX
aiua-9512	118	69	not	not	PART
aiua-9512	118	70	reliably	reliably	ADV
aiua-9512	118	71	identify	identify	VERB
aiua-9512	118	72	the	the	DET
aiua-9512	118	73	ones	one	NOUN
aiua-9512	118	74	who	who	PRON
aiua-9512	118	75	do	do	VERB
aiua-9512	118	76	progress	progress	NOUN
aiua-9512	118	77	and	and	CCONJ
aiua-9512	118	78	die	die	VERB
aiua-9512	118	79	of	of	ADP
aiua-9512	118	80	their	their	PRON
aiua-9512	118	81	disease	disease	NOUN
aiua-9512	118	82	(	(	PUNCT
aiua-9512	118	83	3	3	NUM
aiua-9512	118	84	)	)	PUNCT
aiua-9512	118	85	.	.	PUNCT
aiua-9512	119	1	within	within	ADP
aiua-9512	119	2	this	this	DET
aiua-9512	119	3	context	context	NOUN
aiua-9512	119	4	,	,	PUNCT
aiua-9512	119	5	we	we	PRON
aiua-9512	119	6	could	could	AUX
aiua-9512	119	7	offer	offer	VERB
aiua-9512	119	8	these	these	DET
aiua-9512	119	9	patients	patient	NOUN
aiua-9512	119	10	a	a	DET
aiua-9512	119	11	radical	radical	ADJ
aiua-9512	119	12	treatment	treatment	NOUN
aiua-9512	119	13	early	early	ADV
aiua-9512	119	14	in	in	ADP
aiua-9512	119	15	the	the	DET
aiua-9512	119	16	natural	natural	ADJ
aiua-9512	119	17	course	course	NOUN
aiua-9512	119	18	of	of	ADP
aiua-9512	119	19	the	the	DET
aiua-9512	119	20	disease	disease	NOUN
aiua-9512	119	21	,	,	PUNCT
aiua-9512	119	22	aiming	aim	VERB
aiua-9512	119	23	to	to	PART
aiua-9512	119	24	maximize	maximize	VERB
aiua-9512	119	25	the	the	DET
aiua-9512	119	26	clinical	clinical	ADJ
aiua-9512	119	27	benefit	benefit	NOUN
aiua-9512	119	28	.	.	PUNCT
aiua-9512	120	1	finally	finally	ADV
aiua-9512	120	2	,	,	PUNCT
aiua-9512	120	3	only	only	ADV
aiua-9512	120	4	the	the	DET
aiua-9512	120	5	patient	patient	NOUN
aiua-9512	120	6	’s	’s	PART
aiua-9512	120	7	age	age	NOUN
aiua-9512	120	8	,	,	PUNCT
aiua-9512	120	9	among	among	ADP
aiua-9512	120	10	all	all	DET
aiua-9512	120	11	the	the	DET
aiua-9512	120	12	rest	rest	NOUN
aiua-9512	120	13	studied	study	VERB
aiua-9512	120	14	parameters	parameter	NOUN
aiua-9512	120	15	,	,	PUNCT
aiua-9512	120	16	correlates	correlate	VERB
aiua-9512	120	17	significantly	significantly	ADV
aiua-9512	120	18	with	with	ADP
aiua-9512	120	19	recurrence	recurrence	NOUN
aiua-9512	120	20	and	and	CCONJ
aiua-9512	120	21	rfs	rf	NOUN
aiua-9512	120	22	.	.	PUNCT
aiua-9512	121	1	so	so	ADV
aiua-9512	121	2	,	,	PUNCT
aiua-9512	121	3	the	the	DET
aiua-9512	121	4	implementation	implementation	NOUN
aiua-9512	121	5	of	of	ADP
aiua-9512	121	6	a	a	DET
aiua-9512	121	7	strict	strict	ADJ
aiua-9512	121	8	follow	follow	NOUN
aiua-9512	121	9	up	up	ADP
aiua-9512	121	10	for	for	ADP
aiua-9512	121	11	the	the	DET
aiua-9512	121	12	elderly	elderly	ADJ
aiua-9512	121	13	patients	patient	NOUN
aiua-9512	121	14	with	with	ADP
aiua-9512	121	15	primary	primary	ADJ
aiua-9512	121	16	hgnmiubc	hgnmiubc	NOUN
aiua-9512	121	17	is	be	AUX
aiua-9512	121	18	a	a	DET
aiua-9512	121	19	reasonable	reasonable	ADJ
aiua-9512	121	20	decision	decision	NOUN
aiua-9512	121	21	.	.	PUNCT
aiua-9512	122	1	the	the	DET
aiua-9512	122	2	prospective	prospective	ADJ
aiua-9512	122	3	nature	nature	NOUN
aiua-9512	122	4	of	of	ADP
aiua-9512	122	5	our	our	PRON
aiua-9512	122	6	work	work	NOUN
aiua-9512	122	7	is	be	AUX
aiua-9512	122	8	an	an	DET
aiua-9512	122	9	important	important	ADJ
aiua-9512	122	10	advantage	advantage	NOUN
aiua-9512	122	11	.	.	PUNCT
aiua-9512	123	1	another	another	DET
aiua-9512	123	2	quality	quality	NOUN
aiua-9512	123	3	which	which	PRON
aiua-9512	123	4	worths	worth	VERB
aiua-9512	123	5	to	to	PART
aiua-9512	123	6	be	be	AUX
aiua-9512	123	7	mentioned	mention	VERB
aiua-9512	123	8	is	be	AUX
aiua-9512	123	9	that	that	SCONJ
aiua-9512	123	10	our	our	PRON
aiua-9512	123	11	patients	patient	NOUN
aiua-9512	123	12	are	be	AUX
aiua-9512	123	13	the	the	DET
aiua-9512	123	14	most	most	ADV
aiua-9512	123	15	homogenous	homogenous	ADJ
aiua-9512	123	16	group	group	NOUN
aiua-9512	123	17	compared	compare	VERB
aiua-9512	123	18	to	to	ADP
aiua-9512	123	19	the	the	DET
aiua-9512	123	20	included	include	VERB
aiua-9512	123	21	patients	patient	NOUN
aiua-9512	123	22	of	of	ADP
aiua-9512	123	23	the	the	DET
aiua-9512	123	24	abovementioned	abovementione	VERB
aiua-9512	123	25	researches	research	NOUN
aiua-9512	123	26	(	(	PUNCT
aiua-9512	123	27	different	different	ADJ
aiua-9512	123	28	stages	stage	NOUN
aiua-9512	123	29	,	,	PUNCT
aiua-9512	123	30	different	different	ADJ
aiua-9512	123	31	types	type	NOUN
aiua-9512	123	32	of	of	ADP
aiua-9512	123	33	carcinoma	carcinoma	NOUN
aiua-9512	123	34	)	)	PUNCT
aiua-9512	123	35	.	.	PUNCT
aiua-9512	124	1	they	they	PRON
aiua-9512	124	2	all	all	PRON
aiua-9512	124	3	are	be	AUX
aiua-9512	124	4	primary	primary	ADJ
aiua-9512	124	5	hgnmiubc	hgnmiubc	NOUN
aiua-9512	124	6	patients	patient	NOUN
aiua-9512	124	7	treated	treat	VERB
aiua-9512	124	8	postoperatively	postoperatively	ADV
aiua-9512	124	9	with	with	ADP
aiua-9512	124	10	intravesical	intravesical	ADJ
aiua-9512	124	11	bcg	bcg	PROPN
aiua-9512	124	12	instillations	instillation	NOUN
aiua-9512	124	13	(	(	PUNCT
aiua-9512	124	14	induction	induction	NOUN
aiua-9512	124	15	and	and	CCONJ
aiua-9512	124	16	3	3	NUM
aiua-9512	124	17	-	-	PUNCT
aiua-9512	124	18	year	year	NOUN
aiua-9512	124	19	maintenance	maintenance	NOUN
aiua-9512	124	20	)	)	PUNCT
aiua-9512	124	21	.	.	PUNCT
aiua-9512	125	1	likewise	likewise	ADV
aiua-9512	125	2	,	,	PUNCT
aiua-9512	125	3	we	we	PRON
aiua-9512	125	4	study	study	VERB
aiua-9512	125	5	et-1	et-1	ADV
aiua-9512	125	6	using	use	VERB
aiua-9512	125	7	ihc	ihc	PROPN
aiua-9512	125	8	staining	staining	NOUN
aiua-9512	125	9	,	,	PUNCT
aiua-9512	125	10	which	which	PRON
aiua-9512	125	11	is	be	AUX
aiua-9512	125	12	the	the	DET
aiua-9512	125	13	most	most	ADV
aiua-9512	125	14	common	common	ADJ
aiua-9512	125	15	methodology	methodology	NOUN
aiua-9512	125	16	in	in	ADP
aiua-9512	125	17	current	current	ADJ
aiua-9512	125	18	literature	literature	NOUN
aiua-9512	125	19	.	.	PUNCT
aiua-9512	126	1	in	in	ADP
aiua-9512	126	2	our	our	PRON
aiua-9512	126	3	opinion	opinion	NOUN
aiua-9512	126	4	,	,	PUNCT
aiua-9512	126	5	it	it	PRON
aiua-9512	126	6	is	be	AUX
aiua-9512	126	7	also	also	ADV
aiua-9512	126	8	positive	positive	ADJ
aiua-9512	126	9	the	the	DET
aiua-9512	126	10	fact	fact	NOUN
aiua-9512	126	11	that	that	SCONJ
aiua-9512	126	12	we	we	PRON
aiua-9512	126	13	applied	apply	VERB
aiua-9512	126	14	a	a	DET
aiua-9512	126	15	central	central	ADJ
aiua-9512	126	16	pathology	pathology	NOUN
aiua-9512	126	17	review	review	NOUN
aiua-9512	126	18	.	.	PUNCT
aiua-9512	127	1	on	on	ADP
aiua-9512	127	2	the	the	DET
aiua-9512	127	3	other	other	ADJ
aiua-9512	127	4	hand	hand	NOUN
aiua-9512	127	5	,	,	PUNCT
aiua-9512	127	6	it	it	PRON
aiua-9512	127	7	remains	remain	VERB
aiua-9512	127	8	as	as	ADP
aiua-9512	127	9	a	a	DET
aiua-9512	127	10	disadvantage	disadvantage	NOUN
aiua-9512	127	11	the	the	DET
aiua-9512	127	12	limited	limited	ADJ
aiua-9512	127	13	sample	sample	NOUN
aiua-9512	127	14	.	.	PUNCT
aiua-9512	128	1	regarding	regard	VERB
aiua-9512	128	2	this	this	DET
aiua-9512	128	3	point	point	NOUN
aiua-9512	128	4	,	,	PUNCT
aiua-9512	128	5	we	we	PRON
aiua-9512	128	6	need	need	VERB
aiua-9512	128	7	to	to	PART
aiua-9512	128	8	mention	mention	VERB
aiua-9512	128	9	that	that	SCONJ
aiua-9512	128	10	there	there	PRON
aiua-9512	128	11	is	be	VERB
aiua-9512	128	12	no	no	DET
aiua-9512	128	13	other	other	ADJ
aiua-9512	128	14	similar	similar	ADJ
aiua-9512	128	15	study	study	NOUN
aiua-9512	128	16	addressing	address	VERB
aiua-9512	128	17	the	the	DET
aiua-9512	128	18	same	same	ADJ
aiua-9512	128	19	issues	issue	NOUN
aiua-9512	128	20	,	,	PUNCT
aiua-9512	128	21	meaning	mean	VERB
aiua-9512	128	22	a	a	DET
aiua-9512	128	23	prospective	prospective	ADJ
aiua-9512	128	24	study	study	NOUN
aiua-9512	128	25	of	of	ADP
aiua-9512	128	26	a	a	DET
aiua-9512	128	27	rather	rather	ADV
aiua-9512	128	28	homogenous	homogenous	ADJ
aiua-9512	128	29	cohort	cohort	NOUN
aiua-9512	128	30	.	.	PUNCT
aiua-9512	129	1	the	the	DET
aiua-9512	129	2	standard	standard	NOUN
aiua-9512	129	3	of	of	ADP
aiua-9512	129	4	care	care	NOUN
aiua-9512	129	5	in	in	ADP
aiua-9512	129	6	hgnmiubc	hgnmiubc	PROPN
aiua-9512	129	7	does	do	AUX
aiua-9512	129	8	not	not	PART
aiua-9512	129	9	achieve	achieve	VERB
aiua-9512	129	10	an	an	DET
aiua-9512	129	11	ideal	ideal	ADJ
aiua-9512	129	12	clinical	clinical	ADJ
aiua-9512	129	13	result	result	NOUN
aiua-9512	129	14	.	.	PUNCT
aiua-9512	130	1	the	the	DET
aiua-9512	130	2	prognosis	prognosis	NOUN
aiua-9512	130	3	also	also	ADV
aiua-9512	130	4	remains	remain	VERB
aiua-9512	130	5	problematic	problematic	ADJ
aiua-9512	130	6	.	.	PUNCT
aiua-9512	131	1	taking	take	VERB
aiua-9512	131	2	into	into	ADP
aiua-9512	131	3	account	account	NOUN
aiua-9512	131	4	,	,	PUNCT
aiua-9512	131	5	that	that	SCONJ
aiua-9512	131	6	a	a	DET
aiua-9512	131	7	molecular	molecular	ADJ
aiua-9512	131	8	marker	marker	NOUN
aiua-9512	131	9	could	could	AUX
aiua-9512	131	10	be	be	AUX
aiua-9512	131	11	helpful	helpful	ADJ
aiua-9512	131	12	in	in	ADP
aiua-9512	131	13	this	this	DET
aiua-9512	131	14	field	field	NOUN
aiua-9512	131	15	,	,	PUNCT
aiua-9512	131	16	our	our	PRON
aiua-9512	131	17	study	study	NOUN
aiua-9512	131	18	gives	give	VERB
aiua-9512	131	19	an	an	DET
aiua-9512	131	20	evidence	evidence	NOUN
aiua-9512	131	21	for	for	ADP
aiua-9512	131	22	the	the	DET
aiua-9512	131	23	usefulness	usefulness	NOUN
aiua-9512	131	24	of	of	ADP
aiua-9512	131	25	et-1	et-1	NUM
aiua-9512	131	26	in	in	ADP
aiua-9512	131	27	hgnmiubc	hgnmiubc	NOUN
aiua-9512	131	28	as	as	ADP
aiua-9512	131	29	an	an	DET
aiua-9512	131	30	alert	alert	ADJ
aiua-9512	131	31	marker	marker	NOUN
aiua-9512	131	32	for	for	ADP
aiua-9512	131	33	disease	disease	NOUN
aiua-9512	131	34	recurrence	recurrence	NOUN
aiua-9512	131	35	as	as	ADV
aiua-9512	131	36	well	well	ADV
aiua-9512	131	37	as	as	ADP
aiua-9512	131	38	progression	progression	NOUN
aiua-9512	131	39	.	.	PUNCT
aiua-9512	132	1	conclusions	conclusion	NOUN
aiua-9512	132	2	et-1	et-1	VERB
aiua-9512	132	3	seems	seem	VERB
aiua-9512	132	4	to	to	PART
aiua-9512	132	5	deteriorate	deteriorate	VERB
aiua-9512	132	6	prognosis	prognosis	NOUN
aiua-9512	132	7	in	in	ADP
aiua-9512	132	8	patients	patient	NOUN
aiua-9512	132	9	suffering	suffer	VERB
aiua-9512	132	10	from	from	ADP
aiua-9512	132	11	primary	primary	ADJ
aiua-9512	132	12	high	high	ADJ
aiua-9512	132	13	-	-	PUNCT
aiua-9512	132	14	grade	grade	NOUN
aiua-9512	132	15	non	non	ADJ
aiua-9512	132	16	-	-	ADJ
aiua-9512	132	17	muscle	muscle	ADJ
aiua-9512	132	18	-	-	PUNCT
aiua-9512	132	19	invasive	invasive	ADJ
aiua-9512	132	20	urothelial	urothelial	ADJ
aiua-9512	132	21	bladder	bladder	NOUN
aiua-9512	132	22	cancer	cancer	NOUN
aiua-9512	132	23	,	,	PUNCT
aiua-9512	132	24	who	who	PRON
aiua-9512	132	25	are	be	AUX
aiua-9512	132	26	treated	treat	VERB
aiua-9512	132	27	with	with	ADP
aiua-9512	132	28	adjuvant	adjuvant	ADJ
aiua-9512	132	29	bcg	bcg	PROPN
aiua-9512	132	30	instillations	instillation	NOUN
aiua-9512	132	31	.	.	PUNCT
aiua-9512	133	1	furthermore	furthermore	ADV
aiua-9512	133	2	,	,	PUNCT
aiua-9512	133	3	the	the	DET
aiua-9512	133	4	patient	patient	NOUN
aiua-9512	133	5	’s	’s	PART
aiua-9512	133	6	age	age	NOUN
aiua-9512	133	7	associates	associate	NOUN
aiua-9512	133	8	with	with	ADP
aiua-9512	133	9	an	an	DET
aiua-9512	133	10	increased	increase	VERB
aiua-9512	133	11	likelihood	likelihood	NOUN
aiua-9512	133	12	for	for	ADP
aiua-9512	133	13	recurrence	recurrence	NOUN
aiua-9512	133	14	.	.	PUNCT
aiua-9512	134	1	further	further	ADJ
aiua-9512	134	2	studies	study	NOUN
aiua-9512	134	3	are	be	AUX
aiua-9512	134	4	needed	need	VERB
aiua-9512	134	5	in	in	ADP
aiua-9512	134	6	order	order	NOUN
aiua-9512	134	7	to	to	PART
aiua-9512	134	8	clarify	clarify	VERB
aiua-9512	134	9	the	the	DET
aiua-9512	134	10	potential	potential	ADJ
aiua-9512	134	11	role	role	NOUN
aiua-9512	134	12	of	of	ADP
aiua-9512	134	13	147archivio	147archivio	PROPN
aiua-9512	134	14	italiano	italiano	NOUN
aiua-9512	134	15	di	di	X
aiua-9512	134	16	urologia	urologia	PROPN
aiua-9512	134	17	e	e	PROPN
aiua-9512	134	18	andrologia	andrologia	NOUN
aiua-9512	134	19	2021	2021	NUM
aiua-9512	134	20	;	;	PUNCT
aiua-9512	134	21	93	93	NUM
aiua-9512	134	22	,	,	PUNCT
aiua-9512	134	23	2	2	NUM
aiua-9512	134	24	et-1	et-1	X
aiua-9512	134	25	worsens	worsen	VERB
aiua-9512	134	26	prognosis	prognosis	NOUN
aiua-9512	134	27	in	in	ADP
aiua-9512	134	28	bladder	bladder	NOUN
aiua-9512	134	29	cancer	cancer	NOUN
aiua-9512	134	30	et-1	et-1	PUNCT
aiua-9512	134	31	in	in	ADP
aiua-9512	134	32	the	the	DET
aiua-9512	134	33	active	active	ADJ
aiua-9512	134	34	molecular	molecular	ADJ
aiua-9512	134	35	mechanism	mechanism	NOUN
aiua-9512	134	36	in	in	ADP
aiua-9512	134	37	bladder	bladder	NOUN
aiua-9512	134	38	cancer	cancer	NOUN
aiua-9512	134	39	and	and	CCONJ
aiua-9512	134	40	confirm	confirm	VERB
aiua-9512	134	41	or	or	CCONJ
aiua-9512	134	42	not	not	PART
aiua-9512	134	43	our	our	PRON
aiua-9512	134	44	promising	promising	ADJ
aiua-9512	134	45	finding	finding	NOUN
aiua-9512	134	46	.	.	PUNCT
aiua-9512	135	1	acknowledgements	acknowledgement	VERB
aiua-9512	135	2	the	the	DET
aiua-9512	135	3	corresponding	corresponding	ADJ
aiua-9512	135	4	author	author	NOUN
aiua-9512	135	5	has	have	AUX
aiua-9512	135	6	been	be	AUX
aiua-9512	135	7	awarded	award	VERB
aiua-9512	135	8	a	a	DET
aiua-9512	135	9	supporting	support	VERB
aiua-9512	135	10	funding	funding	NOUN
aiua-9512	135	11	from	from	ADP
aiua-9512	135	12	the	the	DET
aiua-9512	135	13	hellenic	hellenic	PROPN
aiua-9512	135	14	urological	urological	PROPN
aiua-9512	135	15	association	association	PROPN
aiua-9512	135	16	(	(	PUNCT
aiua-9512	135	17	hua	hua	PROPN
aiua-9512	135	18	)	)	PUNCT
aiua-9512	135	19	.	.	PUNCT
aiua-9512	136	1	references	reference	NOUN
aiua-9512	136	2	1	1	NUM
aiua-9512	136	3	.	.	PUNCT
aiua-9512	136	4	sylvester	sylvester	PROPN
aiua-9512	136	5	rj	rj	PROPN
aiua-9512	136	6	,	,	PUNCT
aiua-9512	136	7	brausi	brausi	PROPN
aiua-9512	136	8	ma	ma	PROPN
aiua-9512	136	9	,	,	PUNCT
aiua-9512	136	10	kirkels	kirkel	VERB
aiua-9512	136	11	wj	wj	PROPN
aiua-9512	136	12	,	,	PUNCT
aiua-9512	136	13	et	et	PROPN
aiua-9512	136	14	al	al	PROPN
aiua-9512	136	15	.	.	PUNCT
aiua-9512	137	1	long	long	ADJ
aiua-9512	137	2	-	-	PUNCT
aiua-9512	137	3	term	term	NOUN
aiua-9512	137	4	efficacy	efficacy	NOUN
aiua-9512	137	5	results	result	NOUN
aiua-9512	137	6	of	of	ADP
aiua-9512	137	7	eortc	eortc	ADJ
aiua-9512	137	8	genito	genito	ADJ
aiua-9512	137	9	-	-	PUNCT
aiua-9512	137	10	urinary	urinary	ADJ
aiua-9512	137	11	group	group	NOUN
aiua-9512	137	12	randomized	randomize	VERB
aiua-9512	137	13	phase	phase	NOUN
aiua-9512	137	14	3	3	NUM
aiua-9512	137	15	study	study	NOUN
aiua-9512	137	16	30911	30911	NUM
aiua-9512	137	17	comparing	compare	VERB
aiua-9512	137	18	intravesical	intravesical	ADJ
aiua-9512	137	19	instillations	instillation	NOUN
aiua-9512	137	20	of	of	ADP
aiua-9512	137	21	epirubicin	epirubicin	NOUN
aiua-9512	137	22	,	,	PUNCT
aiua-9512	137	23	bacillus	bacillus	NOUN
aiua-9512	137	24	calmette	calmette	NOUN
aiua-9512	137	25	-	-	PUNCT
aiua-9512	137	26	guérin	guérin	PROPN
aiua-9512	137	27	,	,	PUNCT
aiua-9512	137	28	and	and	CCONJ
aiua-9512	137	29	bacillus	bacillus	NOUN
aiua-9512	137	30	calmette	calmette	NOUN
aiua-9512	137	31	-	-	PUNCT
aiua-9512	137	32	guérin	guérin	PROPN
aiua-9512	137	33	plus	plus	CCONJ
aiua-9512	137	34	isoniazid	isoniazid	NOUN
aiua-9512	137	35	in	in	ADP
aiua-9512	137	36	patients	patient	NOUN
aiua-9512	137	37	with	with	ADP
aiua-9512	137	38	intermediateand	intermediateand	NOUN
aiua-9512	137	39	high	high	ADJ
aiua-9512	137	40	-	-	PUNCT
aiua-9512	137	41	risk	risk	NOUN
aiua-9512	137	42	stage	stage	NOUN
aiua-9512	137	43	ta	ta	AUX
aiua-9512	137	44	t1	t1	VERB
aiua-9512	137	45	urothelial	urothelial	ADJ
aiua-9512	137	46	carcinoma	carcinoma	NOUN
aiua-9512	137	47	of	of	ADP
aiua-9512	137	48	the	the	DET
aiua-9512	137	49	bladder	bladder	NOUN
aiua-9512	137	50	.	.	PUNCT
aiua-9512	138	1	eur	eur	PROPN
aiua-9512	138	2	urol	urol	PROPN
aiua-9512	138	3	.	.	PUNCT
aiua-9512	139	1	2010	2010	NUM
aiua-9512	139	2	;	;	PUNCT
aiua-9512	140	1	57:766	57:766	NUM
aiua-9512	140	2	-	-	SYM
aiua-9512	140	3	773	773	NUM
aiua-9512	140	4	.	.	NOUN
aiua-9512	140	5	2	2	NUM
aiua-9512	140	6	.	.	NOUN
aiua-9512	140	7	soloway	soloway	PROPN
aiua-9512	140	8	m	m	PROPN
aiua-9512	140	9	,	,	PUNCT
aiua-9512	140	10	khoury	khoury	PROPN
aiua-9512	140	11	s.	s.	PROPN
aiua-9512	140	12	bladder	bladder	NOUN
aiua-9512	140	13	cancer	cancer	NOUN
aiua-9512	140	14	.	.	PUNCT
aiua-9512	141	1	2nd	2nd	PROPN
aiua-9512	141	2	edition	edition	PROPN
aiua-9512	141	3	:	:	PUNCT
aiua-9512	141	4	icud	icud	PROPN
aiua-9512	141	5	-	-	PUNCT
aiua-9512	141	6	eau	eau	PROPN
aiua-9512	141	7	2012	2012	NUM
aiua-9512	141	8	;	;	PUNCT
aiua-9512	141	9	254	254	NUM
aiua-9512	141	10	-	-	SYM
aiua-9512	141	11	261	261	NUM
aiua-9512	141	12	.	.	NOUN
aiua-9512	142	1	3	3	NUM
aiua-9512	142	2	.	.	X
aiua-9512	142	3	cambier	cambier	PROPN
aiua-9512	142	4	s	s	PART
aiua-9512	142	5	,	,	PUNCT
aiua-9512	142	6	sylvester	sylvester	PROPN
aiua-9512	142	7	rj	rj	PROPN
aiua-9512	142	8	,	,	PUNCT
aiua-9512	142	9	collette	collette	PROPN
aiua-9512	142	10	l	l	PROPN
aiua-9512	142	11	,	,	PUNCT
aiua-9512	142	12	et	et	PROPN
aiua-9512	142	13	al	al	PROPN
aiua-9512	142	14	.	.	PROPN
aiua-9512	142	15	eortc	eortc	PROPN
aiua-9512	142	16	nomograms	nomogram	NOUN
aiua-9512	142	17	and	and	CCONJ
aiua-9512	142	18	risk	risk	NOUN
aiua-9512	142	19	groups	group	NOUN
aiua-9512	142	20	for	for	ADP
aiua-9512	142	21	predicting	predict	VERB
aiua-9512	142	22	recurrence	recurrence	NOUN
aiua-9512	142	23	,	,	PUNCT
aiua-9512	142	24	progression	progression	NOUN
aiua-9512	142	25	,	,	PUNCT
aiua-9512	142	26	and	and	CCONJ
aiua-9512	142	27	diseasespecific	diseasespecific	VERB
aiua-9512	142	28	and	and	CCONJ
aiua-9512	142	29	overall	overall	ADJ
aiua-9512	142	30	survival	survival	NOUN
aiua-9512	142	31	in	in	ADP
aiua-9512	142	32	non	non	ADJ
aiua-9512	142	33	-	-	ADJ
aiua-9512	142	34	muscle	muscle	ADJ
aiua-9512	142	35	-	-	PUNCT
aiua-9512	142	36	invasive	invasive	ADJ
aiua-9512	142	37	stage	stage	NOUN
aiua-9512	142	38	ta	ta	PROPN
aiua-9512	142	39	-	-	PUNCT
aiua-9512	142	40	t1	t1	NOUN
aiua-9512	142	41	urothelial	urothelial	ADJ
aiua-9512	142	42	bladder	bladder	NOUN
aiua-9512	142	43	cancer	cancer	NOUN
aiua-9512	142	44	patients	patient	NOUN
aiua-9512	142	45	treated	treat	VERB
aiua-9512	142	46	with	with	ADP
aiua-9512	142	47	1	1	NUM
aiua-9512	142	48	-	-	SYM
aiua-9512	142	49	3	3	NUM
aiua-9512	142	50	years	year	NOUN
aiua-9512	142	51	of	of	ADP
aiua-9512	142	52	maintenance	maintenance	NOUN
aiua-9512	142	53	bacillus	bacillus	NOUN
aiua-9512	142	54	calmette	calmette	NOUN
aiua-9512	142	55	-	-	PUNCT
aiua-9512	142	56	guérin	guérin	PROPN
aiua-9512	142	57	.	.	PUNCT
aiua-9512	143	1	eur	eur	PROPN
aiua-9512	143	2	urol	urol	PROPN
aiua-9512	143	3	.	.	PUNCT
aiua-9512	143	4	2016	2016	NUM
aiua-9512	143	5	;	;	PUNCT
aiua-9512	143	6	69:60	69:60	NUM
aiua-9512	143	7	-	-	SYM
aiua-9512	143	8	9	9	NUM
aiua-9512	143	9	.	.	NOUN
aiua-9512	143	10	4	4	NUM
aiua-9512	143	11	.	.	NOUN
aiua-9512	143	12	mitrakas	mitrakas	PROPN
aiua-9512	143	13	l	l	PROPN
aiua-9512	143	14	,	,	PUNCT
aiua-9512	143	15	gravas	gravas	PROPN
aiua-9512	143	16	s	s	PROPN
aiua-9512	143	17	,	,	PUNCT
aiua-9512	143	18	papandreou	papandreou	PROPN
aiua-9512	143	19	c	c	NOUN
aiua-9512	143	20	,	,	PUNCT
aiua-9512	143	21	et	et	PROPN
aiua-9512	143	22	al	al	PROPN
aiua-9512	143	23	.	.	PROPN
aiua-9512	143	24	primary	primary	ADJ
aiua-9512	143	25	high	high	ADJ
aiua-9512	143	26	-	-	PUNCT
aiua-9512	143	27	grade	grade	NOUN
aiua-9512	143	28	non	non	ADJ
aiua-9512	143	29	-	-	ADJ
aiua-9512	143	30	muscle	muscle	ADJ
aiua-9512	143	31	-	-	PUNCT
aiua-9512	143	32	invasive	invasive	ADJ
aiua-9512	143	33	bladder	bladder	NOUN
aiua-9512	143	34	cancer	cancer	NOUN
aiua-9512	143	35	:	:	PUNCT
aiua-9512	143	36	high	high	ADJ
aiua-9512	143	37	nf	nf	NOUN
aiua-9512	143	38	-	-	PUNCT
aiua-9512	143	39	b	b	NOUN
aiua-9512	143	40	expression	expression	NOUN
aiua-9512	143	41	in	in	ADP
aiua-9512	143	42	tumor	tumor	NOUN
aiua-9512	143	43	specimens	specimen	NOUN
aiua-9512	143	44	distinguishes	distinguish	VERB
aiua-9512	143	45	patients	patient	NOUN
aiua-9512	143	46	who	who	PRON
aiua-9512	143	47	are	be	AUX
aiua-9512	143	48	at	at	ADP
aiua-9512	143	49	risk	risk	NOUN
aiua-9512	143	50	for	for	ADP
aiua-9512	143	51	disease	disease	NOUN
aiua-9512	143	52	progression	progression	NOUN
aiua-9512	143	53	.	.	PUNCT
aiua-9512	144	1	pathol	pathol	VERB
aiua-9512	144	2	oncol	oncol	ADJ
aiua-9512	144	3	res	re	NOUN
aiua-9512	144	4	.	.	PUNCT
aiua-9512	144	5	2019	2019	NUM
aiua-9512	144	6	;	;	PUNCT
aiua-9512	144	7	25:225	25:225	NUM
aiua-9512	144	8	-	-	SYM
aiua-9512	144	9	231	231	NUM
aiua-9512	144	10	.	.	PUNCT
aiua-9512	145	1	5	5	NUM
aiua-9512	145	2	.	.	NOUN
aiua-9512	145	3	mitrakas	mitrakas	PROPN
aiua-9512	145	4	l	l	PROPN
aiua-9512	145	5	,	,	PUNCT
aiua-9512	145	6	gravas	gravas	PROPN
aiua-9512	145	7	s	s	PROPN
aiua-9512	145	8	,	,	PUNCT
aiua-9512	145	9	karasavvidou	karasavvidou	PROPN
aiua-9512	145	10	f	f	PROPN
aiua-9512	145	11	,	,	PUNCT
aiua-9512	145	12	et	et	PROPN
aiua-9512	145	13	al	al	PROPN
aiua-9512	145	14	.	.	PUNCT
aiua-9512	146	1	endothelin-1	endothelin-1	DET
aiua-9512	146	2	overexpression	overexpression	NOUN
aiua-9512	146	3	:	:	PUNCT
aiua-9512	146	4	a	a	DET
aiua-9512	146	5	potential	potential	ADJ
aiua-9512	146	6	biomarker	biomarker	NOUN
aiua-9512	146	7	of	of	ADP
aiua-9512	146	8	unfavorable	unfavorable	ADJ
aiua-9512	146	9	prognosis	prognosis	NOUN
aiua-9512	146	10	in	in	ADP
aiua-9512	146	11	nonmetastatic	nonmetastatic	ADJ
aiua-9512	146	12	muscle	muscle	NOUN
aiua-9512	146	13	-	-	PUNCT
aiua-9512	146	14	invasive	invasive	ADJ
aiua-9512	146	15	bladder	bladder	NOUN
aiua-9512	146	16	cancer	cancer	NOUN
aiua-9512	146	17	.	.	PUNCT
aiua-9512	147	1	tumour	tumour	PROPN
aiua-9512	147	2	biol	biol	PROPN
aiua-9512	147	3	.	.	PUNCT
aiua-9512	148	1	2015	2015	NUM
aiua-9512	148	2	;	;	PUNCT
aiua-9512	148	3	36:4699	36:4699	NUM
aiua-9512	148	4	-	-	SYM
aiua-9512	148	5	705	705	NUM
aiua-9512	148	6	.	.	PUNCT
aiua-9512	149	1	erratum	erratum	NOUN
aiua-9512	149	2	in	in	ADP
aiua-9512	149	3	:	:	PUNCT
aiua-9512	149	4	tumour	tumour	NOUN
aiua-9512	149	5	biol	biol	NOUN
aiua-9512	149	6	.	.	PUNCT
aiua-9512	150	1	2015	2015	NUM
aiua-9512	150	2	;	;	PUNCT
aiua-9512	151	1	36:3127	36:3127	NUM
aiua-9512	151	2	6	6	NUM
aiua-9512	151	3	.	.	PUNCT
aiua-9512	151	4	lamm	lamm	PROPN
aiua-9512	151	5	dl	dl	PROPN
aiua-9512	151	6	,	,	PUNCT
aiua-9512	151	7	blumenstein	blumenstein	PROPN
aiua-9512	151	8	ba	ba	PROPN
aiua-9512	151	9	,	,	PUNCT
aiua-9512	151	10	crissman	crissman	NOUN
aiua-9512	151	11	jd	jd	PROPN
aiua-9512	151	12	,	,	PUNCT
aiua-9512	151	13	et	et	PROPN
aiua-9512	151	14	al	al	PROPN
aiua-9512	151	15	.	.	PUNCT
aiua-9512	151	16	maintenance	maintenance	NOUN
aiua-9512	151	17	bacillus	bacillus	NOUN
aiua-9512	151	18	calmette	calmette	NOUN
aiua-9512	151	19	-	-	PUNCT
aiua-9512	151	20	guérin	guérin	PROPN
aiua-9512	151	21	immunotherapy	immunotherapy	NOUN
aiua-9512	151	22	for	for	ADP
aiua-9512	151	23	recurrent	recurrent	NOUN
aiua-9512	151	24	ta	ta	PROPN
aiua-9512	151	25	,	,	PUNCT
aiua-9512	151	26	t1	t1	NOUN
aiua-9512	151	27	and	and	CCONJ
aiua-9512	151	28	carcinoma	carcinoma	NOUN
aiua-9512	151	29	in	in	ADP
aiua-9512	151	30	situ	situ	ADJ
aiua-9512	151	31	transitional	transitional	ADJ
aiua-9512	151	32	cell	cell	NOUN
aiua-9512	151	33	carcinoma	carcinoma	NOUN
aiua-9512	151	34	of	of	ADP
aiua-9512	151	35	the	the	DET
aiua-9512	151	36	bladder	bladder	NOUN
aiua-9512	151	37	:	:	PUNCT
aiua-9512	151	38	a	a	DET
aiua-9512	151	39	randomized	randomized	ADJ
aiua-9512	151	40	southwest	southwest	NOUN
aiua-9512	151	41	oncology	oncology	NOUN
aiua-9512	151	42	group	group	NOUN
aiua-9512	151	43	study	study	NOUN
aiua-9512	151	44	.	.	PUNCT
aiua-9512	152	1	j	j	PROPN
aiua-9512	152	2	urol	urol	PROPN
aiua-9512	152	3	.	.	PROPN
aiua-9512	152	4	2000	2000	NUM
aiua-9512	152	5	;	;	PUNCT
aiua-9512	152	6	163:1124	163:1124	NUM
aiua-9512	152	7	-	-	SYM
aiua-9512	152	8	1129	1129	NUM
aiua-9512	152	9	.	.	PUNCT
aiua-9512	153	1	7	7	NUM
aiua-9512	153	2	.	.	X
aiua-9512	153	3	babjuk	babjuk	PROPN
aiua-9512	153	4	m	m	PROPN
aiua-9512	153	5	,	,	PUNCT
aiua-9512	153	6	böhle	böhle	PROPN
aiua-9512	153	7	a	a	PRON
aiua-9512	153	8	,	,	PUNCT
aiua-9512	153	9	burger	burger	NOUN
aiua-9512	153	10	m	m	PROPN
aiua-9512	153	11	,	,	PUNCT
aiua-9512	153	12	et	et	PROPN
aiua-9512	153	13	al	al	PROPN
aiua-9512	153	14	.	.	PUNCT
aiua-9512	154	1	eau	eau	PROPN
aiua-9512	154	2	guidelines	guideline	NOUN
aiua-9512	154	3	on	on	ADP
aiua-9512	154	4	non	non	ADJ
aiua-9512	154	5	-	-	ADJ
aiua-9512	154	6	muscle	muscle	ADJ
aiua-9512	154	7	-	-	PUNCT
aiua-9512	154	8	invasive	invasive	ADJ
aiua-9512	154	9	urothelial	urothelial	ADJ
aiua-9512	154	10	carcinoma	carcinoma	NOUN
aiua-9512	154	11	of	of	ADP
aiua-9512	154	12	the	the	DET
aiua-9512	154	13	bladder	bladder	NOUN
aiua-9512	154	14	:	:	PUNCT
aiua-9512	154	15	update	update	NOUN
aiua-9512	154	16	2016	2016	NUM
aiua-9512	154	17	.	.	PUNCT
aiua-9512	155	1	eur	eur	PROPN
aiua-9512	155	2	urol	urol	PROPN
aiua-9512	155	3	.	.	PUNCT
aiua-9512	156	1	2017	2017	NUM
aiua-9512	156	2	;	;	PUNCT
aiua-9512	157	1	71:447	71:447	NUM
aiua-9512	157	2	-	-	SYM
aiua-9512	157	3	461	461	NUM
aiua-9512	157	4	.	.	PUNCT
aiua-9512	158	1	8	8	NUM
aiua-9512	158	2	.	.	PUNCT
aiua-9512	158	3	zachos	zachos	PROPN
aiua-9512	158	4	i	i	PROPN
aiua-9512	158	5	,	,	PUNCT
aiua-9512	158	6	tzortzis	tzortzi	VERB
aiua-9512	158	7	v	v	NOUN
aiua-9512	158	8	,	,	PUNCT
aiua-9512	158	9	mitrakas	mitrakas	ADJ
aiua-9512	158	10	l	l	PROPN
aiua-9512	158	11	,	,	PUNCT
aiua-9512	158	12	et	et	PROPN
aiua-9512	158	13	al	al	PROPN
aiua-9512	158	14	.	.	PROPN
aiua-9512	158	15	tumor	tumor	PROPN
aiua-9512	158	16	size	size	NOUN
aiua-9512	158	17	and	and	CCONJ
aiua-9512	158	18	t	t	NOUN
aiua-9512	158	19	stage	stage	NOUN
aiua-9512	158	20	correlate	correlate	VERB
aiua-9512	158	21	independently	independently	ADV
aiua-9512	158	22	with	with	ADP
aiua-9512	158	23	recurrence	recurrence	NOUN
aiua-9512	158	24	and	and	CCONJ
aiua-9512	158	25	progression	progression	NOUN
aiua-9512	158	26	in	in	ADP
aiua-9512	158	27	high	high	ADJ
aiua-9512	158	28	-	-	PUNCT
aiua-9512	158	29	risk	risk	NOUN
aiua-9512	158	30	non	non	ADJ
aiua-9512	158	31	-	-	ADJ
aiua-9512	158	32	muscle	muscle	ADJ
aiua-9512	158	33	-	-	PUNCT
aiua-9512	158	34	invasive	invasive	ADJ
aiua-9512	158	35	bladder	bladder	NOUN
aiua-9512	158	36	cancer	cancer	NOUN
aiua-9512	158	37	patients	patient	NOUN
aiua-9512	158	38	treated	treat	VERB
aiua-9512	158	39	with	with	ADP
aiua-9512	158	40	adjuvant	adjuvant	ADJ
aiua-9512	158	41	bcg	bcg	PROPN
aiua-9512	158	42	.	.	PUNCT
aiua-9512	159	1	tumour	tumour	PROPN
aiua-9512	159	2	biol	biol	PROPN
aiua-9512	159	3	.	.	PUNCT
aiua-9512	160	1	2014	2014	NUM
aiua-9512	160	2	;	;	PUNCT
aiua-9512	160	3	35:4185	35:4185	NUM
aiua-9512	160	4	-	-	SYM
aiua-9512	160	5	4189	4189	NUM
aiua-9512	160	6	.	.	PUNCT
aiua-9512	161	1	9	9	X
aiua-9512	161	2	.	.	X
aiua-9512	161	3	sylvester	sylvester	PROPN
aiua-9512	161	4	rj	rj	PROPN
aiua-9512	161	5	,	,	PUNCT
aiua-9512	161	6	van	van	PROPN
aiua-9512	161	7	der	der	PROPN
aiua-9512	161	8	meijden	meijden	PROPN
aiua-9512	161	9	ap	ap	PROPN
aiua-9512	161	10	,	,	PUNCT
aiua-9512	161	11	oosterlinck	oosterlinck	NOUN
aiua-9512	161	12	w	w	PROPN
aiua-9512	161	13	,	,	PUNCT
aiua-9512	161	14	et	et	PROPN
aiua-9512	161	15	al	al	PROPN
aiua-9512	161	16	.	.	PROPN
aiua-9512	161	17	predicting	predict	VERB
aiua-9512	161	18	recurrence	recurrence	NOUN
aiua-9512	161	19	and	and	CCONJ
aiua-9512	161	20	progression	progression	NOUN
aiua-9512	161	21	in	in	ADP
aiua-9512	161	22	individual	individual	ADJ
aiua-9512	161	23	patients	patient	NOUN
aiua-9512	161	24	with	with	ADP
aiua-9512	161	25	stage	stage	NOUN
aiua-9512	161	26	ta	ta	X
aiua-9512	161	27	t1	t1	NOUN
aiua-9512	161	28	bladder	bladder	NOUN
aiua-9512	161	29	cancer	cancer	NOUN
aiua-9512	161	30	using	use	VERB
aiua-9512	161	31	eortc	eortc	VERB
aiua-9512	161	32	risk	risk	NOUN
aiua-9512	161	33	tables	table	NOUN
aiua-9512	161	34	:	:	PUNCT
aiua-9512	161	35	a	a	DET
aiua-9512	161	36	combined	combined	ADJ
aiua-9512	161	37	analysis	analysis	NOUN
aiua-9512	161	38	of	of	ADP
aiua-9512	161	39	2596	2596	NUM
aiua-9512	161	40	patients	patient	NOUN
aiua-9512	161	41	from	from	ADP
aiua-9512	161	42	seven	seven	NUM
aiua-9512	161	43	eortc	eortc	ADJ
aiua-9512	161	44	trials	trial	NOUN
aiua-9512	161	45	.	.	PUNCT
aiua-9512	162	1	eur	eur	PROPN
aiua-9512	162	2	urol	urol	PROPN
aiua-9512	162	3	.	.	PUNCT
aiua-9512	163	1	2006	2006	NUM
aiua-9512	163	2	;	;	PUNCT
aiua-9512	163	3	49:466	49:466	NUM
aiua-9512	163	4	-	-	SYM
aiua-9512	163	5	5	5	NUM
aiua-9512	163	6	.	.	NOUN
aiua-9512	163	7	10	10	NUM
aiua-9512	163	8	.	.	PUNCT
aiua-9512	163	9	palou	palou	PROPN
aiua-9512	163	10	j	j	PROPN
aiua-9512	163	11	,	,	PUNCT
aiua-9512	163	12	sylvester	sylvester	PROPN
aiua-9512	163	13	rj	rj	PROPN
aiua-9512	163	14	,	,	PUNCT
aiua-9512	163	15	faba	faba	NOUN
aiua-9512	163	16	or	or	CCONJ
aiua-9512	163	17	,	,	PUNCT
aiua-9512	163	18	et	et	PROPN
aiua-9512	163	19	al	al	PROPN
aiua-9512	163	20	.	.	PROPN
aiua-9512	163	21	female	female	ADJ
aiua-9512	163	22	gender	gender	NOUN
aiua-9512	163	23	and	and	CCONJ
aiua-9512	163	24	carcinoma	carcinoma	NOUN
aiua-9512	163	25	in	in	ADP
aiua-9512	163	26	situ	situ	NOUN
aiua-9512	163	27	in	in	ADP
aiua-9512	163	28	the	the	DET
aiua-9512	163	29	prostatic	prostatic	ADJ
aiua-9512	163	30	urethra	urethra	NOUN
aiua-9512	163	31	are	be	AUX
aiua-9512	163	32	prognostic	prognostic	ADJ
aiua-9512	163	33	factors	factor	NOUN
aiua-9512	163	34	for	for	ADP
aiua-9512	163	35	recurrence	recurrence	NOUN
aiua-9512	163	36	,	,	PUNCT
aiua-9512	163	37	progression	progression	NOUN
aiua-9512	163	38	,	,	PUNCT
aiua-9512	163	39	and	and	CCONJ
aiua-9512	163	40	disease	disease	NOUN
aiua-9512	163	41	-	-	PUNCT
aiua-9512	163	42	specific	specific	ADJ
aiua-9512	163	43	mortality	mortality	NOUN
aiua-9512	163	44	in	in	ADP
aiua-9512	163	45	t1g3	t1g3	ADP
aiua-9512	163	46	bladder	bladder	NOUN
aiua-9512	163	47	cancer	cancer	NOUN
aiua-9512	163	48	patients	patient	NOUN
aiua-9512	163	49	treated	treat	VERB
aiua-9512	163	50	with	with	ADP
aiua-9512	163	51	bacillus	bacillus	NOUN
aiua-9512	163	52	calmette	calmette	NOUN
aiua-9512	163	53	-	-	PUNCT
aiua-9512	163	54	guérin	guérin	PROPN
aiua-9512	163	55	.	.	PUNCT
aiua-9512	164	1	eur	eur	PROPN
aiua-9512	164	2	urol	urol	PROPN
aiua-9512	164	3	.	.	PUNCT
aiua-9512	164	4	2012	2012	NUM
aiua-9512	164	5	;	;	PUNCT
aiua-9512	164	6	62:118	62:118	NUM
aiua-9512	164	7	-	-	SYM
aiua-9512	164	8	25	25	NUM
aiua-9512	164	9	.	.	PUNCT
aiua-9512	165	1	11	11	NUM
aiua-9512	165	2	.	.	PUNCT
aiua-9512	166	1	gontero	gontero	PROPN
aiua-9512	166	2	p	p	NOUN
aiua-9512	166	3	,	,	PUNCT
aiua-9512	166	4	sylvester	sylvester	ADJ
aiua-9512	166	5	r	r	NOUN
aiua-9512	166	6	,	,	PUNCT
aiua-9512	166	7	pisano	pisano	NOUN
aiua-9512	166	8	f	f	PROPN
aiua-9512	166	9	,	,	PUNCT
aiua-9512	166	10	et	et	PROPN
aiua-9512	166	11	al	al	PROPN
aiua-9512	166	12	.	.	PUNCT
aiua-9512	167	1	prognostic	prognostic	ADJ
aiua-9512	167	2	factors	factor	NOUN
aiua-9512	167	3	and	and	CCONJ
aiua-9512	167	4	risk	risk	NOUN
aiua-9512	167	5	groups	group	NOUN
aiua-9512	167	6	in	in	ADP
aiua-9512	167	7	t1g3	t1g3	CCONJ
aiua-9512	167	8	non	non	ADJ
aiua-9512	167	9	-	-	ADJ
aiua-9512	167	10	muscle	muscle	ADJ
aiua-9512	167	11	-	-	PUNCT
aiua-9512	167	12	invasive	invasive	ADJ
aiua-9512	167	13	bladder	bladder	NOUN
aiua-9512	167	14	cancer	cancer	NOUN
aiua-9512	167	15	patients	patient	NOUN
aiua-9512	167	16	initially	initially	ADV
aiua-9512	167	17	treated	treat	VERB
aiua-9512	167	18	with	with	ADP
aiua-9512	167	19	bacillus	bacillus	NOUN
aiua-9512	167	20	calmette	calmette	NOUN
aiua-9512	167	21	-	-	PUNCT
aiua-9512	167	22	guérin	guérin	PROPN
aiua-9512	167	23	:	:	PUNCT
aiua-9512	167	24	results	result	NOUN
aiua-9512	167	25	of	of	ADP
aiua-9512	167	26	a	a	DET
aiua-9512	167	27	retrospective	retrospective	ADJ
aiua-9512	167	28	multicenter	multicenter	NOUN
aiua-9512	167	29	study	study	NOUN
aiua-9512	167	30	of	of	ADP
aiua-9512	167	31	2451	2451	NUM
aiua-9512	167	32	patients	patient	NOUN
aiua-9512	167	33	.	.	PUNCT
aiua-9512	168	1	eur	eur	PROPN
aiua-9512	168	2	urol	urol	PROPN
aiua-9512	168	3	.	.	PUNCT
aiua-9512	169	1	2015	2015	NUM
aiua-9512	169	2	;	;	PUNCT
aiua-9512	169	3	67:74	67:74	NUM
aiua-9512	169	4	-	-	SYM
aiua-9512	169	5	82	82	NUM
aiua-9512	169	6	.	.	NOUN
aiua-9512	170	1	12	12	NUM
aiua-9512	170	2	.	.	PUNCT
aiua-9512	171	1	sahan	sahan	PROPN
aiua-9512	171	2	a	a	PRON
aiua-9512	171	3	,	,	PUNCT
aiua-9512	171	4	gerin	gerin	NOUN
aiua-9512	171	5	f	f	X
aiua-9512	171	6	,	,	PUNCT
aiua-9512	171	7	garayev	garayev	NOUN
aiua-9512	171	8	a	a	PRON
aiua-9512	171	9	,	,	PUNCT
aiua-9512	171	10	et	et	PROPN
aiua-9512	171	11	al	al	PROPN
aiua-9512	171	12	.	.	PUNCT
aiua-9512	172	1	the	the	DET
aiua-9512	172	2	impact	impact	NOUN
aiua-9512	172	3	of	of	ADP
aiua-9512	172	4	tumor	tumor	NOUN
aiua-9512	172	5	invasion	invasion	NOUN
aiua-9512	172	6	to	to	PART
aiua-9512	172	7	muscularis	muscularis	VERB
aiua-9512	172	8	mucosaevascular	mucosaevascular	ADJ
aiua-9512	172	9	plexus	plexus	NOUN
aiua-9512	172	10	on	on	ADP
aiua-9512	172	11	patient	patient	ADJ
aiua-9512	172	12	outcome	outcome	NOUN
aiua-9512	172	13	in	in	ADP
aiua-9512	172	14	pt1	pt1	PROPN
aiua-9512	172	15	bladder	bladder	NOUN
aiua-9512	172	16	urothelial	urothelial	ADJ
aiua-9512	172	17	carcinoma	carcinoma	NOUN
aiua-9512	172	18	.	.	PUNCT
aiua-9512	173	1	arch	arch	ADJ
aiua-9512	173	2	ital	ital	PROPN
aiua-9512	173	3	urol	urol	PROPN
aiua-9512	173	4	androl	androl	PROPN
aiua-9512	173	5	.	.	PUNCT
aiua-9512	174	1	2020	2020	NUM
aiua-9512	174	2	;	;	PUNCT
aiua-9512	174	3	92:239	92:239	NUM
aiua-9512	174	4	-	-	SYM
aiua-9512	174	5	243	243	NUM
aiua-9512	174	6	.	.	NOUN
aiua-9512	175	1	13	13	NUM
aiua-9512	175	2	.	.	X
aiua-9512	176	1	eltze	eltze	PROPN
aiua-9512	176	2	e	e	NOUN
aiua-9512	176	3	,	,	PUNCT
aiua-9512	176	4	wild	wild	PROPN
aiua-9512	176	5	pj	pj	PROPN
aiua-9512	176	6	,	,	PUNCT
aiua-9512	176	7	wülfing	wülfe	VERB
aiua-9512	176	8	c	c	PROPN
aiua-9512	176	9	,	,	PUNCT
aiua-9512	176	10	et	et	PROPN
aiua-9512	176	11	al	al	PROPN
aiua-9512	176	12	.	.	PUNCT
aiua-9512	176	13	expression	expression	NOUN
aiua-9512	176	14	of	of	ADP
aiua-9512	176	15	the	the	DET
aiua-9512	176	16	endothelin	endothelin	PROPN
aiua-9512	176	17	axis	axis	NOUN
aiua-9512	176	18	in	in	ADP
aiua-9512	176	19	noninvasive	noninvasive	ADJ
aiua-9512	176	20	and	and	CCONJ
aiua-9512	176	21	superficially	superficially	ADV
aiua-9512	176	22	invasive	invasive	ADJ
aiua-9512	176	23	bladder	bladder	NOUN
aiua-9512	176	24	cancer	cancer	NOUN
aiua-9512	176	25	.	.	PUNCT
aiua-9512	177	1	relation	relation	NOUN
aiua-9512	177	2	to	to	ADP
aiua-9512	177	3	clinicopathologic	clinicopathologic	ADJ
aiua-9512	177	4	and	and	CCONJ
aiua-9512	177	5	molecular	molecular	ADJ
aiua-9512	177	6	prognostic	prognostic	ADJ
aiua-9512	177	7	parameters	parameter	NOUN
aiua-9512	177	8	.	.	PUNCT
aiua-9512	178	1	eur	eur	PROPN
aiua-9512	178	2	urol	urol	PROPN
aiua-9512	178	3	.	.	PUNCT
aiua-9512	178	4	2009	2009	NUM
aiua-9512	178	5	;	;	PUNCT
aiua-9512	178	6	56:837	56:837	NUM
aiua-9512	178	7	-	-	SYM
aiua-9512	178	8	847	847	NUM
aiua-9512	178	9	.	.	PUNCT
aiua-9512	179	1	14	14	NUM
aiua-9512	179	2	.	.	PUNCT
aiua-9512	180	1	wülfing	wülfe	VERB
aiua-9512	180	2	c	c	PROPN
aiua-9512	180	3	,	,	PUNCT
aiua-9512	180	4	eltze	eltze	PROPN
aiua-9512	180	5	e	e	NOUN
aiua-9512	180	6	,	,	PUNCT
aiua-9512	180	7	yamini	yamini	PROPN
aiua-9512	180	8	j	j	PROPN
aiua-9512	180	9	,	,	PUNCT
aiua-9512	180	10	et	et	PROPN
aiua-9512	180	11	al	al	PROPN
aiua-9512	180	12	.	.	PUNCT
aiua-9512	180	13	expression	expression	NOUN
aiua-9512	180	14	of	of	ADP
aiua-9512	180	15	the	the	DET
aiua-9512	180	16	endothelin	endothelin	PROPN
aiua-9512	180	17	axis	axis	NOUN
aiua-9512	180	18	in	in	ADP
aiua-9512	180	19	bladder	bladder	NOUN
aiua-9512	180	20	cancer	cancer	NOUN
aiua-9512	180	21	:	:	PUNCT
aiua-9512	180	22	relationship	relationship	NOUN
aiua-9512	180	23	to	to	ADP
aiua-9512	180	24	clinicopathologic	clinicopathologic	ADJ
aiua-9512	180	25	parameters	parameter	NOUN
aiua-9512	180	26	and	and	CCONJ
aiua-9512	180	27	long	long	ADJ
aiua-9512	180	28	-	-	PUNCT
aiua-9512	180	29	term	term	NOUN
aiua-9512	180	30	survival	survival	NOUN
aiua-9512	180	31	.	.	PUNCT
aiua-9512	181	1	eur	eur	PROPN
aiua-9512	181	2	urol	urol	PROPN
aiua-9512	181	3	.	.	PUNCT
aiua-9512	181	4	2005	2005	NUM
aiua-9512	181	5	;	;	PUNCT
aiua-9512	181	6	47:593	47:593	NUM
aiua-9512	181	7	-	-	SYM
aiua-9512	181	8	600	600	NUM
aiua-9512	181	9	.	.	NOUN
aiua-9512	181	10	15	15	NUM
aiua-9512	181	11	.	.	PUNCT
aiua-9512	182	1	wülfing	wülfe	VERB
aiua-9512	182	2	c	c	PROPN
aiua-9512	182	3	,	,	PUNCT
aiua-9512	182	4	tiemann	tiemann	PROPN
aiua-9512	182	5	a	a	PRON
aiua-9512	182	6	,	,	PUNCT
aiua-9512	182	7	persigehl	persigehl	PROPN
aiua-9512	182	8	t	t	PROPN
aiua-9512	182	9	,	,	PUNCT
aiua-9512	182	10	et	et	PROPN
aiua-9512	182	11	al	al	PROPN
aiua-9512	182	12	.	.	PROPN
aiua-9512	183	1	in	in	ADP
aiua-9512	183	2	vivo	vivo	ADJ
aiua-9512	183	3	activity	activity	NOUN
aiua-9512	183	4	of	of	ADP
aiua-9512	183	5	abt627	abt627	PROPN
aiua-9512	183	6	,	,	PUNCT
aiua-9512	183	7	a	a	DET
aiua-9512	183	8	selective	selective	ADJ
aiua-9512	183	9	endothelin	endothelin	NOUN
aiua-9512	183	10	-	-	PUNCT
aiua-9512	183	11	a	a	DET
aiua-9512	183	12	-	-	PUNCT
aiua-9512	183	13	receptor	receptor	NOUN
aiua-9512	183	14	antagonist	antagonist	NOUN
aiua-9512	183	15	,	,	PUNCT
aiua-9512	183	16	in	in	ADP
aiua-9512	183	17	bladder	bladder	NOUN
aiua-9512	183	18	cancer	cancer	NOUN
aiua-9512	183	19	xenograft	xenograft	NOUN
aiua-9512	183	20	tumors	tumor	NOUN
aiua-9512	183	21	.	.	PUNCT
aiua-9512	184	1	proc	proc	NOUN
aiua-9512	184	2	am	be	AUX
aiua-9512	184	3	soc	soc	NOUN
aiua-9512	184	4	cancer	cancer	NOUN
aiua-9512	184	5	res	re	NOUN
aiua-9512	184	6	.	.	PUNCT
aiua-9512	184	7	2005	2005	NUM
aiua-9512	184	8	;	;	PUNCT
aiua-9512	184	9	46	46	NUM
aiua-9512	184	10	:	:	PUNCT
aiua-9512	184	11	abstract	abstract	ADJ
aiua-9512	184	12	3039	3039	NUM
aiua-9512	184	13	.	.	PUNCT
aiua-9512	185	1	16	16	NUM
aiua-9512	185	2	.	.	PUNCT
aiua-9512	186	1	herrmann	herrmann	PROPN
aiua-9512	186	2	e	e	PROPN
aiua-9512	186	3	,	,	PUNCT
aiua-9512	186	4	tiemann	tiemann	PROPN
aiua-9512	186	5	a	a	X
aiua-9512	186	6	,	,	PUNCT
aiua-9512	186	7	eltze	eltze	PROPN
aiua-9512	186	8	e	e	NOUN
aiua-9512	186	9	,	,	PUNCT
aiua-9512	186	10	et	et	PROPN
aiua-9512	186	11	al	al	PROPN
aiua-9512	186	12	.	.	PUNCT
aiua-9512	187	1	endothelin	endothelin	PROPN
aiua-9512	187	2	-	-	PUNCT
aiua-9512	187	3	a	a	DET
aiua-9512	187	4	-	-	PUNCT
aiua-9512	187	5	receptor	receptor	NOUN
aiua-9512	187	6	antagonism	antagonism	NOUN
aiua-9512	187	7	with	with	ADP
aiua-9512	187	8	atrasentan	atrasentan	PROPN
aiua-9512	187	9	exhibits	exhibit	VERB
aiua-9512	187	10	limited	limited	ADJ
aiua-9512	187	11	activity	activity	NOUN
aiua-9512	187	12	on	on	ADP
aiua-9512	187	13	the	the	DET
aiua-9512	187	14	ku-1919	ku-1919	NOUN
aiua-9512	187	15	bladder	bladder	NOUN
aiua-9512	187	16	cancer	cancer	NOUN
aiua-9512	187	17	cell	cell	NOUN
aiua-9512	187	18	line	line	NOUN
aiua-9512	187	19	in	in	ADP
aiua-9512	187	20	a	a	DET
aiua-9512	187	21	mouse	mouse	NOUN
aiua-9512	187	22	model	model	NOUN
aiua-9512	187	23	.	.	PUNCT
aiua-9512	188	1	j	j	PROPN
aiua-9512	188	2	cancer	cancer	NOUN
aiua-9512	188	3	res	re	VERB
aiua-9512	188	4	clin	clin	PROPN
aiua-9512	188	5	oncol	oncol	PROPN
aiua-9512	188	6	.	.	PUNCT
aiua-9512	189	1	2009	2009	NUM
aiua-9512	189	2	;	;	PUNCT
aiua-9512	189	3	135:1455	135:1455	NUM
aiua-9512	189	4	-	-	SYM
aiua-9512	189	5	1462	1462	NUM
aiua-9512	189	6	.	.	PUNCT
aiua-9512	190	1	17	17	NUM
aiua-9512	190	2	.	.	PUNCT
aiua-9512	191	1	herrmann	herrmann	PROPN
aiua-9512	191	2	e	e	PROPN
aiua-9512	191	3	,	,	PUNCT
aiua-9512	191	4	bögemann	bögemann	PROPN
aiua-9512	191	5	m	m	PROPN
aiua-9512	191	6	,	,	PUNCT
aiua-9512	191	7	bierer	bierer	PROPN
aiua-9512	191	8	s	s	PROPN
aiua-9512	191	9	,	,	PUNCT
aiua-9512	191	10	et	et	PROPN
aiua-9512	191	11	al	al	PROPN
aiua-9512	191	12	.	.	PUNCT
aiua-9512	192	1	the	the	DET
aiua-9512	192	2	role	role	NOUN
aiua-9512	192	3	of	of	ADP
aiua-9512	192	4	the	the	DET
aiua-9512	192	5	endothelin	endothelin	PROPN
aiua-9512	192	6	axis	axis	NOUN
aiua-9512	192	7	and	and	CCONJ
aiua-9512	192	8	microvessel	microvessel	NOUN
aiua-9512	192	9	density	density	NOUN
aiua-9512	192	10	in	in	ADP
aiua-9512	192	11	bladder	bladder	NOUN
aiua-9512	192	12	cancer	cancer	NOUN
aiua-9512	192	13	correlation	correlation	NOUN
aiua-9512	192	14	with	with	ADP
aiua-9512	192	15	tumor	tumor	NOUN
aiua-9512	192	16	angiogenesis	angiogenesis	NOUN
aiua-9512	192	17	and	and	CCONJ
aiua-9512	192	18	clinical	clinical	ADJ
aiua-9512	192	19	prognosis	prognosis	NOUN
aiua-9512	192	20	.	.	PUNCT
aiua-9512	193	1	oncol	oncol	PROPN
aiua-9512	193	2	rep	rep	PROPN
aiua-9512	193	3	.	.	PROPN
aiua-9512	193	4	2007	2007	NUM
aiua-9512	193	5	;	;	PUNCT
aiua-9512	193	6	18:133	18:133	NUM
aiua-9512	193	7	-	-	SYM
aiua-9512	193	8	138	138	NUM
aiua-9512	193	9	.	.	PUNCT
aiua-9512	194	1	correspondence	correspondence	NOUN
aiua-9512	194	2	lampros	lampro	VERB
aiua-9512	194	3	mitrakas	mitrakas	PROPN
aiua-9512	194	4	,	,	PUNCT
aiua-9512	194	5	md	md	PROPN
aiua-9512	194	6	,	,	PUNCT
aiua-9512	194	7	phd	phd	NOUN
aiua-9512	194	8	(	(	PUNCT
aiua-9512	194	9	corresponding	correspond	VERB
aiua-9512	194	10	author	author	NOUN
aiua-9512	194	11	)	)	PUNCT
aiua-9512	195	1	lamprosmit@gmail.com	lamprosmit@gmail.com	PROPN
aiua-9512	195	2	roosevelt	roosevelt	PROPN
aiua-9512	195	3	61	61	NUM
aiua-9512	195	4	,	,	PUNCT
aiua-9512	195	5	41222	41222	NUM
aiua-9512	195	6	larissa	larissa	PROPN
aiua-9512	195	7	(	(	PUNCT
aiua-9512	195	8	greece	greece	PROPN
aiua-9512	195	9	)	)	PUNCT
aiua-9512	195	10	stavros	stavros	PROPN
aiua-9512	195	11	gravas	gravas	PROPN
aiua-9512	195	12	,	,	PUNCT
aiua-9512	195	13	md	md	PROPN
aiua-9512	195	14	,	,	PUNCT
aiua-9512	195	15	phd	phd	NOUN
aiua-9512	195	16	sgravas2002@yahoo.com	sgravas2002@yahoo.com	X
aiua-9512	196	1	ioannis	ioannis	PROPN
aiua-9512	196	2	zachos	zachos	PROPN
aiua-9512	196	3	,	,	PUNCT
aiua-9512	196	4	md	md	PROPN
aiua-9512	196	5	,	,	PUNCT
aiua-9512	196	6	phd	phd	PROPN
aiua-9512	196	7	johnbzac@yahoo.gr	johnbzac@yahoo.gr	PROPN
aiua-9512	196	8	anastasios	anastasio	VERB
aiua-9512	196	9	karatzas	karatzas	PROPN
aiua-9512	196	10	,	,	PUNCT
aiua-9512	196	11	md	md	PROPN
aiua-9512	196	12	,	,	PUNCT
aiua-9512	196	13	phd	phd	NOUN
aiua-9512	196	14	adkaratzas@yahoo.gr	adkaratzas@yahoo.gr	NOUN
aiua-9512	196	15	athanasios	athanasio	VERB
aiua-9512	196	16	oeconomou	oeconomou	ADV
aiua-9512	196	17	,	,	PUNCT
aiua-9512	196	18	md	md	PROPN
aiua-9512	196	19	thaoik@hotmail.com	thaoik@hotmail.com	PROPN
aiua-9512	196	20	vasilios	vasilio	VERB
aiua-9512	196	21	tzortzis	tzortzi	NOUN
aiua-9512	196	22	,	,	PUNCT
aiua-9512	196	23	md	md	PROPN
aiua-9512	196	24	,	,	PUNCT
aiua-9512	196	25	phd	phd	PROPN
aiua-9512	196	26	tzorvas@otenet.gr	tzorvas@otenet.gr	PROPN
aiua-9512	196	27	department	department	PROPN
aiua-9512	196	28	of	of	ADP
aiua-9512	196	29	urology	urology	NOUN
aiua-9512	196	30	,	,	PUNCT
aiua-9512	196	31	university	university	NOUN
aiua-9512	196	32	hospital	hospital	NOUN
aiua-9512	196	33	of	of	ADP
aiua-9512	196	34	larissa	larissa	PROPN
aiua-9512	196	35	,	,	PUNCT
aiua-9512	197	1	41110	41110	NUM
aiua-9512	197	2	larissa	larissa	PROPN
aiua-9512	197	3	(	(	PUNCT
aiua-9512	197	4	greece	greece	PROPN
aiua-9512	197	5	)	)	PUNCT
aiua-9512	197	6	foteini	foteini	PROPN
aiua-9512	197	7	karasavvidou	karasavvidou	PROPN
aiua-9512	197	8	,	,	PUNCT
aiua-9512	197	9	md	md	PROPN
aiua-9512	197	10	,	,	PUNCT
aiua-9512	197	11	phd	phd	NOUN
aiua-9512	197	12	fotkarasa@yahoo.gr	fotkarasa@yahoo.gr	PROPN
aiua-9512	197	13	georgios	georgios	PROPN
aiua-9512	197	14	koukoulis	koukouli	VERB
aiua-9512	197	15	,	,	PUNCT
aiua-9512	197	16	md	md	PROPN
aiua-9512	197	17	,	,	PUNCT
aiua-9512	197	18	phd	phd	PROPN
aiua-9512	197	19	kougeo@med.uth.gr	kougeo@med.uth.gr	PROPN
aiua-9512	197	20	department	department	PROPN
aiua-9512	197	21	of	of	ADP
aiua-9512	197	22	pathology	pathology	PROPN
aiua-9512	197	23	and	and	CCONJ
aiua-9512	197	24	cytology	cytology	NOUN
aiua-9512	197	25	,	,	PUNCT
aiua-9512	197	26	university	university	NOUN
aiua-9512	197	27	hospital	hospital	NOUN
aiua-9512	197	28	of	of	ADP
aiua-9512	197	29	larissa	larissa	PROPN
aiua-9512	197	30	,	,	PUNCT
aiua-9512	197	31	41110	41110	NUM
aiua-9512	197	32	larissa	larissa	PROPN
aiua-9512	197	33	(	(	PUNCT
aiua-9512	197	34	greece	greece	PROPN
aiua-9512	197	35	)	)	PUNCT
aiua-9512	197	36	christos	christos	PROPN
aiua-9512	197	37	papandreou	papandreou	PROPN
aiua-9512	197	38	,	,	PUNCT
aiua-9512	197	39	md	md	PROPN
aiua-9512	197	40	,	,	PUNCT
aiua-9512	197	41	phd	phd	PROPN
aiua-9512	197	42	cpapandreou@auth.gr	cpapandreou@auth.gr	PROPN
aiua-9512	197	43	department	department	PROPN
aiua-9512	197	44	of	of	ADP
aiua-9512	197	45	oncology	oncology	NOUN
aiua-9512	197	46	,	,	PUNCT
aiua-9512	197	47	n.papageorgiou	n.papageorgiou	ADJ
aiua-9512	197	48	hospital	hospital	NOUN
aiua-9512	197	49	of	of	ADP
aiua-9512	197	50	thessaloniki	thessaloniki	PROPN
aiua-9512	197	51	ring	ring	NOUN
aiua-9512	197	52	road	road	NOUN
aiua-9512	197	53	of	of	ADP
aiua-9512	197	54	thessaloniki	thessaloniki	PROPN
aiua-9512	197	55	,	,	PUNCT
aiua-9512	198	1	56	56	NUM
aiua-9512	198	2	403	403	NUM
aiua-9512	198	3	thessaloniki	thessaloniki	PROPN
aiua-9512	198	4	(	(	PUNCT
aiua-9512	198	5	greece	greece	PROPN
aiua-9512	198	6	)	)	PUNCT